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The purpose of this study was to examine the relationship 
among plasma levels of prostaglandin E2 (PGE2), leukotriene B4 
(LTB4), creatine kinase (CK), lactic acid (LA), and delayed-onset 
muscle soreness (DOMS) after an acute weight lifting bout involving 
eccentric contractions in order to determine if PGE2 and/or LTB4 
contribute to DOMS. Fourteen college males participated in this 
study. Nine subjects were randomly assigned to a group which 
performed a weight lifting bout involving the major muscle groups 
of the body. Five subjects served as non-exercising controls. Two 
weeks prior to the weight lifting session both groups were tested 
for their one-repetition maximum (1RM) on the exercises used in the 
workout. Two weeks after 1RM testing, subjects in the treatment 
group performed three sets of each exercise at an intensity of 70% 
of their 1RM to volitional failure. Venous blood samples and ratings 
of perceived muscle soreness were obtained before the workout, 
immediately after the workout, and every 24 hours after the 
workout for five days. Venous blood samples and ratings of 
perceived muscle soreness were obtained for the control group every 
24 hours for six days. 
A MANOVA and t-tests determined that there were no 
significant changes in any of variables from resting values in the 
control group over the 120-hour sampling period. After the workout 
DOMS was significantly elevated immediately after the workout, 
peaked 24 hours after the workout, and returned to baseline by 120 
hours. Plasma CK was significantly elevated after the workout, 
peaked 96 hours after the workout (1307.3 + 617.4 IU/L), and 
remained elevated thereafter. Plasma LA was elevated immediately 
after exercise (10.7 + 1.6 mM) and returned to baseline (1.3 + mM) by 
24 hours. Plasma PGEZ and LTB4 remained at baseline levels after 
exercise (51.4+ 15.8 pg/ml & 15.3 ± 3.4 pg/ml, respectively). These 
results suggest that plasma levels of PGE2 and LTB4 are not 
associated with DOMS resulting from a weight lifting bout involving 
eccentric contractions. 
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CHAPTER I 
THE PROBLEM 
Introduction 
Delayed onset muscle soreness (DOMS) is a tender, aching 
feeling in muscles that have undergone unaccustomed exercise. 
DOMS usually develops 24 hours after exercise, peaks 48-72 hours 
after exercise, and gradually diminishes in intensity until there is 
no more soreness or pain (Armstrong, 1984; Asmussen, 1956; Hough, 
1902). The sensation of DOMS may persist 4-7 days after exercise 
(Ebbeling & Clarkson, 1989). Eccentric activity often results in 
DOMS (Byrnes et al., 1985; Clarkson, Byrnes, McCormick, Turcotte & 
White, 1986; Friden, 1984) and can range in intensity from mild to 
severe, depending on the intensity and duration of the activity 
(Tiidus & lanuzzo, 1983). 
Increases in blood levels of creatine kinase (CK) have also been 
associated with DOMS and have been used as indicators of muscle 
damage (Armstrong, 1986; Byrnes et al., 1985; Clarkson, Byrnes, 
Gillisson & Harper, 1987; Clarkson et al., 1986; Evans et al., 1986; 
Manfredi et al., 1991; Maughan et al., 1989; Tiidus & lanuzzo, 1983). 
The time course of changes in CK in the blood can vary, depending on 
the type of exercise, duration, and intensity (Hortobagyi & Denahan, 
1989). Eccentric contractions appear to be particularly effective in 
elevating blood CK values (Ebbeling & Clarkson, 1989). Activities 
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such as downhill running appear to result in peak plasma levels of 
CK 18 to 24 hours after exercise (Byrnes et al., 1985). Peak values 
of CK in plasma appear to be delayed in activities involving intense, 
eccentric muscular activity, with peak values not occuring until 48-
120 hours after exercise (Clarkson & Tremblay, 1988; Jones, 
Newham, Round & Tolfree, 1986; Newham, Jones & Edwards, 1986). 
Although increases in CK and DOMS are both associated with 
unaccustomed exercise, the time course of DOMS does not coincide 
with the changes in blood CK levels (Ebbeling & Clarkson, 1989; 
Newham et al., 1986). Therefore, the elevation of blood CK levels 
and the generation of DOMS may be caused by different mechanisms 
(Ebbeling & Clarkson, 1989; Evans & Cannon, 1991). 
The idea that DOMS results from an accumulation of lactic acid 
has been a popular explanation for DOMS within the exercise 
community (Ebbeling & Clarkson, 1989). This hypothesis does not 
seem plausible, since, eccentric contractions involve less energy 
expenditure than other types of contractions (Abbott, Bigland & 
Ritchie, 1952; Armstrong, Laughlin, Rome & Taylor, 1983; Asmussen, 
1953; Bonde-Peterson, Knuttgen & Henriksson, 1972). Furthermore, 
Schwane, Watrous, Johnson & Armstrong (1983) found that downhill 
running involved significantly lower rates of oxygen consumption 
and resulted in lower levels of lactic acid, but produced more severe 
DOMS. 
Presently, the mechanism of DOMS has not been identified 
(Armstrong, 1984; Ebbeling & Clarkson, 1989; Smith, 1992). Several 
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theories have been proposed to explain DOMS (Ebbeling & Clarkson, 
1989). One theory which is currently being explored is that the acute 
inflammatory response underlies DOMS (Hikida, Staron, Hagernam, 
Sherman & Costill, 1983; Kuipers, Drukker, Frederik, Geurten & 
Kranenburg, 1983; Smith, 1991; Stauber, 1989). Similarities 
between DOMS and the acute inflammatory response have been 
observed (Armstrong, 1984; Armstrong, 1986; Armstrong, Ogilvie & 
Schwane, 1983; Cannon et al., 1989b; Castor, 1981; Colley, Fleck, 
Goode, Muller & Myers, 1983; Doherty, Downey, Worthen, Haslett & 
Henson, 1988; Friden, Sjostrom & Ekblom, 1983; Janoff & Carp, 
1982; Kasperek & Snider, 1985; Newham, McPhail, Mills & Edwards, 
1983; Ryan & Majno, 1977). This acute inflammatory response may 
produce a series of local and systemic events, including DOMS, which 
serve to repair exercise-induced tissue damage and protect from 
further injury (Evans & Cannon, 1991; Stauber, 1989; Stauber, 
Clarkson, Fritz & Evans, 1990). 
The products of the inflammatory process which are similar in 
characteristics to DOMS are pain and hyperalgesia (Bennett, 1988; 
Ebbeling & Clarkson, 1989; Smith, 1991; Taiwo, Goetzl & Levine, 
1987; Tidball, 1991). The generation of pain due to inflammation is 
usually associated with III and IV pain afferents (Martin, Basbaum, 
Kwiat, Goetzl & Levine, 1987; Mense, 1977; Mense & Schmidt, 1977). 
These pain afferents are slow conducting nerve fibers which respond 
to noxious stimuli and have a high threshold for mechanical 
stimulation (Mense, 1981; Mense, 1982). They are primarily 
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distributed in the connective tissue surrounding muscle fibers and 
are especially concentrated around arterioles and capillaries (Mense, 
1977). A large number of pain afferents can also be found at the 
myotendinous junctions (Tidball, 1991). These afferent fibers 
respond to chemical, mechanical, and thermal stimuli (Fock & Mense, 
1976; Martin et al., 1987). In addition, there are a number of 
inflammatory mediators which can lower the pain threshold or 
increase pain sensitivity resulting from activation of these pain 
afferents by noxious stimuli (Martin et al., 1987; Mense, 1981; 
Taiwo et al., 1987). These include: bradykinin, norepinephrine, and 
products of arachidonic acid metabolism (Madison, Whitsel, Suarez-
Roca & Maixner, 1992; Martin et al., 1987; Mense, 1981; Taiwo et al., 
1987). 
A paucity of research exists regarding inflammatory mediators 
and DOMS. One group of inflammatory mediators which may be 
associated with the generation of DOMS are products of arachidonic 
metabolism. Products of arachidonic metabolism are formed by a 
cascade of reactions which result in the production of arachidonic 
acid metabolites, namely, prostanoids and leukotrienes. To initiate 
this cascade of reactions phospholipid membranes are acted upon by 
the enzyme phospholipase A2. A schematic diagram of the 
conversion of arachadonic acid to prostaglandins and thromboxanes 
via the cyclooxygenase pathway and leukotrienes via the 
lipoxygenase pathway is presented in Figure 1. Two of the products 
of arachidonic acid metabolism-prostaglandins and leukotrienes may 
5 
be involved in the sensation of DOMS, due to their ability to increase 
the sensitivity of pain afferents to chemical, thermal, and 
mechanical stimuli (Bennett, 1988; Ford-Hutchinson & Letts, 1986; 
Martin et al., 1987; Mense, 1981). Recent research has indicated 
that increased prostaglandin synthesis and release may accompany 
DOMS (Bansil, 1984; Smith et al., 1993; Wells, 1991). 
Eccentric contractions have been associated with the 
generation of DOMS (Asmussen, 1953; Clarkson et al., 1986; Friden 
et al., 1983; Newham, Mills, Qugley & Edwards, 1983). Products of 
arachidonic acid metabolism may be associated with the generation 
of DOMS, since muscle fibers which are subjected to eccentric 
contractions may disrupt sarcolemmal and myofibrillar elements 
(Armstrong, 1990). This may allow phospholipase A2 to activate the 
phospholipid elements of the muscle fiber (Armstrong, 1990). 
Eccentric contractions have been shown to result in damage to 
skeletal muscle fibers, as indicated by myofibrillar and 
sarcolemmal disturbances in animals (Armstrong et al., 1983), and 
humans (Evans et al., 1986; Friden et al.,1983; Sjostrom & Ekblom, 
1981; Jones et al., 1986; McCully & Faulkner, 1985). 
Connective tissue disruption has also been associated with 
DOMS (Abraham, 1977; Stauber et al., 1990; Tidball, 1991). 
Disruption of connective tissue associated with contractile 
elements may accompany muscle damage resulting from eccentric 
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Figure 1. Conversion of arachidonic acid to leukotrienes, 
prostaglandins, and thromboxanes. 
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exercise (Friden et al., 1983; Friden et al., 1981; Fritz & Stauber, 
1988; Stauber et al., 1990) This disruption of connective tissue 
could result in the migration of inflammatory cells, primarily 
monocytes, into the damaged area (Postlethwaite & Kang, 1976). 
Armstrong has suggested that arachidonic acid metabolism 
during and immediately after exercise may serve as an important 
autogenic mechanism in muscle fiber injury (Armstrong, Warren & 
Warren, 1991). Therefore, arachidonic acid metabolites may play a 
role in the response to muscle fiber and connective tissue damage 
due to exercise, resulting in a number of responses, including DOMS. 
Two products of arachidonic acid metabolism that are 
commonly associated with hyperalgesia are prostaglandin E2 (PGE2) 
and leukotriene B4 (LTB4) (Ferreira, 1972; Ferreira, Moncada & Vane, 
1974; Levine, Gooding, Donati, Borden & Goetzl, 1985; Madison et al., 
1992; Martin et al., 1987; Rackham & Ford-Hutchinson, 1983; Soter, 
Lewis, Corey & Austen, 1983; Taiwo et al., 1987). These substances 
can be produced by virtually all inflammatory cell types, with the 
exception of lymphocytes (Moore, 1985). Of all the types of cells 
associated with the acute inflammatory response, the macrophage is 
considered to play a primary role in wound healing, with macrophage 
levels peaking 24 to 48 hours after tissue injury (Hurley, 1983; 
Peacock, 1983; Ryan & Majno, 1977). Additionally, the macrophage 
appears to be the predominant cell type at the injury site resulting 
from eccentric activity (Armstrong, 1984; Jones et al., 1986; Round, 
Jones & Cambridge, 1987; Tullson & Armstrong, 1981). Macrophages 
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play an important role in the production of prostaglandins during the 
inflammatory response (Ferraris, DeRubertis, Hudson & Wolfe, 1974; 
Goldyne & Stobo, 1979; Kennedy, Stobo & Goldyne, 1980; Kurland & 
Bockman, 1978; Morley, Bray, Jones, Nugteren & VanDorp, 1979). In 
addition, macrophages are also responsible for the production of 
leukotrienes during the acute inflammatory response (Neill, 
Henderson & Klebanoff, 1985; Williams, Czop & Austen, 1984). In 
both instances macrophage concentrations appear to peak between 
24 to 48 hours. Macrophages synthesize and release leukotrienes 
during the inflammatory process (Neill et al., 1985; Williams et al., 
1984). Therefore, release of prostaglandins and leukotrienes 
may exhibit a time course similar to DOMS. This suggests a possible 
relationship between these arachidonic acid metabolites and DOMS. 
There are several other cell types involved in acute 
inflammation and the wound healing process which are capable of 
producing leukotrienes and prostaglandins (Lefer, 1985; Moore, 
1985). Fibroblasts infiltrate areas of tissue injury and are involved 
in deposition of collagen and other substances associated with 
connective tissue (Dayer, Roelke & Krane, 1981; Koun, Halushka & 
LeRoy, 1980). Infiltration by fibroblasts has been found in rat 
muscle tissue following downhill running, a predominately eccentric 
activity (Armstrong et al., 1983; Tullson & Armstrong, 1981). 
Infiltration of injured tissue by neutrophils occurs early in 
the inflammatory process, with a life span of only one to two days 
(Bainton, 1988). A similar neutrophil response has also been 
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observed with exercise, with increases in circulating neutrophils 
occuring during (Steel, Evans & Smith, 1974) and for several hours 
after exercise (Cannon et al., 1990; Smith, McCammon, Smith, 
Chamness & O'Brien, 1989). Neutrophil infiltration of muscle tissue 
has been observed immediately and two hours after exercise 
(Kuipers et al., 1983). 
Mast cells are also involved in the inflammatory process 
(Peters et al., 1987). Eccentric exercise has been shown to result in 
mast cell degranulation 48 hours after exercise in association with 
a disruption of the extracellular matrix surrounding skeletal muscle 
(Stauber et al., 1990). 
Although products of arachidonic acid metabolism appear to be 
likely candidates for playing a role in the manifestation of DOMS, 
currently only prostaglandins of the E series have been associated 
with DOMS. Bansil, et al. (1984 ) found a similar time course for 
increases in plasma PGEi after eccentric exercise, indicating a 
possible relationship between these variables. 
Smith and co-workers (Smith et al., 1993) found significant 
increases in plasma PGE2 48 hours after peformance of the eccentric 
phase of a chest press exercise which resulted in DOMS. On the 
other hand, Wells (1991) found that performance of the eccentric 
phase of a chest press exercise did not result in increases in plasma 
PGE2. Instead, plasma PGE2 levels decreased 96 hours after exercise. 
Based on current research, the relationship between DOMS and PGE2 
has not been established. 
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The possibility exists that products of arachidonic acid 
metabolism other than PGE2 are involved in DOMS. Leukotriene B4 is 
the leukotriene most associated with the production of hyperalgesia 
(Levine, Lau, Kwiat & Goetzl, 1984; Martin, 1990; Martin, Basbaum, 
Goetzl & Levine, 1988; Rackham & Ford-Hutchinson, 1983), and 
therefore, may be involved in the generation of DOMS. The 
relationship between DOMS and LTB4 has not been investigated. 
However, a wide range of inflammatory mediators are capable 
of synthesizing and releasing LTB4. Muscle fiber or connective 
tissue damage caused by eccentric exercise may result in increased 
synthesis and release of LTB4. 
PGE2 and LTB4 may play a role in the generation of DOMS by 
sensitizing type III and type IV pain afferents associated with areas 
of tissue damage to noxious stimuli. Under these conditions the pain 
receptors may be more susceptible to mechanical or chemical 
stimuli than which would occur normally (Davies, Bailey & 
Goldenberg, 1984; Juan, 1978; Levine et al., 1984; Martin, 1990; 
Martin et al., 1988; Mense, 1981; Taiwo et al., 1987). Chemical 
substances associated with the inflammatory process involving 
connective tissue and muscle tissue degeneration and repair may 
then stimulate these pain afferents, resulting in the sensation of 
pain (Fock & Mense, 1976; Mense, 1981; Stauber, 1989; Stauber et 
al., 1990; Taiwo et al., 1987). DOMS is usually experienced during 
contraction or palpatation of the affected muscle (Armstrong, 
1984). It has been suggested by Smith (Smith, 1991) that a low 
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level of edema may be associated with DOMS. Therefore, during 
muscular contraction small increases in pressure may occur which 
might provide a mechanical stimulus for sensitized pain receptors. 
Hence, in addition to chemical stimulation, III and IV pain afferents 
may be stimulated by mechanical input when sensitized by PGE2 and 
LTB4. Thus, it can be proposed that DOMS results from sensitization 
of pain receptors by either PGE2, LTB4, or both arachidonic acid 
metabolites which are stimulated by chemical and mechanical 
stimuli. 
Statement of the Problem 
The purpose of this study is to examine the relationship of 
plasma levels of PGE2, LTB4, CK, lactic acid, and DOMS over 120-
hours after an acute weight lifting bout involving eccentric 
contractions in order to determine if PGE2 and/or LTB4 are 
contributing factors in the process of DOMS. The response of plasma 
lactic acid to the weight lifting bout will be examined in order to 
estblish that the weight lifting bout elicits responses which are 
typical of heavy resistance exercise protocols. The plasma CK 
response to the weight lifting bout will be examined in order to 
establish that the weight lifting bout provides the plasma CK 
response which is typically associated with exercise which results 
in DOMS. 
Hypotheses 
An acute weight lifting bout to exhaustion which involves all 
the major muscle groups of the body will cause delayed onset 
muscle soreness. The resulting soreness should also be accompanied 
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by increases in plasma creatine kinase values. Increases in plasma 
lactic acid should also be seen immediately after the weight lifting 
bout. Plasma lactic acid should return to baseline values by 24 
hours after exercise. 
It has been suggested that increased levels of certain 
inflammatory mediators may play a role in the generation of DOMS. 
Therefore, similar increases in the inflammatory mediators PGE2 and 
LTB4 and DOMS over time may indicate a relationship among these 
variables. The following hypotheses will be tested in this study: 
1. The acute weight lifting bout will result in the 
manifestation of DOMS with a time course similar to that which has 
been documented in the literature. 
2. The acute weight lifting bout will result in an increase in 
plasma lactic acid values immediately after exercise, and will 
return to resting values by 24 hours after exercise. 
3. The acute weight lifting bout will result in elevated plasma 
creatine kinase levels which will peak 48-120 hours after the acute 
weight lifting bout. 
4. The acute weight lifting bout will result in increases in 
plasma levels of PGE2 which will exhibit a time course similar to 
that of DOMS over the 120-hour time period. 
5. The acute weight lifting bout will result in increases in 
plasma levels of LTB4 which will exhibit a time course similar to 
that of DOMS over the 120-hour time period. 
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6. Plasma levels of PGE2 and DOMS will be significantly 
correlated before and immediately after the weight lifting bout, as 
well as 24 hours, 48 hours, 72 hours, 96 hours, and 120 hours after 
the weight lifting bout. 
7. Plasma levels of LTB4 and DOMS will be significantly 
correlated before and immediately after the weight lifting bout, as 
well as 24 hours, 48 hours, 72 hours, 96 hours, and 120 hours after 
the weight lifting bout. 
Delimitations 
1. The subjects will be sedentary college-aged males who will 
be instructed to refrain from exercise prior to and during the study. 
2. The subjects will be instructed to fast for four hours prior 
to the collection of blood samples. 
Limitations 
1. It must be assumed that each subject is attempting to 
perform maximally during the weight lifting sessions. 
2. Muscle soreness will be assessed by having each subject 
rate muscle soreness on a subjective scale. 
Significance of the Study 
The results of this investigation will help determine if plasma 
PGE2, plasma LTB4, are related to the generation of DOMS following 
an intense weight lifting bout. This will help determine if PGEZ and 
LTB4 are contributing factors in the process of DOMS resulting from 
exercise which is associated with muscle damage. 
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Plasma levels of PGE2 associated with exercise have shown a 
great deal of variability in the current literature. Furthermore, 
plasma levels of LTB4 in association with exercise have not been 
established. Therefore, this study provides further information 
which will help establish an accurate range of values for plasma 
LTB4 and PGE2 associated with exercise. 
Definition of Terms 
1. Delayed onset muscle soreness (DOMSV the dull, aching pain 
which is accompanied by muscular tenderness and stiffness. DOMS 
usually develops 24-48 hours after exercise and gradually increases 
in severity, usually peaking 24-72 hours after exercise. DOMS is 
usually associated with eccentric muscle contractions. 
2. Creatine Kinase- the enzyme in muscle responsible for the 
formation of ATP from the reaction of ADP and creatine phosphate. 
The release of CK into the blood is associated with alterations in 
the muscle cell membrane. 
3. Prostaglandin Eg/PGEgVan unsaturated lipid made from 
fatty acid precursors which belongs to the E series of prostanoids. 
PGE2 acts locally as a tissue hormone and has a wide variety of 
actions including: vasodilation of capillaries, increases in vascular 
permeability, sensitization of afferent pain receptors, and 
mediation of immune functions. 
4. Leukotriene Ba (LTB^I-a member of the leukotriene family 
formed via the lipoxygenase pathway from arachidonic acid which 
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induces leukocyte accumulation, affects vascular permeability and 
modulates pain responses. 
5. Eccentric contraction-a contraction in which the muscle 
lengthens while developing tension against an external resistance 
which exceeds the force generated by the muscle. 
6. Concentric contraction-a contraction in which the muscle 
shortens as it develops the tension necessary to overcome an 
external resistance. 
7. Repetition- The number of consecutive times a particular 
movement or exercise is performed. 
8. Set-the number of groups of repetitions of a particular 
movement or exercise. 
9. One repetition maximum (IRMVthe most resistance which can be 
overcome in a particular exercise for one repetition. 
Abbreviations 
CK: creatine kinase 
DOMS: delayed-onset muscle soreness 
IL-1: interleukin-1 
LTB4: leukotriene B4 
MTJ: myotendinous junction 
NSAIDS: non-steroidal anti-inflammatory drugs 
PGE2: prostaglandin E2 
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CHAPTER II 
REVIEW OF LITERATURE 
Introduction 
The purpose of this study was to examine the time course 
relationship of PGE2, LTB4, and DOMS resulting from an intense 
weight lifting bout. The literature review will be organized under 
the following headings: Theories of Delayed-Onset Muscle Soreness, 
Muscle Tissue and Connective Tissue Damage and DOMS, 
Inflammation and DOMS, Prostaglandin E2 and DOMS, Leukotriene B4 
and DOMS, and Summary. 
Theories of Delayed-Onset Muscle Soreness 
Muscle soreness can result from strenuous or unaccustomed 
exercise. Muscle soreness can occur during or immediately after 
exercise, as well as 24-72 hours after exercise. These two types of 
soreness have been classified as temporary and delayed muscle 
soreness, respectively (Talag, 1973). Temporary muscle soreness 
can occur during exercise and persist for several hours after 
exercise. It is thought that this type of soreness results from the 
accumulation of metabolic end-products which affect local pain 
afferents and contribute to tissue edema (Asmussen, 1956; 
Brendstrup, 1962; Hough, 1902). 
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The sensation of pain associated with delayed-onset muscle 
soreness usually starts 24 hours after exercise, peaking 24-48 
hours after exercise, and may persist for several days (Armstrong, 
1984; Ebbeling & Clarkson, 1989; Friden, 1984). DOMS has been 
primarily associated with eccentric contractions (Byrnes, 1985; 
Byrnes et al., 1985; Clarkson et al., 1987; Clarkson et al., 1986; 
Clarkson & Tremblay, 1988; Cote, 1988; Davies & Barnes, 1972; 
Ebbeling & Clarkson, 1989; Newham, Jones & Clarkson, 1987; 
Newham et al., 1986; Newham et al., 1983). The cause of DOMS has 
not yet been determined. Three primary factors have been suggested 
as causal agents of DOMS (Armstrong, 1984; Ebbeling & Clarkson, 
1989; McArdle, Katch & Katch, 1991). These factors include: 1) torn 
muscle tissue or connective tissue resulting from high contractile 
tension; 2) accumulation of metabolic waste products from muscle 
contraction; 3) muscle spasms produced by altered neural activation 
resulting from increases in contractile tension. 
The idea that muscle spasms promoted DOMS was originaly 
proposed by Travell, Rinzler & Herman (1942). This theory of 
soreness suggests that muscle pain resulting from increased 
contractile activity causes or promotes a positive feedback cycle 
which leads to tonic muscular spasm (DeVries, 1980). This spasm 
may then cause further pain through the production of local ischemia 
(DeVries, 1980). In support of this theory, DeVries and co-workers 
have reported increases in electromyographic (EMG) activity in sore 
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muscles (Cobb, DeVries, Urban, Luekens & Bagg, 1975; DeVries, 
1960; DeVries, 1966; DeVries, 1968). 
In contrast, McGlynn, Laughlin & Rowe (1979) reported 
increases in EMG activity in muscle, but the magnititude of these 
increases were not related to the perception of soreness. In 
addition, other researchers have not observed increases in EMG 
activity in sore muscles (Abraham, 1977; Newham et al., 1983). 
The accumulation of metabolic metabolites, primarily lactic 
acid, have been suggested to cause DOMS. DOMS is primarily 
associated with eccentric contractions (Clarkson et al., 1986; Talag, 
1973), which have a lower metabolic cost than concentric 
contractions at the same power output (Armstrong et al., 1983; 
Bonde-Peterson et al., 1972). Therefore, eccentric contractions 
should result in a lesser accumulation of lactic acid than concentric 
contractions at the same power output. 
Schwane et al. (1983) examined the relationship between blood 
lactic acid levels and DOMS following downhill and level running in 
humans. The downhill running resulted in DOMS which was not 
accompanied by significant increases in plasma lactic acid. 
Conversly, subjects running only on a level surface demonstrated 
significant increases in plasma lactic acid without experiencing 
DOMS. 
Kuipers et al. (1983) reported that rats running on a treadmill 
at a low intensity demonstrated indications of muscle damage 
without an elevation in plasma lactic acid values. The findings of 
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Kuipers et al. further support the contention that DOMS does not 
result from an accumulation of lactic acid. 
Muscle Tissue and Connective Tissue Damage and POMS 
The idea that a disruption in the myofibrillar elements is 
responsible for DOMS was first proposed by Hough in 1902 (Hough, 
1902). Subsequently, the theory that DOMS results from muscle 
tissue and/or connective damage has gained considerable support 
(Armstrong, 1984; Brooks & Fahey, 1985; Ebbeling & Clarkson, 1989). 
As previously noted, DOMS is primarily associated with eccentric 
contractions. These eccentric contractions have been shown to 
result in considerable damage to muscle fibers in both animal 
(Armstrong et al., 1983; Kuipers et al., 1983; McCully & Faulkner, 
1985; Ogilvie, Armstrong, Baird & Bottoms, 1988) and human studies 
(Friden, 1984; Friden et al., 1983; Friden et al., 1981; Jones et al., 
1986; Manfredi et al., 1991; Newham et al., 1983; O'Reilly et al., 
1987). In rodents, disruption of myofibrillar banding patterns and 
sarcolemmal disruption, as well as fiber degeneration has been 
demonstrated immediately after eccentric contractions (Armstrong 
et al., 1983; McCully & Faulkner, 1985). At 24 hours after eccentric 
contraction, increases in the size of necrotic lesions in muscle 
fibers were observed (Armstrong et al., 1983; McCully & Faulkner, 
1985). These necrotic lesions appeared to peak in size at 48 hours 
(Armstrong et al., 1983; McCully & Faulkner, 1985). Infiltration by 
monocytes, macrophages, and fibroblasts were also noted at 24 
hours by Armstrong et al. (1983). 
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Similar types of muscle fiber damage have also been reported 
in humans. Myofibrillar disruption, which includes focal damage, 
disruption and streaming of the Z-band, and distribution of Z-line 
material througout the fiber has been observed in muscle biopsies 
taken immediately after eccentric exercise (Friden et al., 1983; 
Manfredi et al., 1991; Newham et al., 1983; O'Reilly et al., 1987). 
Disruption of the sarcoplasmic reticulum, as well as evidence of 
mitochondrial damage has also been reported in severly damaged 
fibers immediately after eccentric exercise (Manfredi et al., 1991). 
This damage appeared to become more extensive over the next 2-3 
days, with increases in size of the focal areas of muscle damage and 
increased Z-band disruption (Friden et al., 1983; Friden et al., 1981; 
Newham et al., 1983). Some researchers have indicated that this 
type of muscle damage can take approximately 10 days to repair 
(Newham, 1988). O'Reilly et al. (1987) and Manfredi et al. (1991) 
reported the presence of muscle fiber damage in muscle biopsies 10 
days after eccentric exercise. Although it appears that this muscle 
fiber damage is related to the generation of DOMS, the mechanism by 
which this muscle damage contributes to DOMS is not understood 
(Armstrong, 1984; Newham, 1988). 
It has been demonstrated that eccentric contractions resulting 
in DOMS are also responsible for increases in plasma CK values 
(Byrnes et al., 1985; Clarkson et al., 1986; Clarkson & Tremblay, 
1988; Maughan et al., 1989; Newham et al., 1986). Hence, increases 
in plasma values of CK have been used as an indirect indicator of 
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muscle damage (Armstrong, 1984; Evans et al., 1986; Schwane, 
Johnson, Vandenakker & Armstrong, 1983). It has been established 
that the magnitude and time course for increases in plasma CK 
depends on the type of exercise performed, as well as the intensity 
and duration of the exercise (Ebbeling & Clarkson, 1989; Tiidus & 
lanuzzo, 1983). Byrnes et al. (1985) and Schwane et al. (1983) 
reported significant increases in plasma CK approximately six hours 
after exercise, with plasma CK levels peaking around 24 hours after 
exercise. 
Other types of eccentric activities have resulted in peak 
increases in plasma CK which have occurred later than 24 hours 
after exercise. Newham et al. (1986) reported peak levels of plasma 
CK in subjects 4-7 days after downhill walking on a treadmill 
inclined at 13°. Similar results were obtained by Evans et al. (1986) 
using subjects who exercised on a cycle ergometer designed for 
eccentric leg exercise. Plasma CK values were elevated three hours 
after exercise and peaked 3-5 days later. Clarkson & Tremblay, 
(1988) had subjects perform 70 repetitions using eccentric 
exercises involving the forearm flexors. This exercise protocol 
resulted in significant increases in plasma CK levels which 
persisted five days after exercise. 
The time course of CK increases in plasma has also been 
investigated using a regimen of high-intensity weight lifting 
contractions. Paul, DeLany, Snook, Seifert & Kirby (1989) examined 
the effect of a high-intensity weight lifting bout on serum and 
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urinary markers of skeletal muscle damage in trained and untrained 
weight lifters. Subjects performed three sets of repetitions to 
fatigue using 70-80% of their 1RM on the bench press, shoulder 
press, latissiumus pulldown, arm curl, leg press and leg curl. All of 
the exercises were performed on Universal Gym Equipment. One 
minute of rest was provided between sets, and two minutes of rest 
were utilized between exercises. Significantly elevated levels of 
serum CK were observed 12 hours after exercise, with higher values 
obtained after 24 hours. Serum CK values were not obtained after 
24 hours by the investigators. 
In order to examine the relationship between indicators of 
muscle damage over a longer period of time than that which was 
used by Paul et al. (1989), Boyer, Lewis & Goldfarb (1991) examined 
the effect of a high-intensity weight lifting bout on DOMS, plasma 
CK, and plasma malondialdehyde over a 72-hour time period. 
Subjects performed three sets of repetitions to volitional 
exhaustion on the following free weight exercises: bench press, 
triceps pushdowns, military press, barbell curl, and reverse-grip 
curl. The exercises were performed at 70% of the subject's 1RM. 
The subjects were allowed to rest two minutes between each set of 
each exercise. The investigators reported that despite a trend 
toward increasing CK values 24 hours after exercise, significant 
increases in plasma CK were not observed until 72 hours after 
exercise. Unlike plasma CK values, muscle soreness was 
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significantly increased from baseline values 24 and 48 hours after 
exercise, with muscle soreness peaking 48 hours after exercise. 
Connective tissue damage has also been purported to play a 
role in the generation of DOMS. The pain associated with DOMS is 
usually experienced in the areas around the musculotendinous 
junctions (Asmussen, 1956; Komi & Buskirk, 1972; Komi & Rusko, 
1974; Newham et al., 1983). The manifestation of pain in areas 
where connective tissue is most abundant led Asmussen (1956) to 
hypothesize that DOMS was caused by over-stretching of the series 
elastic components of muscle tissue. However, Newham (1988) has 
suggested that the localisation of pain may be dependent on the 
intensity, duration, and type of eccentric contraction performed. 
Abraham (1977) concluded that exercise-induced damage to 
connective tissue elements associated with muscle was responsible 
for soreness. Abraham found an increased hydroxyproline/creatinine 
ratio in urine collected througout the day subjects experienced peak 
soreness. Since hydroxyproline is a unique breakdown product of 
connective tissue (Kivirikko, 1970), this suggests connective tissue 
breakdown occurs concomitantly with peak soreness. 
Work by Stauber et al. (1990) has also suggested that 
connective tissue disruption is associated with eccentric muscle 
action. Stauber et al. found chondroitin 6-sulfate proteoglycan 
localization in the endomysial area around muscle fibers 48 hours 
after 70 maximal eccentric contractions of the elbow flexors. 
Proteoglycans are important components of the extracellular matrix 
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associated with connective tissue, and, hence, their degradation 
serve as indicators of extracellular matrix and connective tissue 
disruption (Stauber et al., 1990). Similar findings were reported by 
Fritz & Stauber (1988) in rat muscles subjected to forced 
lengthening. Histological disruption of the proteoglycan complex 
was evident in damaged muscle fibers by 24 hours. 
Direct evidence that connective tissue disruption occurs as a 
result of mechanical stress has not been documented. Therefore, 
studies examining connective tissue disruption have been limited to 
examination of products of connective tissue and proteoglycan 
breakdown (Abraham, 1977; Fritz & Stauber, 1988; Stauber, 1989; 
Stauber et al., 1990). Because the time course of DOMS and muscle 
fiber damage resulting from eccentric exercise are not comparable, 
Stauber and co-workers have suggested that connective tissue and 
extracellular matrix may be associated with DOMS, since it appears 
that the time course of this disruption more closely resemble that 
of DOMS (Fritz & Stauber, 1988; Stauber, 1989; Stauber et al., 1990). 
As previously described, the myotendinous junction (MTJ) is an 
area which muscle soreness is usually experienced. The MTJs are 
interfaces between tendons and muscles and are sites of force 
transmission resulting from contraction of contractile elements 
(Tidball, 1991). The structure of MTJ is complex and appears to 
consist of myofibirils which terminate into a dense material which 
is attached to the cell membrane via structural proteins (Tidball, 
1991). The muscle cell is associated with the extracellular matrix 
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via structural proteins. Components of the extracelluar matrix 
involved in the MTJ include proteoglycans and a wide variety of 
other structural molecules. 
There appears to be an association between both muscle and 
connective tissue damage at the MTJ and DOMS. MTJs are thought to 
be primary sites of lesions associated with muscle fiber tears 
(Garrett & Tidball, 1988). Tidball (1991) has suggested that damage 
to MTJ may be involved in the generation of DOMS. Eccentric loading 
resulting in incomplete tears has been shown to result in edema and 
inflammation at the MTJ from rats, indicating a possible underlying 
mechanism for DOMS (Almekinders & Gilbert, 1986). The time 
course of morphological changes resulting from partial tears at the 
MTJ also appears to be similar to that of DOMS. Initial insults at the 
MTJ are followed by an inflammatory response for the next 1-4 days 
(Almekinders & Gilbert, 1986; Garrett & Tidball, 1988), with muscle 
repair occuring at four days following injury (Almekinders & Gilbert, 
1986). Thus, repair of damage at MTJs seems to follow a time 
course similar to the disappearance of DOMS. 
Although it is widely believed that tissue damage is 
associated with DOMS, the mechanism by which this damage results 
in the generation of DOMS is presently not known. One theory which 
has been suggested is that muscle edema is responsible for 
producing DOMS (Friden, Sfakianos & Hargens, 1986; Howell, Chila, 
Ford, David & Gates, 1985; McArdle et al., 1991). Friden (1984) 
suggested that as a result of myofibrillar damage, degraded protein 
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compounds and protein-bound ions are released (Friden, 1984; 
Salminen & Vihko, 1983). This would effect an increase in osmotic 
pressure, causing fluid to build up. This subsequent increase in fluid 
pressure could then activiate nocioceptors located in areas where 
connective tissue and the contractile components meet (Mense & 
Schmidt, 1974), resulting in soreness (Friden, Sfakianos, Hargens & 
Akeson, 1988). Friden et al. (1988) examined intramuscular 
pressure and morphological changes which occur after eccentric 
exercise and concluded that muscle fiber swelling following 
eccentric exercise was associated with DOMS. Eccentric 
contractions involving the anterior tibialis muscle resulted in 
increases in size of type II muscle fibers after exercise in some 
subjects. In addition, this increase in size was significantly 
correlated with the length of time needed to return to resting 
pressure. The eccentrically stressed muscles exhibited increased 
water content as compared to resting values. No muscle fiber 
necrosis or significant signs of inflammation were observed in 
eccentrically stressed muscle tissue. 
Other studies have been undertaken to establish if there is a 
relationship between DOMS and edema. Bobbert, Hollander & Huijing 
(1986) found increases in limb volume relative to controls 48 and 72 
hours after eccentric calf exercise. Friden et al. (1986) found fluid 
pressure in the anterior tibial compartment of the leg increased 48 
hours after exercise, when DOMS usually peaks. 
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In contrast, Talag (Talag, 1973) failed to find a significant 
correlation between limb volume and DOMS following eccentric 
contractions of the forearm flexors. Furthermore, Newham (1988) 
found no significant increases in intramuscular pressure of the 
elbow flexor compartment after eccentric contraction. Newham 
hypothesized these results may have been obtained because the 
compartment around the elbow flexors is more distensible than the 
tibialis anterior compartment, which has been shown to demonstrate 
increases in intramuscular pressure after eccentric contractions 
(Friden et al., 1986). Based on these studies it appears that the 
research regarding the relationship between DOMS and edema is 
equivocal and further research is necessary. 
Another theory explaining the generation of DOMS from tissue 
damage resulting from eccentric loading is that acute inflammation 
underlies DOMS (Brooks & Fahey, 1985; Evans & Cannon, 1991; Smith, 
1991; Smith, 1992; Stauber, 1989). The association between DOMS 
and acute inflammation will be examined in the following 
discussion. 
Acute Inflammation and DOMS 
The inflammatory response is a series of events which 
represents the body's ability to defend against infection and promote 
the healing of tissue damage. This inflammatory response serves to 
provide plasma and cellular infiltrates to extravascular tissue, as 
well as play a role in the clearance and repair of damaged tissues 
(Evans & Cannon, 1991; Sell, 1987). Inflammation initiated by 
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trauma or tissue necrosis can be characterized by the following 
phases (Sell, 1987): 1) immediate vasoconstriction followed by 
vasodilation resulting in increased blood flow to the damaged area 
and, subsequently, edema, 2) infiltration of neutrophils into damaged 
tissue, 3) tissue infiltration by mononuclear cells 
(lymphocytes,macrophages), 4) clearing and repair of damaged tissue 
or fibroblastic cell proliferation when there is significant tissue 
loss. The classic signs of inflammation include: redness, swelling, 
calor, pain, and loss of function. Because physiological changes 
associated with DOMS are similar to some of the classic signs of 
inflammation, the two phenomena have been linked (Brendstrup, 
1962; Smith, 1991). 
Because the acute inflammatory response results in a series of 
events which have been observed following eccentrically-induced 
muscle contraction and connective tissue damage, some researchers 
have associated DOMS with the acute inflammatory response 
(Armstrong, 1984; Armstrong et al., 1983; Brooks & Fahey, 1985; 
Hikida et al., 1983; Kuipers, Drukker, Frederiks, P.Geurten & 
Kranenburg, 1983). A number of studies involving both animals and 
humans have associated an acute inflammatory response with 
muscle fiber and connective tissue damage. Armstrong et al. (1983) 
examined muscles following downhill walking (eccentric 
contractions) in the rat. The size of the necrotic lesions in muscle 
fibers appeared to peak at 48 hours, which is similar to the peak 
soreness for DOMS. In addition, the investigators found increases in 
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mononuclear cells in the interstitium of the muscles and in some of 
the muscle fibers by 24 hours after exercise, and remained at this 
level 48 hours after exercise. However, neutrophils were rarely 
found in muscle tissues at any time. This finding led the 
investigators to conclude that the inflammatory response observed 
in this situation was not respresentative of inflammation in the 
classical sense. 
Findings similar to those reported by Armstrong et al. (1983) 
were reported by Faulkner, Jones & Round (1989) in mice muscle 
fibers following forced lengthening. The muscle fibers 
demonstrated infiltration of muscle fibers by mononuclear cells. On 
the other hand, Kuipers et al. (1983) found neutrophil infiltration in 
the soleus muscles from rats which ran for up to two hours uphill, 
which involved lengthening of the soleus muscle. 
Studies involving humans have also suggested a link between 
inflammation and muscle damage associated with DOMS. Smith et al. 
(1989) reported significant increases in neutrophils after eccentric 
exercise (downhill running). Increases in neutrophils were also 
observed after concentric exercise (uphill running). However, 
neutrophil levels after eccentric exercise were significantly higher 
than those observed after concentric exercise. Cannon et al. (1990) 
demonstrated similar findings, with circulating levels of 
neutrophils significantly higher than resting values thirty-six hours 
after eccentric exercise (downhill running). 
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The appearance of macrophages in areas where necrotic 
lesions have been observed after eccentric exercise has been 
documented in human studies 24 to 48 hours after exercise (Round et 
al., 1987), which reflects a time course similar to that of DOMS. 
However, other human studies have indicated that although 
mononuclear cell infiltration does occur, this infiltration was not 
observed until after DOMS had been considerably reduced or 
disappeared (Jones et al., 1986; Manfredi et al., 1991; O'Reilly et al., 
1987). 
One of the cytokines involved in the acute phase reaction 
which has been associated with muscle tissue damage from 
eccentric muscle contraction is interleukin-1 (IL-1). IL-1 can be 
released from blood monocytes (Dinarello et al., 1987) and 
macrophages at the site of tissue injury (Dinarello, 1988). IL-1 is 
also associated with increased sensitivity to pain (Ferreira, 
Lorenzette, Bristow & Poole, 19). Cannon et al. (1989b) found 
increased levels of IL-1 p in human muscle tissue up to 5 days after 
eccentric exercise. Cannon et al. (1991) conducted another study to 
determine the influence of damaging exercise on cytokine production 
and muscle tissue breakdown and reported significant increases in 
endotoxin-induced secretion of IL-1 p in cells obtained from subjects 
exercising eccentrically 24 hours after exercise. Evans et al. (1986) 
found increased plasma levels of IL-1 three hours after eccentric 
exercise. It appears from these studies that IL-1 levels increase 
following eccentric activity. 
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Connective tissue damage has also been associated with the 
acute inflammatory response (Castor, 1981; Postlethwaite & Kang, 
1976), as well as DOMS (Armstrong, 1984; Armstrong et al., 1983; 
Friden, 1984; Stauber, 1989). Armstrong et al. (1983) noted active 
fibroblasts were present in the interstitium of the soleus of rats 
following eccentric exercise. Since these cells are involved in 
synthesis and release of substances associated with connective 
tissue it was proposed that the exercise may have stimulated these 
cells for repair processes. 
Stauber et al. (1990) suggested that disruption of connective 
tissue initiates the inflammatory response, since mast cell granules 
were found 48 hours after eccentric exercise. Furthermore, Stauber 
et al. hypothesized that DOMS was caused from an inflammatory 
response to extracelluar matrix disruption. Further study is 
necessary to determine the association between connective tissue 
disruption, the acute inflammatory response, and muscle soreness. 
Research also exists which concludes that muscle and 
connective tissue damage does not result in the acute inflammatory 
response, thereby, rejecting the hypothesis that acute inflammation 
underlies DOMS. 
As previously described, work by Jones et al. (1986) indicated 
that although mononuclear ceil infiltration was observed in damaged 
human muscle tissue, the time course of this infiltration was much 
slower than the time course of DOMS. Friden et al. (1983) and Friden 
et al. (1981) found no mononuclear cell infiltration two to three 
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days after eccentric muscle contraction in humans despite DOMS 
occuring during this time. 
Schwane et al. (1983) examined the effect of eccentric 
exercise (downhill running) on peripheral white blood cell (WBC) 
count, an indicator of the activation of the acute inflammatory 
response, on seven male subjects. No significant increases in 
peripheral WBC count were observed after the exercise. Similar 
results were obtained by Bobbert et al. (1986) with humans utilizing 
eccentric exercise, and Janssen, Kuipers, Verstappen & Costill 
(1983), who eccentrically exercised rats. It should be noted that 
WBC is a very indirect measure for inflammation. 
Based on the research presented dealing with DOMS and acute 
inflammation the relationship between these variables appears 
equivocal. However, the discrepancies in the literature may be 
attributed to several factors. The size of the tissue sample taken 
from muscle in morphological studies is extremely small compared 
to the overall size of the muscle. In addition, muscle biopsies are 
taken from the belly of the muscle. Therefore, it is possible that 
the muscle biopsy missed the site of muscle damage, due to its' 
small size (Manfredi et al., 1991; O'Reilly et al., 1987). 
Additionally, there is the possibiltiy that the site of the injury is in 
another area besides the belly of the muscle, such as the MTF 
(Tidball, 1991). Hence, a muscle biopsy might miss the necrotic 
lesion sites. Moreover, Armstrong, (1984) has indicated that the 
muscle biopsy could easily miss lesions sites within the muscle. 
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The discrepancies between studies involving WBCs and plasma 
neutrophil counts may be a result of different intensities and 
duration of exercise utilized. 
As previously described, similarities between DOMS and 
various aspects of the acute inflammatory response have resulted in 
studies which examined the relationship between tissue damage, 
swelling, and tissue infiltration by cellular components. Another 
important aspect of both DOMS and the inflammatory response is 
pain (Armstrong, 1984; Ebbeling & Clarkson, 1989; Friden, 1984; 
Ryan & Majno, 1977). The generation of muscle pain results from the 
activation of myelinated type III and unmyelinated type IV afferent 
fibers (Berberich, Hoheisel & Mense, 1988; Franz & Mense, 1975; 
Goodman, 1983; Iggo, 1961; Kumazawa & Mizumura, 1978; Mense, 
1977; Paintal, 1960). These pain afferents are activated by noxious 
stimuli (Kniffki, Schomburg & Steffens, 1981; Martin et al., 1987; 
Mense, 1977; Moncada, Ferreira & Vane, 1978), mechanical (Martin et 
al., 1987; Mense & Meyer, 1985), as well as chemical stimuli (Boivie 
& Perl, 1975; Martin et al., 1987). These pain afferents have 
polymodal nerve endings located in the sheaths surrounding muscle 
fibers, tendons and, througout skeletal muscle fibers (Armstrong, 
1984; Mense & Meyer, 1985; Mense & Schmidt, 1977). Type III and IV 
nerve fibers which are classified as cutaneous receptors have been 
extensively studied. Group III and IV afferent fibers innervating 
skeletal muscle have been less well studied (Mense & Meyer, 1985). 
However, it appears that skeletal muscle pain is mediated by group 
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III and IV afferents similarily to cutaneous areas (Kniffki et al., 
1981; Mense, 1982; Mense & Meyer, 1985). It has not been 
definitively established that these nerve fibers are responsible for 
the generation of DOMS (Armstrong, 1984; Byrnes & Clarkson, 1986; 
Smith, 1991). 
Chemical substances which can activate these nerve afferents 
include: bradykinin, 5-hydroxytryptamine, histamine, and potassium 
(Fock & Mense, 1976; Mense, 1982). In addition to the substances 
which directly activate these pain afferents, there are substances 
which modulate the activity of these nerve endings. Products of 
arachadonic acid metabolism-particularly prostaglandins and 
leukotrienes and 5-hydroxytryptamine can sensitize these receptors 
to noxious stimuli by reducing the threshold of activation (Juan, 
1978; Martin et al., 1987; Mense, 1981). Histamine, 5-
hydroxytryptamine, bradykinin, and products of arachidonic acid 
metabolism are mediators in the inflammatory process (Sharma & 
Mohsin, 1990). Therefore, these substances are possible candidates 
for the production of DOMS via the inflammatory response. Products 
of arachidonic acid metabolism and bradykinin have been 
demonstrated to be potent mediators of inflammation and pain 
(Bennett, 1988; Juan, 1978; Mense, 1981; Rackham & Ford-
Hutchinson, 1983; Sharma & Mohsin, 1990). Currently, the role 
which bradykinin might play in producing DOMS has not been 
investigated. Lack of appropriate procedures in measuring 
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bradykinin have made determination of its role unfeasable at this 
time. 
Several studies have suggested that arachidonic acid 
metabolites, namely prostaglandin E, may be associated with DOMS 
(Bansil, 1984; Wells, 1991; Smith et al., 1993). Two products of 
arachidonic acid metabolism, prostaglandins and leukotrienes are 
mediators of a great number of immune responses. These two 
inflammatory mediators are important components in the generation 
of pain resulting from tissue trauma (Bennett, 1988; Juan, 1978; 
Larsen & Henson, 1983; Levine et al., 1984; Levine, Lam, Taiwo, 
Donatoni & Goetzl, 1986). PGE2 and LTB4, a prostaglandin and 
leukotriene respectively, are particularly important primary 
mediators of immune function (Ninemann, 1988). Although LTB4 has 
not been associated with DOMS in the exercise literature, its role as 
a primary mediator of inflammation and pain in conjuction with 
PGE2 suggests that LTB4 may be involved in DOMS. The following 
discussion wi l l  examine the l i terature regarding prostaglandin Ez, 
leukotriene B4, and DOMS. 
Prostaglandin E2 and DOMS 
Prostaglandins are unsaturated lipids which are composed of 
20 carbon atoms attached to a carboxyl group. A cyclopentane ring 
is attached at carbons 8-12. Prostaglandins and thromboxanes 
belong to a family of related lipid compounds called prostanoids. 
Thromboxanes are non-prostaglandin compounds which are derived 
from the same precursors as prostaglandins. The term prostaglandin 
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was first suggested by vonEuler in 1934 for the spasmogen isolated 
from the prostate gland of humans and sheep (vonEuler, 1934). In 
1960, Bergstrom and Sjovall identified two separate classes of 
prostaglandins-PGE and PGF (Bergstrom & Sjovall, 1960a; Bergstrom 
& Sjovall, 1960b). Another class of prostaglandins was identified 
by Lee and co-workers in the kidney medulla of the rabbit (Lee, 
1967). This class of prostaglandins was first referred to as 
medullin, but was subsequently classified as PGA2. In addition to 
these classes of prostaglandins, PGB, PGC, PGD, PGH, and PGI have 
also been isolated. The various series of prostaglandins are 
distinguished from each other by alterations in the cyclopentane 
ring and substitutions in the aliphatic side chains. These 
differences result in the varying biological properties which are 
expressed through the different classes of prostaglandins. Within 
each class of prostaglandins differences in the number of double 
bonds in the aliphatic side chains are indicated by a subscript 
number. Of the different numbers of aliphatic side chains, the PG2!s 
are the most frequently occuring species. 
The most common synthesis of prostaglandins involves 
formation from arachidonic acid in response to a stimuli. When 
arachidonic acid is released from membranes via phospholipase A2, 
the enzyme cyclooxygenase acts to form the cyclic endoperoxide 
PGG2. This reaction has been shown to be inhibited by aspirin, 
indomethacin, and other non-steroidal anti-inflammatory drugs (Lee, 
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1967). PGG2 is then converted to PGH2. PGH2 can then be converted 
to PGE2, PGD2, and PGF2a-
Once synthesized, prostaglandins are released locally and 
serve as mediators of a wide variety of biological actions. Although 
prostaglandins act locally, they can be released into the venous 
circulation, where they are metabolized in the lungs. Prostaglandins 
are rapidly degraded within the lungs (Oates et al., 1980). PGE and 
PGF can be metabolized in a single passage through the lungs. 
Prostaglandins have been implicated in numerous processes 
such as water excretion, renal blood flow and sodium excretion, 
reproduction, platelet function, digestion, hormone secretion, and 
carbohydrate and fat metabolism. The relationship between 
prostaglandins and DOMS is based on the role that prostaglandins 
play in the immune response and acute inflammation. Prostanoids 
are found at the site of tissue inflammation. There are several 
sources of these prostanoids associated with inflammation. The 
skin, smooth muscle, and blood vessels associated with the site of 
inflammation have the ability to synthesize prostanoids. As the 
inflammatory response progresses, prostaglandin synthesis and 
release can occur from leukocytes, monocytes, and macrophages 
(Ferraris et al., 1974; Goldyne & Stobo, 1979; Kurland & Bockman, 
1978; Morley et al., 1979; Zurier & Sayadoff, 1975). Macrophages 
are a major source of prostaglandin secretion and release (Ferraris 
et al., 1974; Goldyne & Stobo, 1979; Kurland & Bockman, 1978; 
Morley et al., 1979), and are also affected by prostaglandins 
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(Ninemann, 1988). Monocytes were shown to be the primary source 
of prostaglandins in blood, particularly PGE (Bankhurst, Hastain, 
Goodwin & Peake, 1981). Macrophages which produce prostaglandin E 
function to suppress the immune response by induction of suppressor 
T cells, interaction with lymphocytes (demonstrated in a culture 
medium), and mediation of T-cell supressor factors (Humes et al., 
1977). Prostaglandin E production inhibits both lymphocyte activity 
and subsequent secretion of PGE (Bonta & Parnham, 1982). 
Furthermore, macrophage production of PGE2 appears to be regulated 
by T lymphocytes (Goodwin, Kaszubowski & Williams, 1979; 
Goodwin, Wiik, Lewis & Williams, 1979). 
The breakdown of connective tissue matricies associated with 
tissue injury and inflammation may be mediated by the production of 
PGE2. Dayer, Trentham & Krane (1982) reported that mononuclear 
cells from both normal subjects and subjects with rhuematoid 
arthritis responded to the presence of collagen with release of PGE2. 
Furthermore, the release of substances such as collagen have been 
suggested as a possible mediator of the immunological response 
associated with rheumatiod arthiritis (Dayer, Robinson & Krane, 
1977; Dayer, Russell & Krane, 1977; Deuppens, Rodriguez & Goodwin, 
1981; Goodwin, Ceuppens & Rodriguez, 1983; Ninemann, 1988). Since 
collagen release has been associated with connective tissue damage 
and the generation of DOMS from exercise (Abraham, 1977; 
Armstrong, 1984; Stauber, 1989; Stauber et al., 1990; Stauber, 
39 
Fritz, Vogelbach & Dahlmann, 1988), a relationship between 
mononuclear cell production of PGE2 and DOMS is plausible. 
Prostaglandin E production occurs early on in the inflammatory 
process. This is due to the important role that neutrophils play in 
production and secretion of prostaglandins (Zurier & Sayadoff, 
1975). Secretion and function of histamine, an immunological 
mediator of pain (Bennett, 1988), is potentiated by the presence of E 
series prostaglandins (Sondergaard & Greaves, 1971). 
The link between PGE2 and the generation of DOMS has been 
suggested because of the important role which PGE2 plays in the 
production of hyperalgesia (Larsen & Henson, 1983). Nociocepters 
located in muscle are capable of exhibiting a decrease in threshold 
of activation and response to stimuli which are usually not capable 
of producing excitability (Campbell, Meyer & LaMotte, 1979; 
Fitzgerald, 1979; Fitzgerald & Lynn, 1977; Lynn, 1979). This 
decrease in threshold when compounds such as PGE2 are present has 
been termed hyperalgesia (LaMotte, Thalhammer & Robinson, 1982; 
LaMotte, Thalhammer & Robinson, 1983) or sensitization (Bessou & 
Perl, 1969; Habgood, 1950). This state of hyperalgesia can result in 
increased activation of type III and IV pain afferents by stimuli 
which may not normally activate these pain afferents. In this state 
of hyperalgesia these pain receptors are more likely to respond to 
heat, cold, pressure, and chemical substances than is the case in the 
absence of these sensitizing agents (Campbell et al., 1979; Croze, 
Duclaux & Kenshalo, 1976; Fitzgerald, 1979; Fitzgerald & Lynn, 
40 
1977; Handwerker, 1975; Lynn, 1979). Eicosanoid products of 
arachidonic acid metabolism, particularly prostaglandin E2, have 
been shown to produce this hyperalgesia (Ferreira, 1972; Ferreira et 
al., 1974; Juan, 1978; Juhlin & Michaelsson, 1969; Mense, 1981; 
Staszewska-Barczak, Ferreira & Vane, 1976) . It has been 
documented that prostaglandin E2 hyperalgesia is involved in the 
sensation of peripheral pain (Ferreira, 1972; Ferreira, Nakamura & 
Castro, 1978; Handwerker, 1975; Mense, 1981; Mense, 1982). 
Activation of the inflammatory response results in the production of 
chemical substances such as bradykinin, 5-hydroxytryptamine 
(serotonin), and histamine, which directly activate type III and IV 
nocioceptors, resulting in pain (Bennett, 1988; Franz & Mense, 1975; 
Juan & Lembeck, 1974; Juan & Lembeck, 1976; Mense, 1977; Mense, 
1981; Mense, 1982). Furthermore, production and secretion of these 
inflammatory mediators, particularly bradykinin, further stimulate 
prostaglandin Ez production (Burch, Connor & Axelrod, 1988; Juan & 
Lembeck, 1976; Lembeck, Popper & Juan, 1976; Ninemann, 1988). 
As previously described, muscle injury associated with DOMS 
often involves an inflammatory component. This inflammatory 
response may result in the release of prostaglandin E2 and algesic 
substances, such as histamine and bradykinin (Bankhurst et al., 
1981; Ferraris et al., 1974; Goldyne & Stobo, 1979; Juan & Lembeck, 
1976; Kennedy et al., 1980; Kurland & Bockman, 1978; Lembeck et 
al., 1976; Mense, 1981; Morley et al., 1979; Smith, 1991; Zurier & 
Sayadoff, 1975). This has led to the hypothesis that PGE2 may play 
41 
an important role in the sensation of DOMS (Armstrong, 1984; Smith, 
1991). Prostaglandins may be released during the post-exercise 
period and sensitize type III and IV nocioceptors. This enhanced 
sensitivity could result in activation of these pain afferents by 
chemicals associated with the inflammatory process activated by 
post-exercise muscle damage, producing pain. Tissue edema has 
also been associated with this tissue damage (Friden et ai., 1986; 
Newham, 1988). This edema may result in increases in 
intramuscular pressure in non-compliant compartments and 
increases in intramuscular pressure during contraction in compliant 
compartments. Nocioceptors which respond to mechanical 
stimulation may not normally discharge under these circumstances 
(Martin et al., 1987; Mense, 1982; Smith, 1991). However, the 
presence of PGE2 may result in these nocioceptors discharging with 
these conditions, thereby, producing pain. If these conditions do 
exist during the time period after exercise resulting in muscle 
damage, it is plausable that PGE2 sensitization accompanied by 
increased concentrations of inflammatory mediators and mechanical 
distortion are responsible for DOMS. 
The idea that PGE2 may play a role in DOMS resulting from 
exercise appears plausible based on current research regarding 
exercise and prostaglandins, particularly PGE2. Much of the 
literature regarding prostaglandins and exercise pertains to renal 
prostaglandin synthesis (Lijnen, Fagard, Staessen & Amery, 1982; 
Lijnen, Staessen, Fagard & Amery, 1990; Nowak & Wennmalm, 1978; 
42 
Zambraski, Dodelson, Guidotti & Harnett, 1986; Zambraski & Dunn, 
1980). During exercise (Kotchen et al., 1971) plasma renin levels 
increase and this increase is thought to be related to renal 
prostaglandin release (Kotchen et al., 1971). Although all tissues 
are capable of synthesizing and releasing prostaglandins, the kidney 
has the greatest capacity for synthesis and release of 
prostaglandins (Dunn & Hood, 1977). The results of these studies are 
summarized in Table 1. Collectively, these studies suggest that 
acute exercise stimulates renal PGE2 release. 
Other researchers have examined the effect of aerobic 
exercise on PGE2 release and have reported conflicting results. 
Several studies have indicated that plasma PGE2 concentrations 
increase with aerobic exercise (Demers, Harrison, Halbert & Santen, 
1981; Nowak & Wennmalm, 1978). Although plasma PGE2 levels 
were not reported, Pedersen et al. (Pedersen, 1991) indicated that 
increases in PGE2 production by circulating neutrophils occurred 
during and two hours after exercise. The results of these studies 
are summarized in Table 1. It is possible that any differences in 
plasma PGE2 concentrations observed in these studies may be due to 
the mode, intensity, and duration of exercise used. 
Table 1 
Exercise-Induced Changes in PGE2 Concentration in Various Tissues 
Investi- • 
gators 
Date Exercise 
Mode 
Subjects Tissue [PGE2] 
at Rest 
[PGE2] 
during 
Exercise 
[PGE2] 
-Post 
Exercise 
Demers 
etal. 
1981 42.2 K 
run 
male & 
female 
plasma 1147 
±453 
pg/ml 
NA 5 min. 
after 
1674+237 
pg/ml 
Lijnen 
et al. 
1982 bicycle 
ergometer 
hyper­
tensive 
males & 
females 
plasma @80 pg/ml @60 pg/ml NA 
Lijnen 
et al. 
1991 bicycle 
ergometer 
men plasma 42.3 
(14.1-
112.8) 
45.8 
(21.1-
84.6) 
NA 
Nowak & 
Wennmalm 
1978 bicycle 
ergometer 
men femoral 
plasma 
pg/ml 
19 + 5 
pg/rnl 
pg/ml 
40 + 9 
pg/ml* 
NA 
Smith et 
al. 
1993 
Zambraski 1986 
et al. 
Zambraski 1980 
et al. 
Eccentric 
bench 
press 
treadmill 
running 
treadmill 
running 
male & 
female 
females 
dogs 
plasma 
urine 
renal 
plasma 
326+137 
pg/ml 
111+23 
pg/min. 
49-313 
pg/ml 
NA 
45 + 23 
pg/min.* 
80-800 
pg/ml 
24 hrs 
after 
2071+261 
pg/ml* 
88 + 40 
pg/min. 
657 pg/ml 
Note: indicates significant difference from pre-exercise values at the p< 0.05 level; NA = not 
available. 
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Although the aforementioned studies indicate that PGE2 
production increases with exercise, they do not address the question 
of whether PGE2 synthesis and secretion is associated with DOMS 
for several reasons. First, these studies primarily attempted to 
examine the role which prostaglandins play in processes other than 
DOMS, particularly renal processes. Therefore, the presence of DOMS 
in these studies was not investigated, and hence, the relationship 
between increases in DOMS and PGE2 production was not examined. 
Secondly, increases in PGE2 concentrations in the venous 
circulation are most likely due to overflow from tissues where local 
metabolism is unable to keep up with local synthesis and secretion 
of PGE2 (Lee & Katayama, 1985). This overflow into the circulation 
is rapidly metabolized by a single passage through the lungs. Thus, 
prostaglandin concentrations in the circulation should not remain 
elevated once tissue production decreases and overflow into the 
circulation diminishes. If the increase in plasma PGE2 results from 
processes occuring during exercise rather than from the delayed 
effects of exercise-induced muscle damage and subsequent 
inflammatory processes, PGE2 concentrations in the plasma should 
return to normal shortly after exercise. This would suggest that the 
increases in plasma PGE2 demonstrated in these studies are not 
necessarily related to DOMS. However, the sensitization of 
nocioceptors can remain even after PGE2 levels have returned to 
normal (Ferreira et al., 1978,Fitzgerald & Lynn 1977 ; Martin et al., 
1987). This heightened sensitization has only been shown to last for 
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up to several hours (Ferreira et al., 1978; Fitzgerald & Lynn, 1977; 
Martin et al., 1987). Since DOMS is usually not experienced until 24 
after exercise (Armstrong, 1984; Ebbeling & Clarkson, 1989), this 
release of PGE2 during exercise is probably not related to DOMS. 
In addition to studies examining changes in PGE2 
concentrations resulting from primarily aerobic activity, research 
exists which examined the relationship between PGE2, DOMS and 
muscular activity which results in muscle damage and repair. This 
research is represented by several areas of study. The three areas 
which will be discussed in this review include: 1) the relationship 
between PGE2 synthesis and muscle growth and repair, 2) the 
relationship between DOMS and PGE2 after muscular activity, and 3) 
the effects of non-steroidal anti-inflammatory drugs (NSAIDS) 
which inhibit synthesis of prostaglandins on DOMS. 
It has been established that prostaglandins are regulators of 
protein turnover in skeletal muscle (Baracos, Greenberg & Goldberg, 
1986; Rodemann & Goldberg, 1982; Turinsky, 1986) In particular, it 
has been demonstrated that PGE2 alters protein degradation 
(Turinsky, 1986). Research indicates that mechanical forces which 
are applied to skeletal muscle affect changes in protein synthesis 
and degradation via increased release of arachidonic acid and 
increased prostaglandin synthesis (Smith, Palmer & Reeds, 1983). 
This has been demonstrated both in vitro (Smith et al., 1983) and in 
vivo (McMillan, Reeds, Lobley & Palmer, 1987; Templeton, Padalino & 
Moss, 1986). Vandenburgh, Hatfaludy, Sohar & Shansky (1990) 
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investigated the relationship between protein turnover resulting 
from intermittent mechanical stimulation of avian skeletal muscle 
cells in vitro for 48 hours. They found increases in PGE2 and PGF2« 
efflux from these muscle cells. Efflux rates of PGE2 and PGF2« 
increased dramatically during the first five hours of stimulation. 
However, PGE2 efflux rates returned to control levels by 24 hours 
after mechanical stimulation, while PGF2a efflux rates continued to 
be elevated for at least 48 hours. Since mechanical stress is 
related to generation of DOMS, it is possible that this stretch-
induced increase in PGE2 efflux from skeletal muscle plays a role in 
muscle soreness. However, it is not known if this stretched-induced 
increase in skeletal muscle PGE2 efflux is associated with increased 
production of PGE2 resulting from tissue injury (Vandenburgh et al., 
1990). 
Although the research involving stretch-induced increases in 
PGE2 efflux only hint at a relationship between PGE2 and DOMS, 
studies exist which have investigated the relationship between 
DOMS and PGE2. These studies have examined the time course 
relationship between prostaglandins and DOMS and have yielded 
conflicting results (Bansil, 1984; Smith et al., 1993; Wells, 1991). 
The results of these studies are summarized in Table 1 and Table 2. 
In order to investigate the relationship between 
prostaglandins E, F2a and DOMS, Bansil examined the time course of 
changes in plasma PGEi, PGF2«, and DOMS in 22 young, male subjects 
after the performance of three sets of 10 repetitions of the barbell 
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squat at an intensity of 67.5% of the subjects' one repetition 
maximum (1 RM). Blood samples were taken immediately before, 
after, and every 12 hours after the squats for a period of 72 hours. 
Bansil found significant increases in PGEi immediately after 
exercise. PGEi levels were found to peak 36 hours after exercise. 
PGFza plasma levels were reported to follow a time course similar 
to that of PGEi. DOMS was present 24 hours after exercise and 
peaked at 48 hours after exercise. Based on this data Bansil 
concluded that the onset of muscle soreness was related to 
increases in plasma PGEi. Bansil also suggested that the delay in 
the onset of muscle soreness was due to the inhibitory effects of 
PGF2« on PGEi • In a continuation of this work, Bansil examined the 
effects of aspirin, an inhibitor of prostaglandin production, on PGEi, 
PGF2a, and range of motion (ROM). The results of this experiment 
revealed that aspirin ingestion resulted in no changes in plasma 
prostaglandin levels over time. ROM was found to be decreased in 
both the aspirin group and the group not using aspirin. However, the 
magnitude of the loss in ROM was lower in the group ingesting 
aspirin than the ROM decrements observed in the group not ingesting 
aspirin. Based on these results, Bansil concluded that the degree of 
muscle soreness experienced by the aspirin group was less than that 
of the placebo group, further suggesting a relationship between 
prostaglandins and DOMS. However, since actual muscle soreness 
was not evaluated in the study involving aspirin, this conclusion may 
not be valid. 
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There is another problem associated with the study by Bansil 
(1984). In this study plasma PGEi values were measured, rather 
than PGE2. Although PGEi is associated with the production of pain, 
the ability of PGE2 to sensitize nocioceptors, resulting in 
hyperalgesia is better documented in the literature (Ferreira et al., 
1978; Fitzgerald & Lynn, 1977; Juan, 1978; Juan & Lembeck, 1974; 
Martin et al., 1987; Mense, 1981). Additionally, PGE2 is the 
prostaglandin in the PGE series which is usually associated with the 
inflammatory response (Lee & Katayama, 1985; Ninemann, 1988). 
Therefore, conclusions regarding the relationship of DOMS and 
prostaglandins based on the work of Bansil are incomplete until the 
relationship between plasma PGE2 and DOMS has been examined. 
Smith and co-workers (Smith et al., 1993) examined the time 
course relationship between DOMS and plasma PGE2 after the 
eccentric phase of the chest press on the Universal® chest press. 
Plasma PGE2 values were significantly elevated above resting values 
from 24 to 48 hours after exercise, concurrent with peak levels of 
DOMS. Both plasma PGE2 and DOMS returned to baseline values by 72 
hours. Based on the work of Smith et al., it appears that there is an 
association between the manifestation of DOMS and plasma PGE2. 
In an another study examiining the relationship between PGE2 
and DOMS, Wells (1991) sought to determine if indomethacin, an 
inhibitor of prostaglandin synthesis, had an effect on DOMS and 
increases in plasma PGE2, interleukin-1 p, and creatine kinase. 
Twenty-one untrained males were randomly assigned to one of two 
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groups. One group received a placebo and the other group received 75 
mg of Indocin (indomethacin). Each group performed four sets of 12 
eccentric repetitions of the Cybex® chest press at 100% of their 
concentric 1RM. Plasma PGE2 was assessed pre-exercise, six, 12, 
24, 48, 72, 96, and 120 hours post-exercise. Muscle soreness was 
evaluated at the same times except for the six-hour time period. 
The results revealed no significant treatment effects for the indocin 
on DOMS or plasma PGE2. Both groups exhibited significant 
increases in plasma PGE2 and DOMS. Plasma PGE2 levels were not 
significantly different from pre-exercise levels until 96 hours after 
exercise, when PGE2 values were significantly lower than pre-
exercise values. DOMS was significantly elevated 24 hours after 
exercise, and peaked at 48 hours post-exercise. The results of this 
study appear to suggest that PGE2 is not related to DOMS. However, 
the results of this study must be viewed with some caution, since 
Indocin, an inhibitor of prostaglandin synthesis, was not effective in 
decreasing plasma PGE2 levels. 
Much of the research investigating the relationship between 
PGE2 and DOMS have involved non-steroidal anti-inflammatory drugs 
(NSAIDS) (Almekinders & Gilbert, 1986; Donnelly, Maughan & 
Whiting, 1990; Donnelly, McCormick, Maughan, Whiting & Clarkson, 
1988; Francis & Hoobler, 1987; Hasson et al., 1993; Kuipers, Keizer, 
Verstappen & Costill, 1985). The results of these studies are 
summarized in Table 2. NSAIDS inhibit the action of cyclooxygenase, 
an enzyme which is responsible for converting arachidonic acid to 
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prostaglandins and thromboxanes. These studies hypothesized that 
PGE2 was involved in the inflammatory response resulting from 
exercise-induced muscle damage and the generation of DOMS. Hence, 
if PGE2 production was inhibited, then muscle damage and DOMS 
should be reduced. The results of these studies have yielded 
conflicting conclusions. Work by Salminen & Kihlstrom (1987) has 
indicated that the administration of the prostaglandin inhibitor 
indomethacin before and during exercise was effective in reducing 
levels of enzymatic indicators of necrotic lesions in mouse skeletal 
mouse. However, indomethacin treatment after exercise had only a 
slight effect on these markers. A study by Almekinders & Gilbert 
(1986) examining the effect of NSAIDS on muscle healing and the 
inflammatory process after muscle strain in rats yielded similar 
conclusions. Rats which had been given the NSAIDS demonstrated a 
delay in the inflammatory response and muscle regeneration, as 
compared with controls. Based on these studies it appears that 
prostaglandins have an influence on the changes in skeletal muscle 
involving the inflammatory process which are associated with the 
generation of DOMS. 
The ability of NSAIDS to decrease DOMS has been examined by 
several investigators. NSAIDS are thought to block production of 
prostaglandins by inhibiting the metabolism of arachidonic acid by 
the enzyme cyclooxygenase. This reduction of prostaglandins could 
lead to decreased sensitization of pain afferents to noxious stimuli, 
thereby, reducing the sensation of DOMS. However, the research 
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regarding the efficacy of NSAIDS to reduce DOMS is not conclusive. 
Hasson et al. (1993), Francis & Hoobler (1987) and Macintyre & 
McKenzie (1985) reported decreases in DOMS with the use of NSAIDS. 
On the other hand, other investigators have reported that NSAIDS 
were not effective in reducing DOMS (Donnelly et al., 1990; Donnelly 
et al., 1988; Kuipers et al., 1985). The results of these studies are 
summarized in Table 2. 
There are several explanations for the conflicting results 
obtained from these studies. Of particular importance is the fact 
that prostaglandin levels were not assesed in these studies. 
Therefore, it is not known if the NSAIDS were actually effective in 
decreasing prostaglandin production. The previously discussed study 
by Wells (1991) illustrates this point. Wells found that 
indomethacin was not effective in decreasing DOMS. However, 
indomethacin was not efficacious in decreasing prostaglandin levels. 
The possibility exists that if the indomethacin was effective in 
decreasing prostaglandins, then DOMS may have been reduced. 
Table 2 
Effects of Non-steroidal Anti-lnflammatorv Drugs (NSAIDS) on POMS and PGE 
Investigator Exercise Mode [PGE] before 
exercise 
w/out 
NSAIDS 
[PGE] post-
exercise 
w/out 
NSAIDS 
Effect of 
NSAIDS 
on DOMS 
[PGE] w/ 
NSAIDS 
Bansil (1984) 
Donnelly et al. 
(1990) 
Donnelly et al. 
(1988) 
Francis & 
Hobbler 
(1984) 
squat 
downhill 
running 
downhill 
running 
eccentric 
elbow flexion 
377.25a 
NA 
NA 
NA 
604.3 7** 
24 hours post-
exercise 
NA 
NA 
NA 
NA 
no effect on 
DOMS 
no effect on 
DOMS 
reduction in 
DOMS 
suppresed 
PGE, 
NA 
NA 
NA 
Hasson et al. bench stepping 
(1993) 
NA NA 
Kuipers et al. 
(1985) 
Macintyre & 
McKenzie 
(1995) 
eccentric 
bicycle 
ergometer 
eccentric leg 
dynamometer 
NA 
NA 
NA 
NA 
Wells (1991) eccentric 1073.62b 461.37 ± 
bench press Sig^1* 
Note: PGE levels are in pg/ml; indicates significant difference 
aPlasma PGE, value. bPlasma PGE2 value. 
reduction in 
DOMS 
no change in 
DOMS 
Reduction in 
DOMS 
no change in 
DOMS 
NA 
NA 
NA 
no effect 
from pre-exercise values. 
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There may be other reasons for the inability of NSAIDS to 
reduce DOMS or pain. The possibility exists that a prostaglandin 
inhibitor may shift metabolism of arachidonic acid to the 
lipoxygenase pathway, resulting in the increased production of 
leukotrienes, which also cause sensitization of group III and IV pain 
afferents (Bennett, 1988). Hence, in some cases the sensation of 
DOMS may be modulated by leukotrienes when the production of 
prostaglandins is blocked by NSAIDS. 
Finally, the time at which the NSAIDS are ingested may have an 
effect on reduction of DOMS. Since the sensitization of pain 
afferents by prostaglandins may last for several hours (Ferreira et 
al., 1978; Fitzgerald & Lynn, 1977; Martin et al., 1987), blocking 
prostaglandin synthesis some time after the hyperalgesia has been 
established would be ineffective in reducing DOMS. This hypothesis 
was proposed by Hasson et al. (1993) to explain the ability of 
ibuprofen to decrease muscle soreness reported in their 
investigation. Hasson et al. contended that most studies examining 
the effectiveness of NSAIDS to reduce muscle soreness did not 
utilize NSAIDS early enough to prevent the hyperalgesic response 
produced by prostaglandins. They speculated that the NSAIDS must 
be given prior to the exercise in order to inhibit prostaglandin 
production which would result in prolonged hyperalgesia. However, 
Macintyre & McKenzie (1985) demonstrated a decrease in sensation 
of DOMS resulting from eccentric leg exercise on an isokinetic 
dynamometer from 0 to 168 hours post-exercise when Anaprox DS®, 
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a NSAID, was ingested twice daily begining on the first day post-
exercise and stopping at the end of the seventh day post-exercise. 
Since there was no measure of inflammatory mediators, it can only 
be hypothesized that the NSAID reduced inflammation due to muscle 
damage, subsequently reducing DOMS. 
Based on the aforementioned studies examining the 
effectiveness of NSAIDS on reducing exercise-induced DOMS, it has 
not been established if prostaglandin inhibition by NSAIDS is 
effective in reducing DOMS. Furthermore, it appears that other 
factors involved in the inflammatory process as well as the timing 
of the dosages of NSAIDS may play a crucial role in the generation of 
DOMS. 
Leukotriene B4 and DOMS 
Leukotrienes are a group of chemical mediators derived from 
the conversion of arachidonic acid by the calcium-dependent enzyme 
5-lipoxygenase. The term leukotriene was used by Borgeat & 
Samuelsson (1979) to describe a family of compounds which contain 
three conjugated double bonds and a peptide chain containing one, 
two, or three amino acid residues with a sulphur linkage at carbon 
five. There are several different naturally-occurring leukotrienes 
which are alphabetically designated in the order which they were 
discovered. Currently, leukotrienes of the A, B, C, D, and E series 
have been identified in biological tissues. Leukotrienes are normally 
abbreviated LTA4, LTB4, LTC4, etc., with the subscript indicating the 
presence of four double bonds in the molecule. It was established by 
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Radmark, Malmsten, Samuelsson, Clark & Corey (1980) that 
hydroperoxyeicosatetraenoic acid (5-HPETE) is formed from 
arachidonic acid and then converted to LTA4. LTA4 can then be 
metabolized to either LTB4 or LTC4. 
Leukotrienes C4, D4, and E4 are associated with the slow-
reacting substance of anaphylaxis, and are potent 
bronchoconstrictive mediators (Kikawa et al., 1992). Leukotriene B4 
has been associated with leukocyte accumulation and function (Bray, 
Cunningham, Ford-Hutchinson & Smith, 1981a; Ford-Hutchinson, 
1985; Ford-Hutchinson, Bray, Doig, Shipley & Smith, 1980), changes 
in vascular permeability (Bray, Cunningham, Ford-Hutchinson & 
Smith, 1981b; Wedmore & Williams, 1981), and hyperalgesia (Levine 
et al., 1985; Levine et al., 1986; Madison et al., 1992; Martin, 1990; 
Martin et al., 1988; Martin et al., 1987; Rackham & Ford-Hutchinson, 
1983; Soter et al., 1983). 
Numerous cellular and immune functions are affected by LTB4, 
making LTB4 a potent mediator of physiological responses (Ford-
Hutchinson & Letts, 1986; Ninemann, 1988). Since both LTB4 and 
PGE2 produce hyperalgesia in primary afferent nocioceptors, it is 
possible that both PGE2 and LTB4 play a role in the generation of 
DOMS. Although the relationship between PGE2 and DOMS has 
received preliminary investigation, the role that LTB4 may have with 
DOMS has not been studied. However, existing research regarding 
leukotrienes, particularly LTB4, suggest a relationship between LTB4 
and DOMS. Since research does not exist dealing exculsively with 
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LTB4 and DOMS, the relationship between DOMS and LTB4 will be 
discussed based on the following topics: leukotrienes and pain, 
studies involving DOMS and NSAIDS, leukotrienes and the acute 
inflammatory response, and studies examining cell membrane 
permeability and creatine kinase (CK) release. 
As previously described, products of arachidonic acid 
metabolism are potent inducers of hyperalgesia in group III and IV 
receptors. Unlike PGE2, the mechanism by which hyperalgesia is 
produced by LTB4 is dependent on the presence of polymorphonuclear 
leukocytes (PMNLs) (Levine et al., 1984; Wedmore & Williams, 1981). 
PMNLs exposed to LTB4 secretel 5-lipoxygenase products (Ford-
Hutchinson & Letts, 1986). These substances have been shown to 
elicit hyperalgesia in rats (Levine et al., 1985). LTB4 has been found 
to induce hyperalgesia in animals (Levine et al., 1985; Levine et al., 
1986,Levine, 1985 #841; Rackham & Ford-Hutchinson, 1983). 
Furthermore, Martin et al. (1987) concluded that there was a 
correlation between the percentage of afferent fibers sensitized by 
PGE2 and LTB4 in cutaneous high-threshold C- and A-Delta 
mechanonociceptors in the skin of rat hindlimbs. PGE2 and LTB4 
sensitized 73% of C-polymodal, 60% of C-mechano-heat, 42% of C-
mechano-cold nonciceptors and 70% of A-delta high-threshold 
mechanonociceptors. The authors found that in a majority of fibers 
tested that application of one agent, such as PGE2, which produced a 
decrease in threshold was followed by a further threshold decrease 
upon application of the second agent, such as LTB4. Furthermore, a 
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fiber which was unresponsive to one type of eicosanoid was also 
unresponsive to a second eicosanoid agent. This led Martin and 
associates to conclude that a parallel response was found in 
afferent nocicieptors upon exposure to either PGE2 or LTB4. This 
decrease in the threshold of activiation of mechanoreceptors has 
also been demonstrated in other studies (Martin, 1990; Martin et al., 
1988). Hyperalgesia produced by LTB4 has also been reported in 
humans in cutaneous afferents in the skin (Bisgaard & Kristensen, 
1985; Soter et al., 1983). LTB4 was shown to sensitize A-delta 
fibers in dental pulp (Madison et al., 1992). This sensitization was 
found to persist for at least 20 minutes after removal of LTB4. 
The pain associated with chronic inflammation has been linked 
with LTB4. Quinn and Bazan (1990) reported that subjects 
experiencing inflamed, dysfunctional temporal mandibular joint 
syndrome exhibited increased levels of PGE2 (160-1,520 pg/mL) and 
LTB4 (95 to 1,600 pg/mL) also demonstrated high scores on the 
acute synovitis index. This led the authors to conclude that there is 
a correlation between the presence of metabolites of arachidonic 
acic metabolism and temporalmandibular joint synovitis. Although 
no control samples were taken from normal temporamandibular 
joints, the investigators assumed that PGE2 and LTB4 would not be 
present in normal joints. 
Based on these studies it has been theorized that LTB4 is 
effective in sensitizing afferent nociceptors. Furthermore, a 
decrease in the mechanical threshold for excitation for nociceptors 
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can persist for several hours following exposure to LTB4 (Martin et 
al., 1987). If LTB4 plays an important role in inflammatory pain, 
such as the pain associated with DOMS, the presence of LTB4 after 
exercise resulting in muscle damage and activation of the 
inflammatory response needs to be documented. Although studies do 
not exist which directly address the relationship between LTB4 and 
the process of muscle damage and repair, it has been demonstrated 
that LTB4 plays a fundamental role in many aspects of the acute 
inflammatory response (Ninemann, 1988). 
The monocyte and macrophage are inflammatory mediators 
which are important components of the inflammatory response 
accompanying tissue damage resulting from exercise (Armstrong, 
1984; Armstrong et al., 1983; Smith, 1991). Therefore, it has been 
suggested that these inflammatory mediators may play a role in the 
generation of DOMS, since they are a major source of PGE2 (Ferraris 
et al., 1974; Humes et al., 1977; Kurland & Bockman, 1978; Morley et 
al., 1979). Macrophages are also a source of 5-lipoxygenase 
products such as LTB4 (Bonta & Parnham, 1982; Williams et al., 
1984). It has been suggested that the release of both leukotrienes 
and prostaglandins by macrophages represents a feed-back system 
which controls macrophage-lymphocyte interaction (Bonta & 
Parnham, 1982). PGE2 production leads to inhibition of lymphocyte 
responses and PGE2 production by macrophages (Bonta & Parnham, 
1982). On the other hand, leukotrienes appear to stimulate 
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leukocyte activity (Bonta & Parnham, 1982) and promote release of 
PGE2 by macrophages (Feuerstein, Foegh & Ramwell, 1981). 
Neutrophils are also involved in the acute inflammatory 
process and may migrate to areas of injury following tissue damage 
resulting from exercise. Neutrophils are capable of synthesis of 
LTB4 (Borgeat & Samuelsson, 1979). In addition, LTB4 seems to 
promote infiltration of neutrophils during the inflammatory process 
(Smith, Ford-Hutchinson & Bray, 1980; Zurier & Sayadoff, 1975). 
Although neutrophils are capable of synthesizing prostaglandins, the 
metabolism of arachidonic acid promoted by neutrophils yields 
primarily LTB4 (Borgeat & Samuelsson, 1979; Ninemann, 1988). 
LTB4 promotes leukocyte accumulation (Smith et al., 1980; Soter et 
al., 1983), adherence to the vascular endothelium (Bray et al., 
1981a), formation of superoxide anions (Mogbel, Sass-Kuhn, Goetzl & 
Kay, 1983), and enhanced release of lysosomal enzymes (Nagy, Lee, 
Goetzyl, Pickett & Kay, 1982). Because of these potent chemotactic 
and chemokinetic activities, LTB4 may be involved in the process of 
muscle and connective tissue injury and repair which occurs after 
exercise-induced tissue damage, suggesting that LTB4 may be 
involved in the generation of DOMS. 
Other inflammatory mediators besides neutrophils, monocytes, 
and macrophages are capable of synthesizing and secreting LTB4. 
Mast cells are inflammatory mediators which are found in many 
tissues including the lungs, intensines, skin, and connective tissue 
(Peters et al., 1987). Increases in the number of mast cells is often 
62 
associated with painful inflammatory disorders of the joints, such 
as rheumatoid arthritis (Godfrey, Hardi, Engber & Granziana, 1984). 
Mast cells are capable of synthesizing and secreting both histamine 
and products of arachidonic acid metabolism, primarily LTB4 and 
LTC4 (Peters et al., 1987). Elevated levels of LTB4 have been 
reported in the synovial fluid of patients with rheumatoid arthritis 
(Klickstein, Shapleigh & Goetzl, 1980), suggesting a possible 
relationship between mast cell production of LTB4 and generation of 
inflammation related to joint pain. 
In addition to the suggested relationship between painful 
inflammatory disorders of the joints and mast cells which exists in 
the literature, researchers have reported a possible relationship 
between mast cell activity and DOMS. Stauber et al. (1990) 
examined the effects of eccentric activity on the 
extracellular matrix and connective tissue elements associated with 
a contracting muscle. They reported degranulation of mast cells in 
the extracelluar matrix and connective tisssue 24 hours after 
exercise. Furthermore, the authors hypothesized that products 
secreted by mast cells, such as histamine, may play a role in DOMS 
which was experienced by the subjects. This study suggests that 
DOMS may be influenced by the secretion of chemical substances 
secreted by mast cells. The possibility exists that the 
degranulation of mast cells which Stauber et al. observed may have 
resulted in production of mast cells which sensitized pain afferents 
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to mechanical and chemical stimuli, resulting in the sensation of 
DOMS. 
Another body of research involving NSAIDS and DOMS indirectly 
implicates leukotrienes and DOMS. As previously described, 
conflicting results were obtained regarding the efficacy of NSAIDS 
in reducing DOMS. It is possible that the NSAIDS may have been 
effective in blocking sensitization of nociceptors by prostaglandins. 
This inhibition of prostaglandin synthesis occurs by NSAIDS blocking 
the cyclooxygenation of arachidonic acid. However, the NSAIDS used 
in these studies (Almekinders & Gilbert, 1986; Donnelly et al., 1990; 
Donnelly et al., 1988; Francis & Hoobler, 1987; Hasson et al., 1993; 
Kuipers et al., 1985) do not block the lipoxygenase pathway of 
arachidonic acid metabolism. This could cause a diversion of 
arachidonic acid metabolism products into the lipoxygenase 
pathway, resulting in increased levels of algesic compounds such as 
LTB4. Increased levels of LTB4 could promote sensitization of 
nociceptors which is equally effective as PGE2 (Martin et al., 1987), 
resulting in no diminuation of DOMS by NSAIDS. 
Research examining the role lipoxygenase enzymes have in 
promoting the release of intracellular enzymes from damaged 
skeletal muscle also suggests the presence of compounds such as 
LTB4. Jackson, Wagenmakers & Edwards (1987) examined which 
products of arachidonic acid metabolism were important in the 
release of intracelluar enzymes from damaged skeletal muscle in 
vitro using inhibitors of cyclo-oxygenase and lipoxygenase enzymes. 
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They found that the cyclo-oxygenase inhibitor suppressed 
prostaglandin efflux, but not creatine kinase release from the 
damaged muscle. However, use of a lipoxygenase inhibitor was found 
to significantly reduce creatine kinase efflux from the damaged 
muscle. 
Since exercise-induced muscle damage can also result in 
efflux of creatine kinase into the blood and DOMS, the presence of 
products of lipoxygenase products such as LTB4 after exercise which 
promotes muscle damage and DOMS is possible. The inability of 
cyclo-oxygenase inhibitors to prevent CK release from muscle has 
been documented in studies involving exercise resulting in DOMS 
(Hasson et al., 1993). Furthermore, Donnelly et al. (1990) reported 
increases in plasma CK in subjects using ibuprofen, a cyclo-
oxygenase inhibitor following downhill running. 
The role of the lipoxygenase pathway in muscle damage has 
been examined by Barsacchi, Manni, Pelosi, Camici & Ursini (1986). 
Barsacchi and collegues compared the formation of peroxide radicals 
by chemiluminescence from the surface of an isolated, perfused rat 
heart following the addition of hydroperoxides and glutathione-
depleting agents with and without the presence of aspirin. It was 
found that aspirin produced a higher steady state concentration of 
hydroperoxy radicals than without the presence of aspirin. The 
authors concluded that this increase in hydroperoxy radicals was do 
to a shift in arachidonic acid metabolim to the lipoxygenase 
pathway. This shift in metabolism indicates that leukotrienes may 
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contribute to damage resulting from oxidative stress (Lefer, 1985). 
This study supports the hypothesis that oxidative stress may 
contribute to muscle damage and the accompanying muscle soreness 
(Armstrong et al., 1991; Maughan et al., 1989; Sjodin, Westing & 
Apple, 1990). Based on the aforementioned studies, it appears that 
the products of arachidonic acid metabolim may play a role in 
exercise-induced muscle damage and DOMS. 
Summary 
Unaccustomed exercise and exercise involving eccentric 
contractions have been shown to result in muscle damage, as 
indicated by morphological changes, elevation of intracellular 
enzymes in the blood, decreases in the ability to generate muscular 
force, and DOMS. DOMS is usually experienced 24 hours after 
exercise, peaking at 48 hours, and gradually diminishing in intensity 
several days thereafter. Currently the underlying mechanism behind 
the generation of DOMS resulting from this muscle damage is 
unknown. However, it has been theorized that the cascade of 
reactions involved in the acute inflammatory response is triggered 
by muscle injury resulting from this exercise. Although there are a 
wide range of chemicals associated with the inflammatory response 
and the generation of pain, two inflammatory mediators which 
appear to mediate DOMS are PGE2 and LTB4. These products of 
arachidonic acid metabolism are capable of sensitizing type III and 
IV pain afferents which are located in skeletal muscle and in the 
connective tissue elements associated with skeletal muscle. It has 
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been suggested that these inflammatory mediators are secreted by 
components of the immune system, such as macrophages and mast 
cells during the process of muscle breakdown and repair associated 
with the acute inflammatory response. Increases in secretion of 
PGE2 and LTB4 result in sensitization of type III and IV pain 
afferents. Therefore, these pain afferents may be stimulated by 
chemical and mechanical stimulation which might not normally 
promote the sensation of pain. Furthermore, some edema may be 
associated with exercise-induced muscle damage, thereby, causing 
small increases in intramuscular pressure. A combination of these 
factors may result in the production of DOMS. 
The research regarding the role which PGE2 and LTB4 play in 
DOMS is currently incomplete. Three studies have examined the 
relationship of DOMS and prostaglandins of the E series. One study 
reported a similar time course relationship between plasma PGEi 
and DOMS, while another reported a decrease in plasma PGE2 96 
hours after exercise. The relationship between LTB4 and DOMS has 
not yet been addressed. Therefore, this study will help to elucidate 
if there is a relationship between PGE2, LTB4 and DOMS. 
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CHAPTER III 
METHODS AND PROCEDURES 
Introduction 
The purpose of this study was to examine the time course 
relationship of plamsa levels of PGE2, LTB4, and DOMS over 120-
hours resulting from an acute weight lifting bout involving eccentric 
contractions. This chapter will describe the methods which were 
utilized in this study under the following headings: Selection of 
Subjects, Experimental Design, Chemical Analyses, Statistical 
Analyses. 
Selection of Subjects 
Fifteen healthy male volunteers, eighteen to thirty-two years 
of age from the University of North Carolina, Greensboro were 
solicited for this study. Only male subjects under the age of 35 
years were used in this study to provide for a more homogeneous 
subject group, since gender and age differences may exist regarding 
exercise-induced muscle damage and DOMS (Hortobagyi & Denahan, 
1989; Manfredi et al., 1991). Thus, this study reflects the response 
of plasma PGE2, plasma LTB4, and CK to exercise which generates 
DOMS in males under the age of 35. Subjects were recruited by word 
of mouth and flyers and announcements distributed throughout the 
University of North Carolina, Greensboro campus. Subjects solicited 
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were sedentary and had not engaged in resistance training for at 
least two months prior to the study. The subjects were asked to 
refrain from novel physical activity or exercise while participating 
in the study. Each subject was provided with a verbal and 
written explanation of the procedures, risks associated with the 
study, and right to terminate particpation in the study in accordance 
with the University of North Carolina, Greensboro Human Subjects 
Review Committee. The subjects provided a statement of informed 
consent prior to participating in the study (Appendix A). 
Each volunteer completed a medical history questionnaire prior 
to participation in the study (Appendix B). Any volunteers who had 
any illnesses which have an inflammatory component or pain 
syndrome which might be exacerbated by DOMS were excluded from 
the study. Any individual who was being treated with medication 
which can alter inflammatory responses was excluded from the 
study. Any individual who provided postive responses to either 
questions #17 and #18 were excluded from the study. In addition, 
subjects were asked to refrain from taking medications which can 
alter the inflammatory response while participating in this study. 
Each subject was provided with an instruction sheet for subjects, 
which described what they should do in preparation for testing and 
the investigator's telephone number (Appendix C). 
Experimental Design 
Eleven subjects were randomly selected to perform the 
weight lifting bout designed to elicit DOMS and five subjects were 
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randomly selected to serve as controls. Other studies examining the 
effects of resistance exercise on muscle soreness and muscle 
damage have not utilized a control group (Ebbeling & Clarkson, 1989; 
Smith, 1993). Since resting plasma values of plasma PGE2 and LTB4 
seem to be quite variable (Drey, 1975; Granstrom & Kindahl, 1990; 
Sinzinger, 1985), a control group was included to help discern if any 
changes in the variables in the treatment group were merely 
attributable to daily variation. However, due to the difficulty in 
obtaining subjects fulfilling all the criteria to participate in the 
study only five subjects were randomly assigned to the control 
group. Furthermore, decreasing the number of subjects in the 
treatment group to provide for an equal number of subjects in each 
group would result in a decreased ability to detect significant 
changes in the variables as a result of the weight lifting bout (D. 
Herr, personal communication, November 9, 1995). 
Control subjects were tested for their one repetition 
maximum (1RM), but did not perform the weight lifting session. The 
controls were instructed to remain sedentary throughout the 
remainder of the study. The treatment subjects performed a 1RM 
testing session which was followed by the weight lifting bout at 
least two weeks later. Subjects in the treatment group were 
instructed to refrain from any other physical activity during the 
testing period. Venous blood samples and perceived muscle soreness 
ratings were obtained prior to, immediately after, and 24, 48, 72, 
96, and 120 hours after exercise. The controls reported to the 
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laboratory at least two weeks after their 1RM testing session. 
Venous blood samples and perceived muscle soreness ratings were 
obtained from the controls every 24 hours for seven days using the 
same protocol which was used for the treatment group. Subjects in 
both groups were instructed to report to the laboratory in a fasted 
condition prior to the blood draw. All testing sessions, evaluation 
of muscle soreness and blood draws occurred between 7 a.m.-9 a.m. 
1RM Testing 
In order to determine each subject's 70% of 1RM capacities for 
the weight lifting session, each subject's 1RM was determined on 
the following exercises: bench press, triceps pushdowns, military 
press, biceps curls, leg press, and wide grip pulldowns. All of the 
exercises were performed on Universal® Gym Equipment (Irvine, CA, 
USA). The weight lifting sessions, blood drawing, and evaluation of 
muscle soreness were performed in the University of North Carolina, 
Greensboro, Exercise Physiology Laboratory. 
The subjects were tested for their 1RM following a protocol 
described by Fleck & Kraemer (1988) and Pauletto (1991). Prior to 
attempting a maximal effort on each exercise, the subjects 
performed an adequate warm-up. This warm-up consisted of the 
subject performing ten repetitions with a resistance which could be 
performed with extreme ease. Following this set, the subjects 
performed subsequent warm-up sets of 2-5 repetitions with 
increases in intensity of 10-20 pounds per set. When the subject 
felt that the warm-up repetitions were becoming difficult, the 
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subject attempted a single repetition with a resistance 
approximately 10-20 pounds more than his previous warm-up 
repetition(s). Upon completition of this single attempt the subject 
attempted to perform a single repetition with a small increase in 
resistance. If the subject was unable to perform a single repetition 
at a selected weight he was allowed two more attempts to 
successfully complete the lift. If the subject was unsuccessful 
after his third attempt the last successful lift was considered his 
1RM on that particular exercise. 
Each subject was allowed an adequate rest period of 
approximately 3-5 minutes between maximal attempts. Strict 
adherence to proper performance techniques was observed during 
testing. Any lift which was not performed using proper techniques 
was not considered a valid 1RM attempt. 
Weight Lifting Session 
At least two weeks after determination of each subjects' 1RM, 
the eleven exercising subjects performed an acute weight lifting 
session. Each subject began by performing one set of ten 
repetitions at 40% of 1RM on both the bench press and leg press. 
Since these exercises utilize a large number of muscle groups, this 
provided an adequate warm-up for all of the subsequent exercises. 
After this set was performed each subject did a second warm-up set 
of 5 repetitions at 50% of 1 RM. 
Following the two warm-up sets subjects in the treatment 
group started the weight lifting session. The subjects lifted in the 
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same order as was used in the 1RM testing session. Each subject 
performed three sets with a resistance of 70% of each subject's 
1RM. Each set was performed until volitional exhaustion or until the 
subject was unable to properly perform the exercise. Two minutes 
of rest was provided between each set. 
Perceived Muscle Soreness 
Prior to the lifting session subjects were asked to evaluate 
their overall muscle soreness on a scale of 0 to 10 with one being 
normal and ten being very, very, sore on a muscle soreness rating 
sheet (Appendix F). The subjects circled the number which they felt 
best represented their muscle soreness at that time, based on the 
descriptors of soreness accompanying the soreness scale. This 
muscle soreness rating scale is a modified version of the scale used 
by Clarkson (Byrnes & Clarkson, 1986; Clarkson et al., 1987; 
Clarkson et al., 1986). In addition, subjects were asked what muscle 
groups were particularly sore on a chart of the body which was 
positioned underneath the muscle soreness scale. Extensive 
evaluation of muscle soreness in different areas of the body will not 
be utilized in this study. Work by Wells (Wells, 1991) has indicated 
that that one overall rating may be used to report soreness as 
accurately as an average soreness rating of different areas of the 
body. Ratings of muscle soreness for the lifting group were obtained 
prior to lifting, immediately after the lifting bout, 24, 48,72, 96, 
and 120 hours after the lifting bout. The ratings of muscle soreness 
for the control group were obtained every 24 hours for six days. 
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Ratings of perceived muscle soreness were obtained before blood 
sampling for both groups. 
Blood Sampling 
After obtaining muscle soreness ratings from the subjects, the 
subjects were instructed to sit quietly for 10 minutes. After this 
period of time, 20 ml blood samples were taken from an antecubital 
forearm vein with one venapuncture. Blood samples (2) were drawn 
into 10 ml Vacutainer® tubes containing 0.10 microliters of 15% 
ethylenediaminetetraactic acid (EDTA) solution and 0.18 mg of 
acetylsalicylicacid (ASA) dissolved in a 80% ethanol solution. The 
ASA served to inhibit in vitro production of prostaglandins. The 
blood in the Vacutainer® tubes was centrifuged at 3000 rpm for 10 
minutes at 4°C. After centrifugation 500 microliter aliquots of 
plasma were pipetted into polypropylene sample tubes and frozen at 
-80°C for four-six months until analyzed. Sinzinger (1985) has 
indicated that frozen plasma samples which had been used over a 
nine-month period demonstrated a variability of ± 7%, with no 
significant increase in PGE2. The effect of four-six months of 
storage on the concentration of LTB4 in plasma has not been 
documented, although it can be hypothesized that the effects of 
storage may be the same as seen with PGEZ concentrations in 
plasma. 
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Chemical Determinations 
PGE? Determination 
PGE2 concentration in the plasma sample was determined 
using the Prostaglandin E2-Monoclonal Enzyme Immunoassay (EIA) 
Kit from Cayman Chemical Company (Ann Arbor, Ml). Prior to 
analysis, the PGE2 was extracted from the plasma samples using a 
modified version of the PGE2 extraction method described by 
Vandenburgh et al. (Vandenburgh et al., 1990). Five hundred 
microliters of each plasma sample were placed in 10 ml 
polypropylene test tubes and acidified to a pH of 3.5-4.0 with 6N 
HCL. A Cis Sep-Pack solid phase extraction cartridge (Waters 
Division, Millipore, Milford, MA) was washed with 5 ml of pure 
ethanol and then 5 ml of ultra-pure water. The plasma sample was 
then passed through the cartridge, followed by 2.5 ml of ultra-pure 
water. This was followed by 2.5 ml of 15% ethanol and 2.5 ml of 
HPLC grade hexane. The PGE2 was eluted off the cartridge with 3 ml 
of methyl formate into a 7 ml glass scintillation vial. 
To determine recovery percentages, a known amount of PGE2, 
two identical aliquots of PGE2 standard and two identical plasma 
samples were used. One of the PGE2 aliquots was added to one of the 
plasma samples. The sample + standard aliquot, standard-only 
aliquot, and sample- only aliqout were processed in the same manner 
as the other samples. 
The collection vials were placed in a test tube rack and the 
methyl formate was evaporated to dryness under a stream of 
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nitrogen using a S/P® Brand mini-Vap® Six-Port 
Concentrator/Evaporator (Baxter Diagnostics, Inc., Charlotte, NC). 
The EIA was performed according to the instructions 
accompaning the PGE2 kit. This assay utilizes a specific amount of 
PGE2-acetylcholinesterase conjugate which competes for a small 
amount of PGE2 monoclonal antibody in a reaction well. Thus, the 
amount of PGE2-acetylcholinesterase which binds to the PGE2 
monoclonal antibody is inversely proportional to the concentration 
of PGE2 in the sample well. Each well in the kit is coated with goat 
anti-mouse antibody. The antibody-PGE2 complex binds to the goat 
anti-mouse antibody in the wells. Any unbound reagents are removed 
from the wells by rinsing with a wash solution. Ellman's reagent is 
added to each of the wells. Ellman's reagent contains a substrate to 
acetylcholinesterase. The subsequent enzymatic reaction results in 
the appearance of a yellow color which absorbs from 405-420 nm. 
Thus, the intensity of the yellow color is proportional to the amount 
of PGE2-acetylcholinesterase conjugate, which is inversely 
proportional to the concentration of PGE2 in the sample well. 
The EIA buffer solution and wash buffer solutions were 
prepared by adding 500 ml of ultra-pure water to the packets 
provided with the kit. These buffers were then stored at 4°C. The 
lyophilized prostaglandin E2 standard, PGE2 acetylcholinesterase 
conjugate (tracer), and PGE2 monoclonal antibody were reconstituted 
according to the kit instructions and stored at 4°C. One ml of EIA 
buffer was added to the residue in the vials and vortexed. 
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The concentrations of the standards were prepared by labeling 
eight polypropylene test tubes #1-#8. Nine-hundred microliters of 
El A buffer were aliquoted to tube #1 and 500 microliters were 
aliquoted to tubes #2-#8. One-hundred microliters of PGE2 standard 
(10 ng/ml) was added to tube #1 and vortexed. The standard was 
then serially diluted by adding 500 microliters from tube #1 and 
adding to tube #2, vortexing. This process was repeated for tubes 
#3-8. 
After preparation of the standards, the 96 well plate was 
removed from the plate packet and the wells were rinsed once with 
wash buffer. The plate was inverted and blotted on tissue wipes. 
Any wash buffer remaining in the wells was removed by pipetting. 
Before adding any of the reagent to the plate wells a plate format 
was determined. Each plate contained two blanks, two non-specific 
binding wells (NSB), two maximum binding wells (Bo), one total 
activity well, and eight standard concentrations in duplicate. The 
remaining wells contained samples, each assayed in duplicate. This 
plate format was recorded on a template sheet provided with the kit. 
Upon completion of the template, one-hundred microliters of 
EIA buffer was added to each NSB wells. Fifty microliters of EIA 
buffer was added to the Bo wells. Starting with the lowest 
concentration of PGE2 standard (#8), 50 microliters were added to 
each of the lowest two standard wells. This process continued until 
all the standards were aliquoted. 
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Fifty microliters of sample were then added to the 
appropriate wells. Each sample was assayed in duplicate. Fifty 
microliters of PGE2 tracer was added to each well, except for the 
total activity and the blank wells. Finally, fifty microliters of PGE2 
antibody was added to each well, except for the total activity, NSB, 
and the blank wells. The plate was then covered with plastic film 
and incubated for 18 hours at room temperature. 
Prior to developing the plate, one vial of Ellman's Reagent was 
reconstituted with 20 ml of ultra-pure water in an amber bottle and 
stored in the dark. The plate wells were then emptied and rinsed 
five times with wash buffer. After the final rinse with wash buffer, 
the plate was inverted and gently blotted on tissue wipes. Any 
remaining wash buffer was removed by pipette. Two-hundred 
microliters of Ellman's reagent was added to each well and five 
microliters of the acetylcholinesterase tracer was added to the 
total activity well. The plate was then covered with plastic film 
and placed on an orbital shaker in the dark. The plate was allowed to 
develop for 90 minutes. 
After development, the bottom of the plate was wiped with a 
tissue to remove smudges and dirt. The plastic film was carefully 
removed from the plate and the plate was read in a 340 ATTC plate 
reader (SLT Lablnstruments®, Salzburg) at 405 nm. 
A recovery ranging from 64-78% was obtained from this 
procedure. This recovery is not as high as those reported by Smith 
et al. (1993), 80-90%, Dray, Charbonnel & Maclouf (1975), >90%, or 
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Powell (1980), 98%. On the other hand, both Nowak & Wennmalm 
(1978), and Zijlstra & Vincent (1984) reported a 73% recovery of 
PGE2 from plasma. Furthermore, Cayman Chemical Company reports 
that utilization of this type of extraction method and EIA usually 
results in a recovery percentage of 40-75% (J. McDonnell, personal 
communication, August 11, 1995). 
LTBj. Determination 
Determination of the LTB4 values in the plasma samples was 
performed using the Leukotriene B4 Kit by Cayman Chemical Company 
(Ann Arbor, Ml). This kit is an EIA in which LTB4 competes with a 
specific amount of LTB4 acetylcholinesterase conjugate (tracer) for 
a small amount of rabbit antiserum in a reaction well. As previously 
described in the PGE2 assay, the amount of bound tracer is inversely 
proportion to the concentration of free LTB4 in the well. The 
antiserum-LTB4 complex binds to the mouse monoclonal antibody 
which coats the reaction wells. After addition of these reagents to 
the wells they are allowed to incubate. After incubation, the wells 
are washed to remove any unbound reagents and Ellman's reagent is 
added. As previously described, this reagent contains the substrate 
for acetylcholinesterase. The intensity of the color resulting from 
the activity of acetylcholinesterase is measured 
spectrophotometrically at 405-420 nm and is proportional to the 
amount of LTB4 which is bound to a well. The amount of LTB4 bound 
to a well is inversely proportional to the concentration of free LTB4 
in a well. 
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Before performance of the assay, the LTB4 was extracted from 
the samples using the extraction procedure outlined by the LTB4 EIA 
kit. Either 500 or 1000 microliters of each sample was pipetted 
into 2 ml polypropylene test tubes. Two milliliters of ethanol was 
added to each tube and vortexed. Eight milliliters of 0.1 M phosphate 
buffer (pH 4.0) was added and vortexed. A C18 Sep-Pack solid phase 
extraction cartridge (Waters Division, Millipore, Milford, MA) was 
washed with 5 ml of pure ethanol and then 5 ml of ultra-pure water. 
Each sample was then passed through the cartridge and rinsed with 5 
ml of ultra-pure water, followed by 5 ml of HPLC grade hexane. The 
LTB4 was eluted with 3 ml of ethyl acetate into a 7 ml glass 
scintillation vial. The ethyl acetate in the vials was then 
evaporated in the manner previously described. 
To determine recovery percentages, a known amount of LTB4, 
two identical aliquots of LTB4 standard and two identical plasma 
samples were used. One of the LTB4 aliquots was added to one of the 
identical plasma samples. The sample + standard aliquot, standard-
only aliquot, and sample- only aliqout were processed in the same 
manner as the other samples. 
The LTB4 assay was performed according to the instructions 
accompanying the kit, which are identical to the procedures 
described for the PGE2 EIA. A recovery ranging from 91-94% was 
obtained from this procedure. This is higher than the 70% recovery 
for LTB4 reported by Zijlstra & Vincent (1984). According to the 
manufacturer's of the LTB4 EIA kit (Cayman Chemical Company, Ann 
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Arbor), recoveries of 90-100% are possible with this type of 
extraction and assay procedure (P. Balthazour, personal 
communication, August 11, 1995) 
Creatine Kinase Determination 
Plasma levels of creatine kinase were determined using the 
Paramax® (Baxter Diagnostics, Inc., Charlotte, NC) automated 
analyzer. Paramax® Creatine Kinase Reagent (#B6105-4) was used 
for the analysis. This reagent formulation is based on Rosalki's 
modifications of the Oliver procedure (Baxter Diagnostics, 1992). 
This procedure involves a series of coupled reactions. Initially 
creatine phosphate + ADP -» creatine + ATP via the action of CK. 
This reaction is followed by ATP + glucose -» ADP + glucose-6-
phosphate (G-6-P) via the action of hexokinase. Finally glucose-6-
phosphatase serves as a catalyst for the reaction G-6-P + NADP* -» 
6-phosphogluconate + NADPH. The amount of creatine kinase 
activity is proportional to the rate of reduction of NADP+ and is 
measured bichromatically at 340/405nm. 
Prior to CK analysis the Paramax® analyzer was calibrated 
for the creatine kinase assay according to the Paramax® Operating 
Manual (Baxter Diagnostics, 1991). The Paramax® CK reagent 
tablets were removed from their package and allowed to reach room 
temperature. The CK tablet reagent dispenser was then placed into 
the reagent carousel. Dade Monitrol® I & II Quality Control material 
was measured in the analyzer to monitor assay reliability. The 
samples were then poured into Paramax® sample tubes and labeled 
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with a barcode. The samples were then placed in the analyzer 
carousel and the RUN button was pressed. The sample values were 
reported via a printout. Any sample values which were outside of 
the measurement range were diluted with Paramax® Dilutant 
(#B6110-3A) and re-assayed. 
Lactate Determination 
Lactic acid levels of the plasma samples were determined 
using the Paramax® (Baxter Diagnostics, Inc., Charlotte, NC) 
automated analyzer. Paramax® Lactate Reagent (B6106-12) was 
used for lactate analysis. This reagent contains the reactants for 
the reduction of NAD+ to NADH with lactate in the presence of 
lactate dehydrogenase to NADH + 2-p-iodophenyl-3-p-nitrophenyl-5-
phenyl-2H-tetrazolium chloride -> NAD+ + formazan via the action of 
the diaphorase. The formazan is then measured bichromaticaly at 
550/630 nm. 
Prior to lactate measurement the Paramax® analyzer was 
calibrated according to the Paramax® Operating Manual (Baxter 
Diagnostics, 1991) using Paramax® Comprehensive Calibrators I & II 
for plasma (#B6108-1 and #B6108-2). The Paramax® Reagents 
were allowed to reach room temperature then removed from their 
container and placed in the reagent carousel. Dade Monitrol® I & II 
Quality Control material was evaluated by the analyzer to monitor 
assay reliability. The samples were then poured into Paramax® 
sample tubes and labeled with a barcode. The samples were then 
placed in the analyzer carousel and the RUN button was pressed. The 
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sample values were reported via a printout. Any sample values 
which were outside of the measurement range were diluted with 
Paramax® Dilutant (#B6110-3A) and re-assayed. 
Statistical Analyses 
The effect of the weight lifting bout on LTB4, PGE2, CK, DOMS 
and lactate values were determined using a multi-variate analysis 
of variance (MANOVA). A MANOVA was performed on each variable in 
the study for the treatment group. There were not enough subjects 
in the control group to utilize the MANOVA model (n=5) The MANOVA 
evaluated each variable as a vector and tested the hypothesis that 
the mean change in a variable from the mean resting value at each 
time period was zero (n=0). Wilk's lambda was used to determine 
significant F-values. A significant F-value for a MANOVA indicated 
a significant change in a variable over the 120-hour time period. 
In addition to the MANOVA, a ANOVA was performed on the CK 
data since CK values demonstrate a great deal of inter- and intra-
subject variability (Ebbeling & Clarkson, 1989; Maughan et al., 1989; 
Evans, et al., 1986). Furthermore, the number of subjects in this 
study was small (n=14). Thus, a MANOVA performed on the 
treatment group and a 2x6 ANOVA involving the treatment and 
control groups provided for a more accurate assesment of CK 
activity in these groups. 
Paired t-tests were used to determine if specific values were 
significantly different from resting values for a particular variable 
over time in the treatment group. Significant differences between 
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two values at adjacent time periods for a each variable were also 
determined using paired t-tests for the treatment group. This 
procedure illustrates differences between values for a variable at 
two successive time periods. This procedure also determined if 
exercise values differed from the resting values. 
Since a MANOVA was not suitable for analysis of the control 
group data, changes in control group variables over time were 
assesed using paired t-tests. Differences between initial resting 
values and values at other time periods for each variable were 
examined. In addition, differences between values for a variable at 
two succesive time periods were also examined. 
Differences between the control group and treatment group for 
each variable over time were determined using the t-test for two 
group means. 
Pearson correlation coefficients were determined for every 
pair of variables at each time period for both the control and 
workout groups in order to assess relationships between the 
variables at specific time periods. The level of significance was set 
at the 0.05 level for all analyses. 
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CHAPTER IV 
RESULTS 
Introduction 
The results of this study are presented in the following sequence: 
treatment of individual data, subject characteristics, evaluation of 
muscle soreness, plasma creatine kinase values, plasma lactate 
values, plasma PGE2 values, plasma LT64 values, and correlation 
analysis among the variables. 
Treatment of Individual Data 
Sixteen male college students (19-32 years old) participated 
in the study. Eleven subjects were assigned to the weightlifting 
group and five subjects were assigned to the control group. One 
subject in the weightlifting group took NSAIDS during the course of 
the study, and was subsequently removed from the study. A second 
subject in the weight lifting group exhibited plasma CK and PGE2 
values which may have indicated the presence of a clinical condition. 
This subject was removed from the mean treatment group analysis. 
However, the data associated with this subject is presented with 
the correlations among the variables due to the parallel time 
courses exhibited by these inflated values. 
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Subject Characteristics 
Analysis of the subject characteristics by the t-test 
procedure revealed no significant differences between the two 
subject group's age, height, and weight. The mean values of these 
variables are presented in Table 3. 
Table 3 
Subject Characteristics 
Group N Age (years) Weight (kg) Height (cm) 
Treatment 9 25.0 ±_ 1.4 75.9 ± 5.0 180.9 + 3.0 
Control 5 23.2 + 1.4 77.4 ± 3.6 176.8+2.6 
Note. The values represent means ± Standard error of the mean 
(S.E.M.) 
Evaluation of Muscle Soreness 
The control group reported a mean initial soreness rating of 
0.2 + 0.2, and did not show significant changes in perceived muscle 
soreness over the 120-hour time period from initial values (Figure 
2), or between successive time periods (Figure 3). Furthermore, 
there was no significant differences between mean soreness ratings 
for the control and treatment groups at rest. 
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Figure 2. Mean perceived muscle soreness ratings (±S£.M.) for pre-
workout and post-workout time periods in the control and treatment 
groups. "Significant difference from resting mean at the £<0.05 
level. Significant difference between treatment and control group 
means at the p < 0.05 I evel. 
Subjects in the treatment group indicated that their muscle 
soreness was occurred primarily in the area of the chest, shoulders, 
triceps, and quadriceps. A MANOVA indicated a significant main 
effect for muscle soreness (Table 3) in the treatment group. Paired 
t-tests revealed that perceived muscle soreness was significantly 
elevated above resting values post-workout (3.1+0.6), 24 hours (6.2 
+ 0.4), 48 hours (5.0 ± 0.8), 72 hours (3.6 ± 0.7), and 96 hours (2.1 ± 
0.3) after the workout (Figure 2). Paired t-test analyses between 
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succesive time periods in the treatment group revealed significant 
increases in muscle soreness from mean pre-workout muscle 
soreness ratings up to 24 hours after exercise (Figure 3). 
Significant decreases in soreness ratings occurred from 24 hours 
after exercise to 120 hours after exercise (Figure 3). The data 
show that peak muscle soreness occurred at 24 hours for the 
treatment group. 
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Figure 3. Time course changes in perceived muscle soreness ratings 
for the treatment and control groups. Values are mean (+S.E.M.). 
^Significant increase from previous mean at the p <0.05 level. 
^Significant decrease from previous mean at the p<0.05 level. 
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Table 4 
MANOVA tests for Changes in each Variable Over Time in Treatment 
Group 
Variable 
Wilks' 
Lambda df F e 
DOMS 0.017 5 45.27 0.0013 
Lactate 0.058 5 12.90 0.014 
CK 0.32 5 1.65 0.32 
pge2 0.00 5 3.095 0.26 
ltb4 0.077 5 9.52 0.02 
A comparison of the perceived muscle soreness values at each 
time period between the workout and control groups (Figure 2) 
revealed significant differences between groups at 24 hours (6.2 + 
0.4 vs. 0.0 + 0.0), 48 hours (5.0 ± 0.8 vs. 0.2 + 0.2), 72 hours (3.6 + 
0.7 vs. 0.2 + 0.2), and 96 hours (2.1 + 0.5 vs. 0.0 + 0.0). The F-values 
and their respective p-values for the t-tests which were performed 
on the muscle soreness ratings data are presented in Appendix G. 
Plasma Creatine Kinase Values 
T-tests revealed no significant increase in mean CK values 
from mean resting values in the control group (Figure 4). In 
addition, no significant changes in succesive mean control group 
values over the 120-hour time period were obtained (Figure 5). 
Furthermore, no significant differences were found between mean 
resting CK values for the control and treatment groups (Figure 4). 
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Figure 4. Mean plasma CK values (+S.E.M.) for pre-workout and post-
workout time periods in the control and treatment groups. 
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A MANOVA indicated that there was not a significant change in 
CK values over the measured time period for the treatment group 
(Table 4). However, paired t-tests used to illustrate differences 
between specific time periods produced significant differences in 
this group. Increases in CK from resting values (54.9 ± 25.4 IU/L) 
were found at the post-workout period (189.7 + 29.4 IU/L), 72 hours 
90 
after exercise (737.4+ 297.8 IU/L), 96 hours after exercise (1307.3 
+ 617.4 IU/L) and 120 hours after exercise (1178.4 + 502.4 IU/L). 
Significant differences between successive time periods were 
also found in the treatment group (Figure 5). There was a 
significant increase in CK values from 48 hours to 72 hours (254.1 + 
58.4 IU/L to 737.4 + 297.8 IU/L) and from 72 hours to 96 hours 
(737.4+297.8 IU/L to 1307.4+ 617.4 IU/L). The results indicate 
that plasma CK values peaked at 96 hours after the workout and 
remained significantly elevated above resting values at 120-hours 
after the workout. 
The 2x6 AN0VA performed on the control and treatment group 
indicated a significant main effect for groups, indicating a 
significant difference between the plasma CK levels of the two 
groups (Table 5) Conversely, a comparison of the plasma CK values 
at each time period between the workout and control groups 
demonstrated no significant differences (Figure 4). However, 
differences between the control group and treatment group from 24 
hours to 120-hours approached significance. The F-values and their 
respective p-values for the t-tests which were performed on the CK 
data are presented in Appendix G. 
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Figure 5. Time course changes in plasma CK for the treatment and 
control groups. Values are mean (±S.E.M.). *#Significant increase 
from previous mean at the p <0.05 level. 
Table 5 
Analysis of variance for CK (group x time) 
Source <11 
Variance 
Estimate F-ratio p-value 
Group (G) 1 5023429.7 6.89 0.010* 
Time (T) 5 1533182.4 2.10 0.074 
G x T  5 834366.7 1.14 0.34 
Residual 72 729069.7 
Total 83 835592.7 
Note. *p < .05. 
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Plasma Lactate Values 
There were no significant changes in mean plasma lactate 
values over the time period in the control group (Figure 6). No 
significant difference was found between mean resting lactate 
values for the control and treatment groups. (Figure 6 and Figure 7). 
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Figure 6. Mean plasma lactate values (+ S.E.M.) for pre-workout and 
post workout time periods in the control and treatment groups. 
"Significant difference from resting mean at the p < 0.05 level. 
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Figure 7. Time course changes in plasma lactate for the treatment 
and control groups. Values are mean (± S.E.M.) '"Significant increase 
from previous mean at the p < 0.05 level. ^Significant decrease 
from previous mean at the p < 0.05 level. 
A MANOVA indicated that there were was a significant change 
in lactate values over the 120-hour time period in the treatment 
group (Table 4). T-tests revealed a significant increase in mean 
plasma lactate values immediately after exercise from mean resting 
values (1.3 ± 0.2 mM to 10.7 + 1.6 mM; Figure 6). Mean lactate values 
significantly decreased 24 hours after exercise (10.7 mM + 1.6to1.3 
+ 0.1 mM), and were not significantly different from resting values 
thereafter (Figure 7). 
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There were no significant differences between mean lactate 
values of the control and treatment groups pre-workout, and 24, 48, 
72, 96, 120 hours post-workout. (Figure 6). The F-values and their 
respective p-values for the t-tests which were performed on the 
lactate data are presented in Appendix G. 
Plasma PGE2 Values 
No significant differences were found between mean plasma 
PGE2 values at rest and mean plasma PGE2 values at each of the other 
time periods in the control group (Figure 8). In addition, there was 
no significant difference between mean plasma PGE2 values for the 
control group and treatment group at rest (Figure 8). Paired t-tests 
examining differences between successive time periods (Figure 9) 
revealed a significant decrease in plasma PGE2 values from 24 hours 
to 48 hours (71.9 ± 10.0 pg/ml to 50.3 ± 10.2 pg/ml) in the control 
group. 
A MANOVA indicated that there were no significant changes in 
mean plasma PGE2 values from mean resting values (60.6 + 14.8 
pg/ml) over the 120-hour time period in the treatment group (Table 
4). Furthermore, paired t-tests indicated no significant differences 
between PGE2 values after exercise and resting values (Figure 8). 
However, the paired t-test analysis for differences between 
successive time periods (Figure 9) indicated a significant increase 
in mean plasma PGE2 values from 72 hours to 96 hours (59.9 ± 10.2 
pg/ml to 81.7+ 12.3 pg/ml) in the treatment group. No statistical 
difference was found between treatment and control group means at 
comparable time periods. The F-values and their respective p-
values for the t-tests performed on the PGE2 values are presented 
Appendix G. 
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Figure 8. Mean plasma PGEZ values (+ S.E.M.) for pre-workout and 
post-workout time periods in the control and treatment groups. 
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Figure 9. Time course changes in plasma PGE2 values for the 
treatment and control groups. Values are mean (+S.E.M.). 
'"Significant increase from previous mean at the p < 0.05 level. 
^Significant decrese from previous mean at the p < 0.05 level 
97 
Plasma LTB4 values 
No significant differences between mean resting plasma LTB4 
values and mean plasma LTB4 values at the other time periods were 
found in the control group (Figure 10). Furthermore, no significant 
differences were found for plasma LTB4 values at successive time 
periods in this group (Figure 11). No significant differences 
between the control group and treatment group mean resting plasma 
LTB4 values were found (Figure 10). 
The MANOVA indicated that there were significant changes in 
mean plasma LTB4 values over the 120-hour time period in the 
workout group (Table 4). However, paired t-tests did not reveal any 
significant differences between mean resting plasma LTB4 values 
(15.3 + 3.4 pg/ml) and mean plasma LTB4 values at the other time 
periods (Figure 10). Furthermore, there were no significant 
differences between successive time periods after exercise (Figure 
11). No significant differences were found in plasma LTB4 values 
between the control and treatment groups at comparable time 
periods (Figure 10). F-values and their respective p-values for the 
t-tests performed on the LTB4 data are presented in Appendix G. 
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Figure 10. Mean plasma LTB4 values (+S.E.M.) for pre-workout and 
post-workout time periods in the control and treatment groups. 
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Figure! 1. Time course changes in plasma LTB4 values for the 
treatment and control groups. Values are mean (+S.E.M.) 
Correlations among the Variables 
A correlational analysis among the variables was performed to 
assess relationships between changes in the variables from resting 
values. Significant Pearson correlation coefficients for the workout 
group are presented in Table 6. There were no significant Pearson 
correlation coefficients among changes in the variables from resting 
values in the control group. 
One subject in the treatment group (subject #8) was not 
included in the mean statistical analyses due to CK values which 
were of the magnitude to indicate the presence of a pathological 
condition (Clarkson & Ebbeling, 1989). Furthermore, subject #8's 
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PGE2 resting and post-workout values were much higher than the 
values obtained from the treatment group. Subject #8's CK and PGE2 
values are compared to the treatment group's mean CK and PGE2 
values in Table 7. Subject #8's perceived muscle soreness ratings 
and the treatment group's mean perceived muscle soreness ratings 
are compared in Table 8. 
Table 6 
Significant Pearson Correlation Coefficients for Changes Over Time 
in Variables-Workout Group 
Change Score 
Vari­ Post- 24 hr- 48 hr- 72 hr- 96 hr- 120 hr-
able Pre Pre Pre Pre Pre Pre 
DOMS - -
CK la 
(0.92) 
la 
(-0.78) 
la 
(-0.77) 
- - - -
la CK 
(0.92) 
CK 
(-0.78) 
CK 
(-0.77) 
ltb4 
(0.75) 
- -
ltb4 — - - — - - la 
(0.75) 
- - - -
pge2 - -
Note: Change scores represent pre-workout values subtracted from 
value obtained for a particular time period. The level of 
significance for coefficients is p < 0.05. 
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Table 7 
Comparison of Plasma CK and PGE? Values for Subject #8 and 
Treatment Group 
Vari­ Pre- Post- 24 48 72 96 120 
able work- work­ hours hours hours hours hours 
out out 
CK #8 385 499 4,234 15,318 32,928 67,692 38,712 
vs. vs vs. vs. 2 vs. vs. vs. 
T.G. CK 54.9 + 189.7 208.8 254.1 737.4+ 1307.+ 1178.+ 
25.4 ±29.4 + 38.6 + 58.4 297.8 617.4 502.4 
PGE2 176 100 106 120 140 486 52 
#8 vs. vs. vs. vs. vs. vs. vs. 
T.G. 60.6 + 63.7 + 60.9 + 83.1 + 59.9 + 81.7 + 80.8 + 
PGE2 14.8 14.0 9.3 10.2 10.2 12.3 12.9 
Note: T. G. = treatment group. CK values are reported in III, and PGE2 
values are reported in pg/ml. The first value represent that of 
subject #8 and the second value represents the mean value and the 
S.E.M from the treatment group. 
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Table 8 
Comparison of Percieved Muscle Soreness Ratings for Subject #8 and 
Treatment Group 
_ .. Pre^ Post- 24 48 72 96 120 
Subject yyorfc. WOrk- hours hours hours hours hours 
out out 
Subject 0.0 2.0 5.0 5.0 5.0 2.0 1.0 
#8 
T.G. 0.3 3.1 6.2 5.0 3.6 2.1 0.7 
Note: T. G. = treatment group. Treatment group values are mean 
(± S.E.M). 
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CHAPTER V 
DISCUSSION 
Novel physical activities, exercise with a strong eccentric 
component, and activites at a high level of intensity or duration have 
been shown to elicit DOMS (Armstrong, 1984; Byrnes & Clarkson, 
1986; Cleak & Eston, 1992; Newham, 1988; Tiidus & lanuzzo, 1983). 
The specific mechanisms which elicits DOMS is currently not known. 
It has been suggested that DOMS may be caused by an inflammatory 
process resulting from muscle and connective tissue damage (Smith, 
1991). Inflammatory mediators, including PGE2 and LTB4, are 
associated with hyperalgesia and pain (Ferreira et al., 1974; Madison 
et al., 1992; Martin et al., 1987; Taiwo et al., 1987). This study 
examined the relationship between changes in plasma levels of PGE2, 
LTB4, and the time course of DOMS after an acute weight lifting bout 
in order to determine if these inflammatory mediators may play a 
role in the generation of DOMS. 
Changes in plasma levels of CK and lactic acid were examined 
in this study in order to determine if the these blood markers 
exhibited changes typically documented in the literature after 
exercise resulting in DOMS. Thus, these measurements served to 
indicate whether a normal response to this type of exercise was 
elicited. 
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Effect of the Weight Lifting Bout on DOMS 
It was hypothesized that the acute weight lifting bout would result 
in the manifestation of DOMS with a time course similar to that 
which has been documented in the literature. In the present study 
the weight lifting bout resulted in perceived muscle soreness 
ratings which increased significantly from the pre-workout mean 
value (0.3 ± 0.7) to a peak mean value of 6.2 ± 0.4 at 24 hours. Mean 
muscle soreness ratings demonstrated significant decreases at 48 
hours (5.0 ± 2.2), 72 hours (3.6 + 2.1), 96 hours (2.1 ±1.5), and 120 
hours (0.7 + 0.9). Except for the mean muscle soreness rating at 120 
hours, these mean values were significantly higher than pre-workout 
values. 
DOMS is usually characterized in the exercise literature as the 
feeling of pain or tenderness in muscles which usually begins 6-24 
hours after exercise, peaks 24 to 48 hours after exercise, and 
gradually subsides over 5-10 days after exercise until the soreness 
is gone (Armstrong, 1984; Clarkson et al., 1986; Ebbeling & Clarkson, 
1989; Miles & Clarkson, 1994; Newham, 1988). There is a rapid 
adaptation to exercise which causes DOMS. A muscle which has been 
used in a prior exercise bout involving eccentric contractions will 
demonstrate a dimunition in DOMS (Byrnes et al., 1985; Donnelly, 
Clarkson & Maughan, 1992). This preventitive effect has been 
observed up to six weeks after the initial exercise bout (Byrnes et 
al., 1985). However, it appears that the initial "protective" 
exercise bout must be separated by the subsequent exercise bout by 
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a time period greater than 48 hours in order for this protective 
response to be manifested (Smith et al., 1994). The subjects 
participating in the present study were all individuals who were 
currently sedentary and had not engaged in resistance training for at 
least eight weeks in order to eliminate any protective effect from a 
previous weight lifting bout. The time course of the perceived 
muscle soreness ratings followed the time course for perceived 
muscle soreness characterized in the literature. Therefore, the 
hypothesis that the acute weight lifting bout would result in the 
manifestation of DOMS with a time course similar to that which has 
been documented in the literature was accepted. 
As previously described, DOMS usually is not manifested until 
several hours after exercise (Ebbeiing & Clarkson, 1989; Friden, 
1984; Miles & Clarkson, 1994; Smith et al., 1994). In the current 
study, the weight lifting bout resulted in a significant perceived 
muscle soreness rating immediately after exercise compared to 
baseline values. This perception of soreness may not be DOMS, but 
the sensation of soreness associated with fatiguing exercise which 
may persist for a short period of time after exercise (Friden, 1984; 
Miles & Clarkson, 1994) This type of soreness or discomfort is 
thought to be the result of activation of pain receptors by 
compounds associated with metabolism in contracting muscle, such 
as lactic acid (Friden, 1984; Miles & Clarkson, 1994; Talag, 1973). 
In the present study, the weight lifting bout resulted in elevated 
plasma levels of lactic acid. This suggests that the soreness 
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experienced immediately after the weight lifting session may have 
resulted from the accumulation of metabolic products of muscular 
contractions, and was not DOMS. 
Effect of the Weight Lifting Bout on CK 
Resting plasma CK values for the workout group (154.9 + 25.4 III) and 
control group (129.6± 24.2 III) were within the normal range of 50-
200 IU/L for males (Tietz, 1995), and similar to resting values in 
males reported by other researchers (Clarkson, Litchfield, Graves, 
Kirwan & Byrnes, 1985; Clarkson & Tremblay, 1988; Paul et al., 
1989) 
Typically, exercise involving a strong eccentric component is 
associated with the manifestation of DOMS and the appearance of CK 
in the circulation (Appell, Soares & Duarte, 1992; Armstrong, 1986; 
Ebbeling & Clarkson, 1989). Exercise such as downhill running 
(Byrnes et al., 1985; Cannon, Fiatarone, Fielding & Evans, 1994; 
Maughan et al., 1989; Schwane et al., 1983), and some forms of 
eccentric exercise isolating a specific muscle group (Clarkson et al., 
1987) have resulted in increased plasma CK within hours after 
exercise, which peak 18- 24 hours later (Byrnes et al., 1985; Cannon 
et al., 1994; Maughan et al., 1989; Schwane et al., 1983). However, 
it appears that exercise involving a repeated eccentric component at 
a high intensity elicits a delayed increase in plasma CK which may 
not occur until 48 hours after exercise and not reach peak levels 
until three to seven days after exercise (Clarkson & Tremblay, 1988; 
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Donnelly et al., 1992; Evans et al., 1986; Manfredi et al., 1991; 
Newham et al., 1986; Saxton & Donnelly, 1995; Smith et al., 1994). 
The MANOVA performed on the CK data indicated that there 
were no significant changes in plasma CK over the time period after 
exercise. On the other hand, t-tests indicated that plasma CK levels 
were significantly elevated immediately after exercise, with 
plasma CK levels peaking at 1307.3+ 617.4 IU/L 96- hours after 
exercise. Plasma CK levels continued to be significantly elevated 
120 hours after exercise (1178+ 502.4 IU/L). Interpretation of the 
plasma CK results is complicated further by the lack of significant 
differences between control group values and treatment group 
values at each time period. However, the conclusion that significant 
increases in plasma CK occurred as a result of the weight lifting 
bout appears to be valid for several reasons. Although there were no 
significant differences found between the control group and workout 
group at any time period at the p < 0.05 level, at 24, 48, 72, 96, and 
120 hours post-exercise the p values approached the p < 0.05 level 
of significance. This is particularly important since the control 
group (n=5) and workout group (n=9) were small. The interpretation 
of the p values as either significant or not significant should be 
done within the context of sample size, with p values slightly larger 
than the pre-determined level of significance indicating a possible 
significant effect when small sample sizes are analyzed (Ludwig, 
1995). 
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Another factor which may have contributed to the statistical 
results is the large inter-subject variability in plasma CK values in 
both the workout and control groups. Moreover, it appeared that the 
subjects in the workout group could be divided into two groups; one 
group which exhibited only small changes in plasma CK and a second 
group which demonstrated larger changes in plasma CK over the 12-
hour time period. Four of the subjects in the workout group 
demonstrated either small increases (less than 50%) or small 
decreases in plasma CK, while the remaining five subjects 
demonstrated peak plasma CK values at least 200% above resting 
values. This phenomena has been observed by other investigators 
examining exercise and plasma CK levels (Clarkson et al., 1986; 
Maughan et al., 1989; Newham, Jones & Edwards, 1983). Maughan et 
al. (1989) described these two groups as low CK responders and high 
CK responders. Maughan et al. observed that although there were no 
significant differences between the subjects in the high CK 
responders and low CK responders in terms of subject 
characteristics, the two groups demonstrated similar response 
patterns for plasma lactate dehydrogenase, thiobarbituric acid 
reactive substances, and aspartate aminotransferase. In the present 
study there were no predictors of high and low CK response for the 
workout group members. The identification of high CK responders 
and low CK responders after exercise confounds the interepretation 
of plasma CK values. 
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The results of the present study seem to support the 
hypothesis that the weight lifting bout will result in increases in 
plasma CK values which will peak 48-120 hours after exercise. 
Furthermore, the CK response in the present study resulting from the 
workout bout was comparable to those reported by other 
investigators. Newham et al. (1986) examined the effect of downhill 
(primarily eccentric) and uphill (primarily concentric) walking on 
plasma CK values. Newham et al. found that subjects walking 
downhill demonstrated plasma CK values ranging from 70-15,000 
IU/L which peaked four-seven days after the exercise bout. Donnelly 
et al. (1992) reported peak CK values around 6000-7000 IU/L 4-5 
days after exercise consisting of 70 maximal contractions of the 
flexor and extensor muscles of the arm. Smith et al. (1984) reported 
peak serum CK values of 3500 IU/L 3-4 days after exercise involving 
the eccentric phase of the Universal® chest press. Clarkson & 
Tremblay (1988) reported that after exercise involving eccentric 
contraction of the forearm flexors, serum CK values peaked around 
2300 IU/L 4-5 days after exercise. Saxton and Donnelly (1995) 
found serum CK to peak at 1553 + 615 IU/L 96 hours after a regimen 
of eccentric exercise using the flexors of the forearm. 
Although much of the research concerning the effects of 
exercise on CK levels in the blood involves eccentric contraction of 
a specific muscle group or a single movement or exercise, research 
exists which has examined the CK response after a multi-exercise 
resistance protocol. In a previous study by Boyer, Lewis & Goldfarb, 
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(1991), the effects of a weight lifting bout on serum creatine 
kinase, lipid peroxidation, and DOMS were examined using a protocol 
identical to the weight lifting protocol used in the present study, 
except for the type of resistance equipment used. In the former 
study, free weights were used, while the present study utilized 
Universal Centurion® exercise equipment. However, the exercises 
used in both protocols were comparable, and, furthermore, the lower 
body muscle groups were exercised on the Universal Centurion® leg 
press in both protocols. In the earlier study plasma CK values did 
not demonstrate significant increases over baseline values until 72 
hours after exercise. Even though ratings of perceived muscle 
soreness were similar in both studies, peak plasma CK values 
resulting from the workout bout in the present study (1307.3 + 617.4 
IU/L) were 249% higher than in the earlier study (374.4+ 130.7 
IU/L). 
Paul et al. (1989) examined the effects of a high-intensity 
weight lifting bout on serum and urinary markers of skeletal muscle 
damage using a protocol similar to the protocol used in the present 
study. Subjects inexperienced with weight training performed a 
weight lifting bout involving six exercises on Universal® resistance 
equipment. The subjects performed three sets on each exercise at 
an intensity of 70-80% of their 1RM until volitional exhaustion. The 
researchers found significant increases in serum CK values 12 and 
24 hours after exercise, with peak values observed at 24 hours 
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(@620 IU/L). Serum CK values were not determined 24 hours after 
exercise. 
Boone et al. (1990), observed that plasma CK was significantly 
elevated above pre-exercise values immediately post-exercise and 
24 hours after exercise following a weight lifting session 
consisting of free-weight squats with a variety of intensities and 
repetitions in experienced weight lifters. However, these elevated 
levels were still within the range for normal resting values (Tietz, 
1995). 
Effect of the Weight Lifting Bout on Lactic Acid 
In the present study, the weight lifting bout resulted in an 
elevation in plasma lactate (10.7+ 1.6 mM) immediately after 
exercise and returned to baseline values by 24 hours. Therefore, the 
hypothesis that the acute weight lifting bout would result in an 
increase in plasma lactic acid values immediately after exercise, 
and return to resting values by 24 hours after exercise was 
accepted. 
Both the weight lifting group and control group exhibited mean 
resting plasma lactate values which fell into the normal resting 
range for plasma lactate values of 0.3-2.4 mM (Hakkinen & 
Pakarinen, 1993; Kraemer et al., 1993; McMillan et al., 1993; Tietz, 
1995). Similar changes in plasma and whole blood lactate values 
immediately after resistance exercise have been reported by other 
investigators. Rozenek et al. (1990) examined the metabolic 
responses resulting from an exercise bout in athletes using anabolic 
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steroid and athletes not using steroids. The researchers found that 
immediately after performing 5 sets of 10 repetitions in the squat 
that in athletes not using anabolic steroids, mean plasma lactate 
values were 12.1 + 1.4 mM. Plasma lactate values continued to be 
elevated 30 minutes after exercise. Plasma lactate values were not 
measured after this time period. 
In another study by Rozenek and co-workers (Rozenek, Rosenau, 
Rosenau & Stone, 1993), subjects performed five sets of 10 
repetitions in the bench press at 70% of their 1RM. Blood lactate 
levels were measured after each set. At the end of the fifth 
exercise (comparable to a post-exercise value) blood lactate was 
approximately 7 mM. Blood lactate levels were not determined after 
this time period. 
Craig & Kang (1994) used a squat workout to determine the 
role of hGH in exercise-induced muscle hypertrophy. In this study 
mean plasma lactate levels immediately after exercise in the group 
performing a squat at 75% of their 1 RM were 11.59 mM. Subjects 
using an intensity of 90% of their 1 RM demonstrated mean plasma 
lactate values of 12.61 mM. Using a similar squat protocol Hakkinen 
& Pakarinen (1993) reported post-workout blood lactate values of 
15.0 + 4.0 mM. 
In a study examining hormonal responses to resistance 
exercise, Kraemer et al. (1990) had one of the treatment groups 
perform a weight lifting workout on Universal® resistance 
equipment with a protocol similar to the exercise protocol used in 
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the present study. The researchers reported mean post-workout 
blood lactate levels in the 8-10 mM range. 
The elevated post-exercise lactate levels reported in the 
present study and other studies involving resistance exercise are 
usually associated with high intensity exercise (Gollnick, Byly & 
Hodgson, 1986; Karlsson & Jacobs, 1982; Rozenek et al., 1993). 
These studies indicate that high-intensity resistance protocols 
consisting of a high number of repetitions (10 or more repetitions) 
per set with short rest periods between sets seem to elicit higher 
blood lactate levels than high-intensity resistance protocols with a 
lower number of repetitions (5 or more repetitions) per set and 
longer rest periods (Kraemer et al., 1993; Kraemer et al., 1990). 
High-intensity resistance training protocols involving a high number 
of repetitions may also elicit higher levels of DOMS than lower 
repetition protocols, due to the greater number of eccentric 
contractions performed (Clarkson & Tremblay, 1988; Tiidus & 
lanuzzo, 1983). The return of plasma lactate to resting levels fairly 
quickly after exercise is typical (Gladden, 1989). 
Effect of the Weight Lifting Bout on PGE2 
Since some investigators have suggested that DOMS may be the 
result of an inflammatory process resulting from exercise-induced 
muscle damage, it has been suggested that PGE2 may play a role in 
DOMS (Smith, 1991). Smith suggested that increases in synthesis of 
PGE2 results in sensitization of pain afferents and an increase in 
plasma levels of PGE2. In the area of cancer research and treatment 
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plasma prostaglandin levels have been used as a diagnostic tool as a 
measure of tumor malignancy and cancer progress (Chiamoff, 
Malachi & Halbrecht, 1985; Matejka, Gisinger, Porteder, Watzek & 
Sinzinger, 1983; Nell, Porteder, Matejka & Sinzinger, 1989; Petit & 
Kort, 1988), since prostaglandins (including PGE2) serve as 
mediators in carcinogenesis (Bockman, 1983; Honn, Bockman & 
Marnett, 1981) and exhibit elevated levels in tissues with malignent 
tumors (Karmali, 1980). 
Likewise, it could be argued that if exercise-induced muscle 
damage which results in DOMS causes increases in PGE2 synthesis in 
the affected muscle tissue, then this increase will be reflected in 
elevated plasma PGE2 levels. Several studies have examined the 
effect of exercise on plasma PGE2 levels. Most of these studies have 
suggested that exercise causes increases in plasma PGE2 (Demers et 
al., 1981; Lijnen et al., 1990; Nowak & Wennmalm, 1978; Zambraski 
& Dunn, 1980). However, these increases were observed in plasma 
samples taken either during exercise or immediately after exercise. 
It is likely that these increases in plasma PGE2 levels are associated 
with the the role which PGE2 plays in the cardiovascular and renal 
processes associated with exercise (Lee & Katayama, 1985; Lijnen 
et al., 1982; Lijnen et al., 1990; Zambraski et al., 1986). Thus, 
elevated PGE2 levels within this context do not seem to be related to 
DOMS. 
Work by Vandenburgh et al. (1990) indicated that mechanical 
stimulation of avian skeletal muscle resulted in increased PGE2 
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synthesis accompanied by muscle damage. It could be hypothesized 
that a similar response may occur in skeletal muscle which has been 
damaged through exercise. However, the increases in PGE2 efflux 
reported by Vandenburgh et al. returned to control levels by 24 
hours. Therefore, it seems that this PGE2 response is not associated 
with the generation of DOMS, since the time course of PGE2 efflux is 
much shorter than that of DOMS. 
Cannon et al. (1991) examined mononuclear cells from blood 
samples obtained from subjects running downhill on a treadmill. 
PGE2 secretion by plasma mononuclear cells was significantly 
increased 1-2 days after exercise (3-4 ng/ml) in subjects ingesting 
a placebo. However, a treatment group ingesting 800 IU of vitamin E 
daily for 48 days prior to exercise did not exhibit increases in 
secretion of PGE2 by the mononuclear cells. The authors attributed 
this lack of statistical significance to a large amount of variablity 
in secretion levels, and indicate that in this group mononuclear cells 
increased PGE2 secretion approximately 260%. The placebo group 
exhibited significant PGE2, and secretion returned to normal five 
days after exercise. These findings may suggests a similar time 
course for PGE2 production and the generation of DOMS. However, 
production of PGE2 by monocytes in the circulation may not be 
indicative of PGE2 secretion by polymorphonuclear cells and 
leukocytes in areas of muscle damage. 
Based on the aforementioned discussion, Smith's hypothesis 
that a relationship between DOMS and PGE2 may be indicated by 
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elevated plasma levels of PGE2 is tenable. In order to determine if 
plasma PGE2 levels increase in association with DOMS, normal 
resting levels of PGE2 must be established. A great deal of variation 
in resting plasma PGE2 values has been reported by investigators. 
Mean resting PGE2 values in the current study were 51.4+ 15.8 pg/ml 
for the control group and 60.6 pg/ml + 14.8 pg/ml for the treatment 
group. Several studies have reported resting PGE2 lower than those 
found in the present study. Dray et al., (1975), found resting plasma 
PGE2 values to fall in the 3-12 pg/ml range. Using gas 
chromatography negative-ion chemical ionization mass 
spectrometry, Schweer, Kammer & Seyberth (1985) reported plasma 
PGE2 values in the 2-12 pg/ml range in healthy males. 
Similarly, Petit & Kort (1988), reported mean resting plasma 
PGE2 levels of 19.3i3.0 pg/ml. Nowak & Wennmalm (1978) found 
mean resting plasma PGE2 values to range from 15 + 4 to 28 + 6 
pg/ml, depending on whether arterial, subclavian, hepatic, renal and 
femoral venous plasma were analyzed. Lijnen and co-workers 
(Lijnen et al., 1982; Lijnen et al., 1990) have reported mean resting 
plasma PGE2 values of 40-60 pg/ml, which are similar to the values 
reported in the present study. Similar resting values of 48.5 pg/ml 
were reported by Rauramaa et al. (1984) 
Resting plasma PGE2 values have been reported in the 
literature which are higher than those reported in the present study. 
Smith et al. (1993) reported mean resting plasma PGE2 values of 326 
+ 137 pg/ml. Resting plasma PGE2 values as high as 1100 pg/ml 
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have been reported in the literature (Demers et al., 1981; Wells, 
1991). 
The wide variation in resting plasma PGE2 values may be due to 
differences in obtaining samples, handling of samples, PGE2 
extraction methodology, and specificity of the assay for PGE2 (Dray 
et al., 1975; Nell et al., 1989; Peskar, 1985; Petit & Kort, 1988; 
Pradelles, Grassi & Maclouf, 1985). In addition, there seems to be 
daily variations in plasma PGE2 values for an individual (Petit & 
Kort, 1988; Sinzinger, 1985) The time of day which the blood 
sample is taken may also influence plasma PGE2 levels (Dray et al., 
1975). In vitro production of PGE2 can be influenced by factors such 
as venous occlusion, diameter of needle used for sampling, the 
presence of a anticoagulant in sampling tube, processing 
temperature, and presence of a cyclooxygenase inhibitor in the 
sampling tube (Kuzuya, Matsuda, Hoshida, Yamagishi & Tada, 1985; 
Nell et al., 1989; Sinzinger, Reiter & Peskar, 1985). It has been 
suggested that elevated eicosanoid values may be the result of 
sample artifact and measurement of PGE2 analogs and metabolites 
(Dray et al., 1975; Granstrom & Kindahl, 1990; Kuzuya et al., 1985; 
Sinzinger, 1985; Stehle, 1982) It appears that resting plasma PGE2 
values at the lower end of the spectrum reflect less in vitro 
production of PGE2 (Simmet, Peskar & Peskar, 1985). 
In the present study it was hypothesized that a high-intensity 
weight lifting bout would result in DOMS which was accompanied by 
increases in plasma PGE2. However, the weight lifting bout did not 
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appear to have any effect on plasma PGE2 values in subjects in the 
treatment group. Analysis of the control group data revealed a 
significant decrease in plasma PGE2 values from 24 to 48 hours 
post-exercise. However, plasma PGE2 levels seem to exhibit a great 
deal of daily fluctuation. Since this decrease represents the only 
significant change found in the plasma PGE2 analysis, it appears that 
this difference may merely represent a daily fluctuation in plasma 
PGE2. Therefore, the hypothesis that the weight lifting bout would 
result in increases in plasma PGE2 which followed a time course 
similar to that exhibited by DOMS was not supported by the results, 
indicating that plasma PGE2 does not contribute to DOMS. 
These findings are in opposition to those reported by several 
investigators examining the relationship between prostaglandins of 
the E series and DOMS. Bansil (1984) examined the effect of 
performing three sets of ten repetitions on the squat exercise at 
67.5% of 1RM on plasma PGE^ Six females and three males between 
the ages of 20 to 30 were used in the study, and were not engaged in 
weight training. Bansil found the workout bout resulted in 
significantly increased plasma PGET values at 24 hours (604.4 
pg/ml) from resting levels (377.25 pg/ml). Bansil also found that 
the maximal decrease in range of motion at the knee joint occured at 
24 hours, and perceived muscle soreness ratings were also elevated 
at this time. Although both PGET and PGE2 are both associated with 
hyperalgesia (Ferreira, 1972; Juhlin & Michaelsson, 1969), PGE2 is 
the prostaglandin most closely associated with increased 
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sensitization of pain afferents and arthritic conditions in the pain 
literature (Bennett, 1988; Bertin et al., 1994; Martin et a!., 1987; 
Mense, 1981; Srivastava & Mustafa, 1992). The effects of PGE2 and 
PGET are very similar. However, PGET is more potent in increasing 
levels of cAMP in human synovial cells in culture than PGE2 (Zurier, 
1990). PGEi inhibits aggregation of human platelets in culture, 
while PGE2 does not (Zurier, 1990). The plasma PGET values which 
Bansil reported are much higher than the plasma PGET values 
reported by other investigators (Dray et al., 1975; Zurier, 1990). 
These higher plasma PGET values may due to sampling technique, 
extraction methodology, and/or interfering substances, as 
previously described. 
Furthermore, PGET has potent vasoactive effects on penile 
vessels. Since levels of PGET are usually very low in blood (Schror, 
1995), the elevated levels reported by Bansel could result in 
frequent spontaneous erections in the subjects (Mantovani, Colombo, 
Edoardo & Austoni, 1995; Porst, 1995; Schror, 1995) 
A study by Wells (1991) sought to determine if therapeutic 
doses of indomethacin, a cyclooxygenase inhibitor, would reduce 
DOMS and the increases in plasma PGE2 which are hypothesized to 
accompany DOMS. Twenty-one untrained male subjects performed a 
weight lifing bout using the eccentric phase of the Universal® chest 
press. Subjects ingested either a placebo or indomethicin (a 
cyclooxygenase inhibitor), beginning 36 hours prior to the exercise 
and through 72 hours post-exercise. Similar increases in DOMS and 
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CK were found in both groups. Plasma PGE2 was significantly lower 
than resting values 96 hours after exercise (1073.62 pg/ml vs. 
461.37 + 319.96 pg/ml). At 120 hours PGE2 returned to baseline 
values. The decrease in plasma PGE2 levels at 96 hours may merely 
reflect the large inter- and intra-subject variability demonstrated 
in the PGE2 values reported in this study. 
In addition, there was no significant difference between the 
plasma PGE2 values of the group taking the placebo and the group 
taking indomethacin. Indomethacin should block the production of 
PGE2, thereby preventing plasma levels of PGE2 from increasing. 
Since this did not occur in this study, the reliability of the plasma 
PGE2 values reported by Wells are questionable. Furthermore, the 
plasma PGE2 values reported in this study, particularly the mean 
resting values, are of a magnitude which are outside the range 
reported for normal plasma PGE2 values in the literature. This 
seems to indicate that in vitro PGE2 synthesis occured in the 
samples or that intefering substances may have artificially elevated 
PGE2 values obtained by the radioimmunoassay. 
In contrast to the present study, Smith et al. (1993) found 
significant increases in plasma PGE2 values concomitant with 
increases in muscle soreness after exercise consisting of the 
eccentric phase of the Universal® chest press. Plasma PGE2 values 
peaked at 24 hours post-exercise (2071 + 319 pg/ml), and returned 
to resting levels by 72 hours post-exercise (326 + 137 pg/ml). 
Likewise, DOMS peaked at 24 hours and remained elevated until 72 
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hours after exercise. Based on these findings, the investigators 
concluded that PGE2 may be a contributing factor to DOMS. 
Although the magnitude and time course of DOMS reported by 
Smith et al. and the present study are similar, the values obtained 
for plasma PGE2 are very different. Smith and co-workers obtained a 
mean resting plasma PGE2 value of 326 ± 137 pg/ml, which is 
substantially higher than the mean resting value of 60.6 ± 14.8 
pg/ml obtained in the present study. This mean resting plasma PGE2 
value is much higher than levels reported in a majority of the 
studies examining plasma PGE2 levels in humans (Dray et al., 1975; 
Lijnen et al., 1990; Nowak & Wennmalm, 1978; Rauramaa et al., 
1984). Furthermore, the changes in plasma levels of PGE2 obtained 
by Smith et al. are of a magnitude which are not reflected by a 
majority of studies examining changes in plasma PGE2 after exercise 
or some other modulating factor. 
Only one study examining the relationship between plasma 
PGE2 values and exercise seems to corroborate the findings by Smith 
and co-workers. Demers et al. (1981) found plasma PGE2 values to 
be elevated from resting levels (1147 + 453 pg/ml to 1674 + 237 
pg/ml) after a 42.4 kilometer run in males and females. 
Although the values reported by Demers et al. (1981) and Smith et al. 
(1993) are similar, Demers et al. found PGE2 values to be elevated 
immediately after exercise, while Smith and co-workers did not find 
increases in plasma PGE2 until 24 hours after exercise. These 
findings may suggest that the elevation in plasma PGE2 reported in 
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these two studies may represent artificial increases in PGE2 due to 
methodological considerations. Granstrom & Kindahl (1990) suggest 
that very high levels of eicosanoids need to be validated by mass 
spectrometry or suppression of the response by a specific inhibitor 
before these values can be classified as real increases. 
Several factors may have contributed to the difference in the 
plasma PGE2 response reported in the present study and the study by 
Smith et al. (1993). One possible cause for the difference in plasma 
PGE2 values is the use of different PGE2 extraction techniques in the 
two studies. In the present study, the samples were passed through 
a solid phase extraction cartridge, while the samples obtained by 
Smith et al. were analyzed using an extraction method which appears 
to not utilize solid phase extraction cartridges (Pennington, 1988). 
Vandenburgh et al. (1990) suggest that the use of C18 cartridges is 
essential for proper extraction of prostanoids when indomethacin is 
used as a cyclooxygenae inhibitor in sample tubes. 
Another difference between the two studies which may have 
led to differing results may be related to the type of exercise 
modality used. In the present study, a typical weight training 
workout was used which utilized the major muscle groups of the 
body. On the other hand, Smith et al. (1993) used an eccentric 
protocol which stressed the chest, shoulders, and arms. Work by 
Nowak & Wennmalm (1978) suggests that plasma PGE2 values can 
vary, depending on what blood vessel they are taken from. The 
eccentric contractions used by Smith et al. to elicit DOMS 
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overloaded areas which included the muscles of the upper arm and 
forearm. The samples were obtained from the antecubital veins of 
the forearm. Since the samples were obtained from an area which 
was exercised intensely, it is possible that PGE2 values obtained 
from this area might be higher than those obtained from blood 
sampled from the forearm after eccentric exercise which did not 
specifically target this area. However, Sinzinger (1985) indicates 
the sampling site is not a factor in PGE2 levels in plasma. Even if 
this was a contributing factor to the the differences in plasma PGE2 
values obtained in the two studies, the magnitude of the difference 
suggests other causitive factors. Based on the sensitivity of plasma 
PGE2 values to blood sampling techniques, storage and handling of 
samples, extraction methodology, and assay sensitivity (Dray et al., 
1975; Granstrom & Kindahl, 1990; Kinoshita et al., 1985; Kuzuya et 
al., 1985; Nell et al., 1989; Petit & Kort, 1988; Powell, 1980; 
Pradelles et al., 1985; Sinzinger, 1985), it is possible that the 
differences in plasma PGE2 values obtained in these two studies may 
be due to differences in the techniques used to isolate and measure 
plasma PGE2 levels. 
Effect of the Weight Lifting Bout on LTB4 
Leukotriene B4 is an arachidonic acid metabolite which plays a 
major role in tissue edema and swelling, microvascular 
permeability, and migration of polymorphonuclear cells and 
monocytes to injured tissue (Barsacchi et al., 1986; Cambria, 
Anderson, Dikdan, Lysz & II, 1991; Hedqvist, Lindbom, Palmerz & 
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Raud, 1994; Hedqvist, Raud, Palmertz, Kumlin & Dahlen, 1990; Lefer, 
1985). Evans (Evans, 1992; Evans & Cannon, 1991), Cannon et al. 
(1991), and Stauber et al. (1990) suggest that exercise-induced 
muscle damage stimulates an inflammatory response which is 
similar to the acute phase response of inflammation. This response 
has been to shown to result in migration of polymorphonuclear cells 
and monocytes into the affected tissue (Armstrong et al., 1983; 
Faulkner et al., 1989; Fielding et al., 1993; Jones et al., 1986; 
O'Reilly et al., 1987; Stauber et al., 1990), increases in endothelial 
and microvascular permeability (Armstrong et al., 1983; Cannon et 
al., 1994; Stauber et al., 1990), and increased levels of cytokines, 
such as IL-1 and TNF-a, which promote changes in protein 
metabolism and other metabolic events (Cannon et al., 1991; 
Dinarello, 1988; Nawabi, Block, Chakrabarti & Buse, 1990). This 
process may be responsible for the efflux of CK (Armstrong et al., 
1983; Cannon et al., 1994; Evans et al., 1986; Virtanen, Viitasalo, 
Vuori, Vaananen & Takala, 1993) and increases in connective tissue 
and muscle markers(Stauber et al., 1990; Virtanen et al., 1993), 
increases in intramuscular pressure (Crenshaw, Thornell & Friden, 
1994; Friden et al., 1988), and possibly DOMS (Armstrong, 1984; 
Evans & Cannon, 1991; Smith, 1991; Stauber et al., 1990). 
Based on the previous discussion, it appears that LTB4 is a 
prime candidate for playing a role in changes in vascular 
permeability, diapedis and migration of leukocytes (Ford-Hutchinson 
& Letts, 1986; Hedqvist et al., 1994; Hedqvist et al., 1990) and the 
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generation of DOMS (Bennett, 1988; Bertin et al., 1994; Levine et al., 
1986; Madison et al., 1992; Martin et al., 1987; Taiwo et al., 1987). 
Therefore, it was hypothesized that LTB4 may play a role in the 
generation of DOMS. This should lead to increases in plasma levels 
of LTB4 which are associated with the time course changes of DOMS. 
Plasma levels of LTB4 have been used to determine the role 
that this leukotriene has in inflammatory conditions, such as 
arthritis and asthma. Thus, baseline or resting levels of plasma 
LTB4 have been established in the literature. However, the range of 
values reported in the literature is quite large. At the upper end of 
the spectrum are the results reported by Ibe, Kurantstin-Mills, Raf & 
Lessin (1994) in a study to determine the role of leukotrienes in the 
inflammatory process in sickle-cell anemia. Ibe et al. (1994) 
reported mean resting plasma LTB4 values of 8.95 + 0.26 ng/ml. 
Much lower plasma LTB4 values were found by Nieminen et al. 
(1991), examining the effects of platelet-activating factor on 
plasma LTB4. They reported mean plasma LTB4 values of 150-180 
pg/ml. Similar results were reported by Nieminen, Moilanen, 
Koskinen, Karvonen & Tuomisto (1992) examining the effects of 
inhaled budesonide to inhibit the platelet-activating factor-induced 
increases in plasma LTB4. Nieminen et al. (1992) reported plasma 
LTB4 levels ranging from 200-800 pg/ml, slightly higher than in 
their previous study, in subjects inhaling a dilutent control. 
In contrast to these findings, Shindo, Miyakawa & Fukumura 
(1993) measured changes in plasma levels of LTB4 during bronchial 
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asthma. They reported mean resting levels in controls of 23.5 + 3.77 
pg/ml, and mean LTB4 levels in asthmatic patients of 34.2 + 3.77 
pg/ml prior to their asthma attacks. During the asthma attacks 
mean plasma LTB4 values were 118.0 + 49.5 pg/ml. Unlike the other 
studies cited which sampled venous blood from the antecubital vein 
of the forearm, Shindo and Fukumura sampled arterial blood from the 
femoral artery. Nowak & Wennmalm (1978) reported differences in 
plasma PGE2 values depending on whether arterial or venous 
sampling was used, Work by Sinzinger (1985) has suggested that 
there is no difference in eicosanoid measurement when samples are 
either taken from the femoral artery or an antecubital vein. 
Simmet et al. (1985) has suggested that normal levels of 
plasma leukotrienes are in the low pg/ml range. This would seem to 
indicate that the values reported by Shindo et al. (1993), are more 
accurate in representing normal plasma LTB4 values. This idea is 
also suggested by the work of Bertin et al. (1994) examining the 
inflammatory response mediators in human rheumatoid synovial 
fluid. Bertin et al. found LTB4 levels in the synovial fluid of the knee 
joint of patients suffering from rhuematoid arthritis accompanied 
by swollen knees to be around 500 pg/ml. This may indicate that the 
higher values reported by Nieminen (Nieminen et al. 1992; Nieminen 
et al., 1991) and Ibe (Ibe et al., 1994) may not reflect normal plasma 
LTB4 levels. 
It is possible that sampling and handling techniques 
(Granstrom & Kindahl, 1990; Nell et al., 1989; Sinzinger, 1985), and 
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extraction methodology (Kinoshita et at., 1985; Kuzuya et al., 1985), 
may have contributed to the differences in plasma LTB4 levels 
reported in the literature. Of particular importance in relation to 
the elevation of plasma LTB4 levels is that blood samples collected 
in tubes with heparin, and to some extent sodium citrate, as an 
anticoagulant may demonstrate artificially elevated eicosanoid 
levels (Granstrom & Kindahl, 1990; Nell et al., 1989; Sinzinger, 
1985). Heparin is associated with nonspecific intereferences in 
analyses associated with specific antibodies (Granstrom & Kindahl, 
1990; Sinzinger, 1985). Thus, the differences in plasma LTB4 values 
reported in the preceeding studies may be, in part, due to the use of 
heparin as an anticoagulant by Nieminen and co-workers (Nieminen 
et al., 1992; Nieminen et al., 1991), and to some extent by the use of 
sodium citrate by Ibe et al. (1994). 
It was hypothesized that the weight lifting bout would result 
in increases in plasma levels of ltb4 which will exhibit a time 
course similar to that of DOMS over the 120-hour time period. In the 
present study, resting plasma LTB4 values were 15.3 + 3.4 pg/ml in 
the treatment group and 14.4 + 3.9 pg/ml in the control group. These 
values are similar to the results reported by Shindo et al.( 1993). 
According to the MANOVA performed on the plasma LTB4 values, 
there was a significant treatment effect. However, a comparison of 
post-exercise values with resting values and values at succesive 
time periods did not demonstrate any individual differences. No 
significant differences between values for the treatment group and 
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control group were found. Furthermore, there was not a great deal 
of inter- and intra-individual variation in plasma LTB4. Therefore, it 
appears that the significant p-value generated by the MANOVA is not 
a result of actual changes in plasma LTB4 values. Therefore, the 
hypothesis that the weight lifting bout would result in increases in 
plasma levels of ltb4 which will exhibit a time course similar to 
that of DOMS over the 120-hour time period was rejected. Thus, it 
seems that plasma levels of LTB4 are not associated with the 
generation of DOMS. 
Currently the present study is the only research to examine the 
relationship between plasma levels of LTB4 and DOMS resulting from 
a weight lifting bout which is associated with muscle damage. 
However, Cannon et al. (1991) examined the effect of damaging 
eccentric exercise on in vitro production of mediators of 
inflammation, including pge2 and LTB4, by mononuclear cells in 
plasma from individuals supplemented with vitamin E. Cannon et al. 
found that PGE2 production was significantly increased after 
exercise in subjects not supplemented with vitamin E. However, the 
LTB4 concentrations measured in the mononuclear cell cultures were 
not presented by the authors because they determined that the 1-10 
pg/ml concentrations were at a level that might be due to cross-
reaction with the prostaglandins in the culture. Based on the results 
of the present study, these values might be deemed appropriate. 
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Correlations Among the Variables 
Several significant correlations were found in the present 
study between change scores for the variables at a specific time 
period. Significant correlations were found between changes in 
plasma lactate and CK values from resting values immediately after 
exercise (r= 0.92), 24 hours (r= -0.78), and 72 hours (r= -0.77) after 
exercise in the treatment group. A significant correlation was also 
found between plasma lactate and LTB4 (r=0.77) 72 hours after 
exercise. The significant correlations at 24 hours and 72 hours 
between elevated CK levels and lactate values which had returned to 
baseline values do not seem to be relevant. Additionally, the 
significant correlation between lactate values at baseline levels and 
LTB4 at 72 hours does not appear to be pertinent. 
Other researchers have examined the correlations among 
functional and biochemical markers of exercise-induced muscle 
damage. Rodenburg, Bar & Boer (1993) examined correlations 
between plasma CK, myoglobin, DOMS, and extension and flexion 
angle of the elbow after forced extension and flexion of the elbow. 
No significant correlations were found between any of the variables. 
Tiidus & lanuzzo (1983) found a significant correlation (r=0.80) 
between changes in serum CPK activity and changes in the magnitude 
of soreness perception after exercise on a leg extension apparatus. 
This significant relationship was attained by finding the regression 
line for a plot of each group mean score for changes in serum CPK 
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activity and muscle soreness for nine exercise treatment groups and 
one control group. 
The significant correlation between the post-exercise changes 
in plasma lactate and CK appears to be realistic. However, 
interpretation of the CK data is somewhat difficult. A higher post-
exercise plasma lactate value might indicate that a particular 
subject was performing the weight lifting bout at a higher level of 
effort than subjects with lower plasma lactate values. However, 
McMillan et al. (1993) found no difference in plasma lactate values 
between subjects experienced with weight training and untrained 
subjects after a single bout of weight training exercise. 
Schwane et al. (1983) found that downhill running elicited 
increases in plasma CK without any significant changes in lactate 
dehydrogenase activity. Furthermore, they reported there was not a 
significant correlation between LDH activity and plasma CK. Thus, 
the value of the significant correlation between post-exercise 
plasma lactate and CK is questionable. In conclusion, the 
correlations which were hypothesized between DOMS and PGE2, DOMS 
and LTB4, CK and pge2, LTB4 and CK, and PGE2 and LTB4 were rejected. 
The hypothesis that there would not be significant correlations 
between lactate and DOMS, and CK and DOMS was accepted. 
A relationship between plasma CK and PGE2 values was 
suggested by the data from subject #8. Because this subject's CK 
values were at a level associated with muscular disorders 
(Anneslet, Strongwater & Chnittzir, 1985; Stags, 1981; Yasmineh, 
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Abahin, Abbashezhand & Awad, 1978), this subject's values were not 
included in the analyses of the treatment group means. In addition, 
the PGE2 values in this subject seemed to demonstrate time course 
changes similar to those exhibited by plasma CK values over the 
120-hour time period. Furthermore, these PGE2 values were 
substantially higher than those exhibited at rest for the treatment 
group. PGE2 has been shown to play a role in regulation of the 
inflammatory response and is an important regulator of the immune 
response (Roper & Phipps, 1994). Elevated PGE2 production has been 
associated with a number of pathological conditions (Barsacchi et 
al., 1986; Bockman, 1983; Roper & Phipps, 1994; Strobl-JSger, 
Widhalm & Sinzinger, 1986) Therefore, it is possible that there is a 
connection between the changes exhibted in these two variables. 
As previously described the plasma PGE2 changes after the 
workout in subject #8 were substantially higher than the mean 
values in the treatment group. This particular subject also had the 
highest post-exercise lactate value in the treatment group- 17.1 
mM. Values for plasma LTB4 were not measured in this subject, so it 
is not known whether plasma LTB4 levels were elevated in this 
subject. 
Contrary to the elevation in PGE2, subject # 8 reported a peak 
muscular soreness rating of five, from 24 to 72 hours after 
exercise. This is in contrast to a mean peak soreness rating of 6.2 
for the treatment group (Table 6). The hypothesis that increases in 
plasma PGE2 levels were associated with DOMS would predict that 
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subject #8 would experience the most severe intensity of DOMS, 
since he demonstrated the highest PGE2 values. However, other 
subjects reported higher muscle soreness ratings than those 
reported by subject #8, and subject #8's peak soreness rating was 
lower than the mean peak soreness rating. The DOMS and plasma 
PGE2 responses of subject #8, combined with the lack of change in 
the mean plasma PGE2 levels over the 120-hour post-exercise time 
period in the treatment group, provide an arguement that plasma 
PGE2 levels are not associated with the generation DOMS. 
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CHAPTER VI 
CONCLUSIONS AND RECOMMENDATIONS 
The results of the present study indicate that plasma PGE2 and 
LTB4 values do not show increases concominant with the 
manifestation of DOMS after an acute weight lifting bout involving 
eccentric contractions. This suggests that PGE2 and LTB4 probably 
do not contribute to DOMS. However, there is a body of research 
which suggests that these inflammatory mediators may contribute 
to DOMS. Therefore, further investigation into the relationship 
between prostaglandins, leukotrienes, and DOMS in the process of 
muscle damage and repair resulting from exercise is warranted. 
Due to the large variability in baseline levels of plasma PGE2 
and LTB4 exhibited in the present study and in the eicosanoid 
literature, a larger sample size would enhance the ability of the 
study to elucidate changes in the inflammatory mediators as a 
result of the exercise treatment. Based on the experimental design 
the use of seven sampling periods requires three times as many 
subjects as sampling periods (D. Ludwig, personal communication, 
November 9, 1995) in order to maximize statistical power. Thus, 21 
subjects would be an appropriate number of subjects to use in future 
studies with a similar paradigm. Furthermore, it may be important 
to investigate these parameters in an older population, since the CK 
response has been shown to vary, depending on age (Canon et al., 
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1990). 
Since arachidonate and other C20 fatty acids such as a-
linolenate and linoleate are precursors to eicosanoids (Murray, 
Granner, Mayes, and Rodwell, 1990), and dietary intake of these 
fatty acids may influence eicosanoid synthesis. Therefore, future 
studies should monitor the food intake of subjects while 
participating in this type of investigation. This may help reduce the 
variability seen in studies measuring plamsa prostaglandins and 
leukotrienes. 
In the present study subjects only rested for 10 minutes prior 
to blood sampling. It appears that to minimize intra- and inter-
subject variability not attributable to a treatment effect, it is 
important to have the subjects resting for 30 minutes prior to blood 
sampling (Nell et al., 1989; Sinzinger, 1985). Stringent adherence to 
optimal processing, handling, and extraction of samples would 
decrease in vitro production of prostaglandins and help minimize the 
variability associated with measurement of eicosanoids. 
Since PGE2 and LTB4 in the bloodstream are rapidly removed 
from the circulation and metabolized (Granstrom & Kindahl, 1990; 
Keppler, Jedlitschky & Leier, 1994), plasma changes in these 
eicosanoids may be difficult to detect. However, changes in plasma 
LTB4 and PGE2 resulting from a treatment effect may be easier to 
detect through the measurement of longer-lived metabolites of PGE2 
and LTB4 which are more likely to accumulate in the circulation 
(Granstrom, Hamberg, Hansson & Kindahl, 1980; Keppler et al., 1994). 
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Thus, the effects of eccentric exercise on DOMS and these stable 
metabolites should be examined in order determine if plasma PGE2 
and LTB4 reflect the involvement of these eicosanoids in the 
generation of DOMS. 
Although plasma PGE2 and LTB4 appear to indicate there is no 
change in these eicosanoids after exercise-induced muscle 
associated with DOMS, plasma values of PGE2 and LTB4 may not 
reflect tissue levels of PGE2 and LTB4. For example, Evans et al. 
(1986) hypothesized that muscle damage resulting from eccentric 
exercise would result in increased plasma levels of IL-1, a cytokine 
which is a mediator of the acute phase response of inflammation. 
Their research demonstrated that plasma IL-1 levels were 
significantly elevated in untrained subjects 3-hours after eccentric 
exercise, but returned to baseline values by 24 hours. Since the 
onset of DOMS does not usually appear until 24 hours after exercise, 
increases in plasma IL-1 do not follow the same time course as the 
manifestation of DOMS. This indicates that plasma IL-1 was not 
associated with DOMS. Like PGE2 and LTB4, IL-1 is rapidly cleared 
from the circulation (Dinarello, 1988). Hence, IL-1 levels in the 
tissue may be elevated for a longer period of time, thereby, 
promoting components of the inflammatory response which may 
contribute to the manifestation of DOMS. Work by Cannon et al. 
(1989a), validated this contention by demonstrating increased levels 
of IL-1 five days after eccentric exercise. 
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Therefore, it is possible that even though plasma levels of 
PGE2 and LTB4 do not show changes immediately after and 24 hours 
after exercise with an eccentric component, tissue levels of these 
eicosanoids may be elevated. Thus, the systemic levels of these 
inflammatory mediators may not reflect PGE2 and LTB4 activity in 
muscle tissue after exercise which generates DOMS. Future research 
should examine levels of PGE2 and LTB4 in muscle tissue which has 
undergone eccentric contractions which have resulted in DOMS over a 
time period of at least 120 hours. 
The relationship between these eicosanoids and DOMS could 
also be studied using the rat model. Although rats are unable to 
report muscle soreness, Armstrong (Armstrong, 1984; Armstrong et 
al., 1983) has used a rat model to document muscle damage resulting 
from eccentric exercise. Levels of PGE2 and LTB4 could be examined 
in terms of their role in exercise induced muscle damage and repair. 
This would provide information as to the possible role these 
inflammatory mediators play in this adaptive process. The rat 
model provides for a larger sample number and more experimental 
control than with human subjects. 
Future research in this area could also utilize inhibitors of the 
lipoxygenase and cyclooxygenase pathways to determine if DOMS is 
affected by decreased levels of these compounds in muscles 
experiencing soreness. This technique could also be used in the rat 
model to determine if lower levels of PGE2 and/or LTB4 affect the 
normal morphology of muscle damage and repair. 
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Future studies should also examine other biochemical 
mediators and modulators associated with pain and the 
inflammatory process. Bradykinin, histamine, substance p, 
interleukin-lp and 5-hydroxytryptamine are several substances 
which may be involved in the response to mechanical forces during 
muscle contraction which cause muscle damage (Evans & Cannon, 
1991; Fritz & Stauber, 1988; Stauber, 1989; Stauber et al., 1988). 
Accumulation of these substances in areas of muscle damage may 
either directly stimulate pain afferents or increase sensitivity of 
these pain afferents (Bennett, 1988; Ferreira, Lorenzetti, Bristow & 
Poole, 1988; Mense, 1981; Taiwo et al., 1987). 
Currently it is believed that DOMS is but one component of the 
repair and adaptation process which occurs in skeletal muscle when 
it is exposed to unaccustomed mechanical forces or activities. An 
understanding of the mechanisms associated with the generation of 
DOMS will provide some insight into the role which DOMS plays in 
this process and the processes involved in this adaptive process. In 
a clinical setting, this information may provide some understanding 
of the mechanisms involved in the manifestiation of pain in 
rheumatoid arthritis and other painful pathologies. Furthermore, a 
more thorough understanding of this entire damage and adaptation 
process may provide information which can be utilized in the 
treatment of degenerative muscular diseases (Lewis & Haller, 1989) 
and regeneration of muscle fibers damaged by mechanical or 
chemical trauma, ischemia, and other physiological insults (Carlson 
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& Faulkner, 1983; White & Devor, 1993). Therefore, investigation of 
the mechanisms underlying exercise-induced muscle soreness have a 
wide range of implications and merit further intensive study. 
In summary, this study investigated the relationship of plasma 
levels of PGE2, LTB4, CK, lactic acid, and DOMS over 120-hours after 
an acute weight lifting bout involving eccentric contractions in 
order to determine if PGE2 and/or LTB4 contribute to DOMS. This 
study reported no significant increases in plasma PGE2 and LTB4 
after the workout. However, significant increases in plasma CK, a 
marker of muscle damage, were seen immediately after exercise, 
and 3-5 days after exercise. Plasma lactate was significantly 
elevated post-exercise, but returned to baseline values thereafter. 
Muscle soreness was significantly elevated above resting levels 
immediately after exercise, peaking at 24 hours, and finally 
returning to resting levels by 120 hours after exercise. Based on 
these results it appears that PGE2 and LTB4, as indicated by plasma 
levels of these eicosanoids, does not appear to be a factor in the 
generation of DOMS resulting from a weight lifting bout involving 
eccentric contractions. 
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Consent Form for Human Subjects 
THE UNIVERSITY OF NORTH CAROLINA AT GREENSBORO 
SCHOOL OF HEALTH, PHYSICAL EDUCATION AND RECREATION 
Subject's Name: 
Project Title: The Relationship Among Prostaglandin Ez, 
Leukotriene B4, and Delayed Onset Muscle Soreness 
Project Supervisor: Dr. Allan H. Goldfarb, Associate Professor 
Project Coordinator: Brian Boyer, Doctoral Candidate, 
Department of Exercise and Sport Science 
I understand that the purpose of this study is to investigate 
the relationship between delayed onset muscle soreness (DOMS), 
prostaglandin Ez, and leukotriene B4 resulting from a weight lifting 
bout. Whereas this study may not directly benefit me, it may 
advance knowledge in the field of exercise physiology. 
I understand that during the study I will report to the Human 
Performance Laboratory (HPRD 240), for at least seven visits. 
During the first visit I will perform a one-repetition maximum test 
on the following weight training exercises: bench press, triceps 
pushdowns, military press, biceps curls, leg press, and wide grip 
pulldowns. I understand that a one-repetition maximum test 
involves attempting to overcome the most resistance I can with 
maximal effort on these exercises. I understand that during the one-
repetition maximum test I may experience some muscular 
discomfort and I may experience some muscle soreness after the 
testing procedure(24-72 hours). I understand that I will not take any 
medications or other action to reduce the intensity of the soreness. I 
understand that I will contact Brian Boyer before seeking medical 
treatment or if I feel I am experiencing severe muscular pain. I 
understand that I will contact Brian Boyer if I experience any 
stressful situations to which I am not normally accustomed. I 
understand that during this test I will be continuously supervised by 
the researchers in order to insure that proper weight lifting safety 
techniques are being utilized during testing. 
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I understand that I will return to the lab at least two weeks 
after the first testing session for the weight lifting session in a 
fasted state. I understand that upon entering the lab, two 10 
milliliter blood samples will be taken from my antecubital vein, 
located in the elbow region, by venapuncture with a Vacutainer. I 
understand that insertion and removal of the needle may be slightly 
painful, but that the pain will quickly subside. I understand that 
there may be some bruising associated with procurement of a blood 
sample, as well as some risk of infection. However, I also 
understand that the risk of bruising will be minimized since direct 
pressure will be applied to the area upon removal of the needle. In 
addition, I understand that the risk of infection will be minimized 
since only sterile techniques will be used. I understand that after 
the blood sample has been collected that I will begin the weight 
lifting session. I understand that during this session I will perform 
the following exercises: bench press, triceps pushdowns, behind the 
neck press, biceps curls, leg press, and wide grip pulldowns. I 
understand that I will perform three sets of each exercise. 
Additionally, I understand that I will perform as many repetitions as 
possible until muscular failure using a resistance of 70% of my 
one-repetition maximum for each set on a particular exercise. I 
understand that I will be provided with adequate instruction on how 
to properly perform each exercise which will be utilized during the 
weight lifting session. In addition, I understand that I will be given 
a proper warm-up before attempting maximal exertion on each 
exercise, as well as being constantly monitored by the researchers 
throughout the weight lifting session. I understand that 
performance of the exercises during this session may result in some 
muscular discomfort and may provide some muscle soreness for 
several days after the weight lifting session. I understand that 
immediately after the weight lifting session another blood sample 
will be taken in exactly the same manner as the previous blood 
sample. 
I understand that I will return to the laboratory every day for 
the next five days at approximately the same time at which I 
performed the weight lifting session. I understand that during these 
visits blood samples will be taken in exactly the same manner as 
the previous blood samples. 
I confirm that my participation in this study is completely 
voluntary, and that no coercion of any kind has been used to obtain 
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my cooperation. I also understand that I can withdraw my consent 
and terminate my participation in this study at any time. I 
understand that all information obtained in this study will remain 
confidential and anonymous. I understand that a summary of the 
results of the study will be made available to me, per my request, 
after completion of this study. 
I confirm that I have been informed of the procedures that will 
be used in this study. I understand what is required of me as a 
subject, i agree that any questions I have regarding this study and 
the procedures have been answered to my satisfaction; and, I wish to 
give my voluntary cooperation as a participant. 
Signature of Subject Phone Number 
Address 
Witness 
Date 
APPENDIX B 
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Subject Medical History Questionnaire 
1. Has you doctor ever said you have any kind of heart trouble? 
Yes No 
2. Do you frequently have pains in your heart and/or chest or have 
abnormal heart beats? 
Yes No 
3. Do you often feel faint or have spells of severe dizziness? 
Yes No 
4. Has a doctor ever said that you have high blood pressure? 
Yes No 
5. Has a doctor ever indicated that you have a joint or bone problem 
(e.g., arthritis) that has been caused or made worse by exercise 
or that might be made worse with exercise? 
Yes No 
6. Are you unaccustomed to vigorous exercise? 
Yes No 
7. Do you smoke cigarettes? Yes No 
8. Has your father, mother, sister, or brother had any heart trouble 
or strokes before age 50? 
Yes No 
If yes, who and what type of problem? 
9. Has your doctor ever indicated that your cholesterol was/is high? 
Yes No 
10. Do you have diabetes? Yes No 
11. Have you ever had back pain/problems which lasted more than 
one week? Yes No 
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If yes, briefly describe. 
12. Do you presently exercise? Yes No 
If yes, how many days per week? how many hours/day? 
Type of exercise? 
13. Are you currently taking any prescription medications? 
Yes No 
If yes, please explain: 
14. Are you currently taking any over-the-counter medications? 
Yes No 
If yes, please explain: 
15. Has your mother, father, sister, or brother ever had high 
cholesterol, died suddenly, or died prematurely? 
Yes No 
If yes, please explain: 
15. Is there any good physical/mental reason not mentioned here 
why you should not follow a physical activity program even if 
you wanted to? 
Yes No 
If yes, please explain:. 
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17. Are you currently taking any type of supplements? If so, please 
list: 
18. Have you recently been involved in any experiences which you 
consider to be of an unusually stressful nature? If yes, please 
explain: 
19. Have there been any events which have occured recently 
in your life which you consider to be unusual? If yes, please 
explain: 
APPENDIX C 
(SUBJECT INSTRUCTIONS) 
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Instuctions For Weight Lifting Study Participants 
(Please post in a prominent place) 
1. If you are experiencing muscle soreness which you feel is 
inappropriate, immediately call me at school or at home. 
2. Do not take any medications or any other action to alleviate 
muscle soreness. 
3. If you are going to seek any type of medical treatment, please 
inform me prior to visiting a medical professional. 
4. Do not take any type of supplements or new medications during 
the study. 
5. If you have any questions at all regarding the study, please do 
not hesitate to call me. 
Thank you again for your participation in this study. If you 
attempt to reach me at home or at school and I am unavailable, 
please leave a message on my answering machine at home or contact 
Dr. Allan Goldfarb, the faculty director of this research study. 
Brian Boyer 
Home phone number: 282-8141 
School phone number: 334-3039 
Dr. Allan Goldfarb: 334-3029 
APPENDIX D 
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IRM TESTING SESSION 
Name Date Subject 
1 RM 70% IRM 
Bench press 
Triceps pushdowns 
Military press 
Biceps curls 
Leg press 
Wide grip pulidowns 
APPENDIX E 
(WEIGHT LIFTING SESSION FORM) 
193 
WEIGHT LIFTING SESSION 
Name Date Subject 
Exercise Weight Setl Reps Set 2 Reps Set 3 Reps 
Bench press 
Triceps pushdown 
Military press 
Bicep curls 
Leg press 
Wide grip 
pulldowns 
APPENDIX F 
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Perceived Muscle Soreness Rating Scale 
0 1 2 3 4 5 6 7 8 9 1 0  
normal mildly sore very sore very, very, sore 
On the following diagram, circle the areas which seem to be the 
most sore. 
APPENDIX G 
(T-VALUES AND P-VALUES FOR T-TESTS) 
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Table 9 
T-Test Values and p-Values for Differences in POMS Ratings Values 
over 120 Hours in the Treatment Group 
pre post 24 48 72 96 120 
pre I 3.49 12.16 31.36 3.88 3.69 1.41 
pre b 0.008 .0001 .0005 .0046 .0061 .1950 
post 
post 
I 
b 
3.49 
0.008 
- - 3.9 
.004 
- - - - - - - -
24 t 12.16 3.9 -2.81 
24 b 0.008 .004 .023 
48 t 31.36 -2.81 -4.91 
48 b .0005 .023 .0012 
72 I 3.88 -4.91 -3.02 
72 b .0046 .0012 .016 
96 I 3.69 -3.02 -3.77 
96 b .0061 .016 .005 
120 I 1.41 -3.77 
120 P .1950 .005 
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Table 10 
T-Test Values and p-Values for Differences in CK Values over 120 
Hours in the Treatment Group 
pre post 24 48 72 96 120 
pre I 3.83 1.67 1.54 1.95 1.96 2.16 
pre B .0025 .067 .081 .044 .043 .032 
post 
post 
I 
B 
3.83 
.0025 
.55 
.30 
24 T 1.67 .55 .90 
24 B .067 .30 .20 
48 T 1.54 .90 1.98 
48 E .081 .20 .041 
72 T 1.95 1.98 1.98 
72 B .044 .041 .042 
96 T 1.96 1.98 -0.97 
96 B .043 .042 .92 
120 T 2.16 -0.97 
120 B .032 .92 
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Table 11 
T-Test Values and p-Values for Differences in Lactate Values over 
120 Hours in the Treatment Group 
pre post 24 48 72 96 120 
pre I 6.06 .39 .18 .18 -0.89 -2.12 
pre e .0003 .70 .86 .86 .40 .067 
post 
post 
I 
e 
6.06 
.0003 
- - -5.84 
.0004 
24 T .39 -5.84 -0.13 
24 e .70 .0004 .90 
48 T .18 -0.13 0.0 
48 e .86 .90 1.0 
72 I .18 0.0 -0.85 
72 e .86 1.0 .42 
96 I -0.89 -0.85 -0.85 
96 B .40 .42 .42 
120 T -2.12 -0.85 
120 e .067 .42 
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Table 12 
T-Test Values and p-Values for Differences in PGE2 Values over 120 
Hours in the Treatment Group 
pre post 24 48 72 96 120 
pre I -0.04 -0.42 .84 -0.13 1.18 .76 
pre e .97 .69 .43 .90 .28 .48 
post 
post 
I 
e 
-0.04 
.97 
-0.17 
.87 
24 T -0.42 -0.17 1.81 
24 e .69 .87 .11 
48 T .84 1.81 -2.18 
48 e .43 .11 .065 
72 T -0.13 -2.18 2.39 
72 e .90 .065 .048 
96 T 1.18 2.39 -0.78 
96 e .28 .048 .46 
120 T .76 -0.78 
120 p .48 .46 
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Table 13 
T-Test Values and p-Values for Differences in LTB1 Values over 120 
Hours in the Treatment Group 
pre post 24 48 72 96 120 
pre I -0.88 -1.54 -0.11 .60 1.39 .40 
pre b .40 .16 .91 .57 .20 .70 
post I -0.88 -1.55 
post b .40 .16 
24 I -1.54 -1.55 1.14 
24 b .16 .16 .29 
48 T -0.11 1.14 .37 
48 P .91 .29 .72 
72 I .60 .37 1.28 
72 b .91 .72 .23 
96 I 1.39 1.28 -0.71 
96 b .20 .23 .50 
120 I .40 -0.71 
120 b .70 .50 
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Table 14 
T-Test Values and p-Values for Differences in POMS Rating Values 
over 120 Hours in the Control Group 
pre post 24 48 72 96 120 
pre I -1.0 0.0 0.0 -1.0 -1.0 
pre e .37 1.0 1.0 .37 .37 
post I 
post B 
24 T -1.0 1.0 
24 e .37 .37 
48 T 0.0 1.0 
48 e 1.0 .37 
72 I 0.0 -1.0 — 
72 e 1.0 .37 
96 I -1.0 -1.0 
96 e .37 .37 
120 T -1.0 
120 B .37 
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Table 15 
T-Test Values and p-Values for Differences in CK Values over 120 
Hours in the Control Group 
pre post 24 48 72 96 120 
pre I -0.69 .20 -0.60 -0.40 .77 
pre E .53 .85 .58 .71 .48 
post I 
post P 
24 T -0.69 .66 
24 p .53 .54 
48 I .20 .66 -0.75 — 
48 p .85 .54 .49 
72 I -0.60 -0.75 .21 — 
72 p .58 .49 .84 
96 I -0.40 .21 .79 
96 p .71 .84 .47 
120 I .77 .79 
120 p .48 .47 
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Table 16 
T-Test Values and p-Values for Differences in Lactate Values over 
120 Hours in the Control Group 
pre post 24 48 72 96 120 
pre I -1.11 .17 -1.73 -2.58 .16 
pre E .35 .87 .16 .061 .88 
post I 
post D 
24 I -1.11 .90 
24 e .35 .43 
48 I .17 .90 -1.63 — 
48 e .87 .43 .18 
72 I -1.73 -1.63 .11 - -
72 c .16 .18 .91 
96 I -2.58 .11 1.30 
96 e .061 .91 .26 
120 I .16 1.30 
120 B .88 .26 
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Table 17 
T-Test Values and p-Values for Differences in PGE2 Values over 120 
Hours in the Control Group 
pre post 24 48 72 96 120 
pre I 1.62 .16 .97 .74 
pre e .24 .89 .51 .59 
post I 
post D 
24 T 1.62 -4.60 
• 24 e .24 .044 
48 T .16 -4.60 .91 
48 C .89 .044 .46 
72 I .97 .91 1.17 
72 E .51 .46 .45 
96 I 1.17 — -2.05 
96 e .45 .29 
120 I .74 -2.05 - -
120 .59 .29 
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Table 18 
T-Test Values and p-Values for Differences in LTB1 Values over 120 
Hours in the Control Group 
pre post 24 48 72 96 120 
pre I 1.86 1.20 .31 .54 -0.53 
pre e .13 .29 .77 .62 .62 
post I 
post n 
24 T 1.86 -0.54 
24 J2 .13 .62 
48 T 1.20 -0.54 -0.36 
48 e .29 .62 .74 
72 T .31 -0.36 .29 
72 e .77 .74 .78 
96 T .54 .29 -0.83 
96 e .62 .78 .45 
120 T -0.53 -0.83 
120 P .62 .45 
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Table 19 
T-Test Values and p-Values for Differences Between Control and 
Treatment Groups for the Variables at Specific Time Periods 
Variable pre post 24 48 72 96 120 
DOMS I .38 10.50 4.45 3.34 3.29 1.46 
DOMS e .71 .0001 .0008 .0059 .0064 .17 
CK t .39 1.48 1.37 1.53 1.48 1.59 
CK B .35 .082 .098 .076 .082 .069 
Lactate I -0.49 .59 -0.34 .98 -0.01 -1.48 
Lactate e .63 .57 .74 .35 .99 .16 
pge2 t .33 -0.63 1.93 -0.35 .39 1.27 
pge? e .75 .54 .080 .74 .71 .23 
ltb4 I .16 -1.58 -0.22 .18 .59 .98 
ltb* p .87 .14 .83 .86 .56 .34 
APPENDIX H 
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Raw Data for Subject #1 
Height (cm) 
Weight (Kg) 
Age (years) 
175.3 
59.1 
27 
Pre Post 24 48 72 96 120 
DOMS 
(0-10) 
CK 
(IU/L) 
0 3 9 10 8 4 0 
113 131 167 125 259 474 502 
LA 
(mM/L) 
pge2 
(pg/ml) 
0.9 6.0 1.3 0.8 0.8 1.1 0.8 
107.4 47.5 108.5 86.6 97.6 151.8 158.7 
LTB4 
(pg/ml) 9.7 12.0 7.4 8.4 6.5 13.2 8.8 
Raw Data for Subject #2 
Height (cm) 167.6 
Weight (Kg) 63.6 
Age (years) 27 
Pre Post 24 48 72 96 120 
DOMS 
(0-10) 
CK 
(IU/L) 
0 0 0 0 0 0 
204 186 244 204 247 221 
LA 
(mM/L) 0.9 1.0 0.6 0.7 0.4 0.7 
pgez 
(pg/ml) 
ltb4 
(pg/ml) 
60.2 60.0 39.9 
20.1 29.8 18.1 26.0 25.2 22.9 
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Raw Data for Subject #3 
Height (cm) 
Weight (Kg) 
Age (years) 
177.8 
81.8 
22 
DOMS 
(0-10) 
CK 
(IU/L) 
LA 
(mM/L) 
PGE2 
(pg/ml) 
LTB4 
(pg/ml) 
Pre 
0 
68 
2.1 
73.4 
25.9 
Post 24 48 72 96 120 
0 0 0 0 0 
94 68 102 83 91 
1.9 2.0 1.4 1.9 1.4 
91.8 80.8 72.5 91.3 69.3 
28.3 31.6 29.2 28.2 10.4 
Raw Data for Subject #4 
Height (cm) 
Weight (Kg) 
Age (years) 
167.6 
52.3 
21 
DOMS 
(0-10) 
CK 
(IU/L) 
LA 
(mM/L) 
PGE2 
(pg/ml) 
LTB4 
(pg/ml) 
Pre Post 24 48 72 96 120 
0 4 5 2 2 0 0 
84 90 82 75 78 78 78 
1.2 5.7 2.1 0.9 1.4 0.7 0.8 
72.6 9.3 31.9 27.2 31.8 50.4 74.4 
19.4 0.2 4.4 10.2 22.4 18.2 19.0 
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Raw Data for Subject #5 
Height (cm) 
Weight (Kg) 
Age (years) 
190.5 
86.4 
28 
DOMS 
(0-10) 
CK 
(IU/L) 
LA 
(mM/L) 
PGE2 
(pg/ml) 
LTB4 
(pg/ml) 
Pre Post 24 48 72 96 
0 6 6 3 2 1 
145 215 124 233 262 219 
1.33 16.6 1.7 0.9 1.3 1.1 
36.5 61.2 44.2 70.5 20.5 34.3 
9.7 10.6 6.1 8.7 6.0 7.8 
Raw Data for Subject #7 
(data not used in mean analysis) 
Height (cm) 185.4 
Weight (Kg) 74.1 
Age (years) 27 
120 
0 
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1.1 
6.6 
DOMS 
(0-10) 
CK 
(IU/L) 
LA 
(mM/L) 
PGE2 
(pg/ml) 
LTB4 
(pg/ml) 
Pre Post 24 48 72 96 
3 4 5 4 4 2 
85 135 1974 3844 11,058 19,458 
1.2 16.6 1.1 1.1 0.8 0.8 
120 
1 
,238 
1.0 
DOMS 
(0-10) 
CK 
(IU/L) 
LA 
(mM/L) 
PGE2 
(pg/ml) 
LTB4 
(pg/ml) 
DOMS 
(0-10) 
CK 
(IU/L) 
LA 
(mM/L) 
PGE2 
(pg/ml) 
LTB4 
(pg/ml) 
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Raw Data for Subject #8 
(data not used in mean analysis) 
Height (cm) 175.3 
Weight (Kg) 79.5 
Age (years) 21 
Pre Post 24 48 72 96 120 
0 2 5 5 5 2 1 
385 499 4,234 15,318 32,928 67,692 38,712 
0.9 17.1 1.6 1.7 1.7 2.1 1.0 
176 100 106 120 140 507 52 
Raw Data for Subject #9 
Height (cm) 185.4 
Weight (Kg) 90.5 
Age (years) 19 
Pre Post 24 48 72 96 120 
0 4 7 6 4 2 0 
59 109 126 287 2,420 4,826 3,814 
1.4 15.8 1.5 2.2 0.6 2.0 1.7 
50.9 158.9 65.2 94.7 61.2 58.7 31.8 
36.7 23.8 19.5 23.5 32.4 32.8 20.6 
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Raw Data for Subject #10 
Height (cm) 
Weight (Kg) 
Age (years) 
180.3 
77.3 
20 
DOMS 
(0-10) 
CK 
(IU/L) 
LA 
(mM/L) 
PGE2 
(pg/ml) 
LTB4 
(pg/ml) 
Pre 
1 
90 
1.3 
7.4 
Post 24 48 72 96 120 
0 0 0 0 0 
99 90 96 78 84 
1.2 1.0 0.7 1.3 
41.4 48.7 50.2 42.8 
12.1 5.6 6.1 12.0 8.1 
Raw Data for Subject #11 
Height (cm) 185.4 
Weight (Kg) 74.1 
Age (years) 23 
DOMS 
(0-10) 
CK 
(IU/L) 
LA 
(mM/L) 
PGE2 
(pg/ml) 
LTB4 
(pg/ml) 
Pre Post 24 48 72 96 
0 2 5 4 2 1 
147 148 82 66 83 85 
0.8 4.0 1.2 2.1 2.3 0.8 
29.5 41.1 67.7 52.3 64.3 
4.4 7.6 8.6 6.1 9.8 25.4 
120 
0 
87 
0.7 
67.1 
8.2 
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Raw Data for Subject #13 
Height (cm) 
Weight (Kg) 
Age (years) 
182.9 
80.0 
21 
DOMS 
(0-10) 
CK 
(IU/L) 
LA 
(mM/L) 
PGE2 
(pg/ml) 
LTB4 
(pg/ml) 
Pre Post 24 48 72 96 120 
0 0 1 1 0 0 
128 106 129 85 83 250 
1.8 0.9 2.1 1.0 1.4 2.6 
14.2 11.6 18.0 6.3 6.9 7.8 
Raw Data for Subject #14 
Height (cm) 
Weight (Kg) 
Age (years) 
178.0 
73.0 
27 
DOMS 
(0-10) 
CK 
(IU/L) 
LA 
(mM/L) 
PGE2 
(pg/ml) 
LTB4 
(pg/ml) 
Pre Post 24 48 72 96 120 
0 5 5 4 3 2 0 
264 283 275 275 544 902 1,331 
0.9 12.3 1.2 0.6 1.0 0.9 0.7 
55.8 44.7 48.2 77.3 100.1 97.0 96.9 
8.7 7.3 8.3 10.9 11.7 5.6 26.4 
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Raw Data for Subject #15 
Height (cm) 
Weight (Kg) 
Age (years) 
190.5 
94.5 
21 
DOMS 
(0-10) 
CK 
(IU/L) 
LA 
(mM/L) 
PGE2 
(pg/ml) 
LTB4 
(pg/ml) 
Pre 
0 
216 
0.9 
40.6 
18.9 
Post 
1 
281 
15.6 
69.9 
25.7 
24 48 72 96 120 
6 6 5 4 2 
311 169 187 203 247 
0.8 1.8 1.6 1.3 0.9 
85.5 123.0 50.7 119.5 64.4 
24.5 17.7 27.5 30.3 29.2 
Raw Data for Subject #16 
Height (cm) 
Weight (Kg) 
Age (years) 
188.0 
88.6 
32 
DOMS 
(0-10) 
CK 
(IU/L) 
LA 
(mM/L) 
PGE2 
(pg/ml) 
LTB4 
(pg/ml) 
Pre Post 24 48 72 96 120 
2 0 6 4 1 2 2 
102 124 334 499 2,113 4,222 3,680 
2.5 10.4 1.5 1.6 1.6 1.2 1.7 
2.0 92.0 18.9 120.5 72.0 69.4 77.4 
22.3 17.6 12.0 41.1 20.1 29.1 20.8 
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Raw Data for Subject #17 
Height (cm) 
Weight (Kg) 
Age (years) 
175.3 
84.1 
26 
Pre Post 24 48 72 96 120 
DOMS 
(0-10) 
CK 
(IU/L) 
LA 
(mM/L) 
pge2 
(pg/ml) 
LTB4 
(pg/ml) 
0 - - 0  0 0 0 0 0 
158 126 128 117 125 110 
0.9 0.9 1.2 1.2 1.0 1.2 
20.7 63.9 39.1 77.2 45.0 
4.5 - - 8.8 8.4 8.4 5.8 12.2 
Raw Data for Subject #18 
Height (cm) 167.6 
Weight (Kg) 64.5 
Age (years) 27 
Pre Post 24 48 72 96 120 
DOMS 
(0-10) 
CK 
(IU/L) 
1 3 7 6 5 4 2 
264 326 378 558 691 757 666 
LA 
(mM/L) 
pge2 
(pg/ml) 
1.4 10.1 0.7 0.8 1.1 0.6 0.6 
149.9 48.8 77.8 95.4 45.5 89.6 75.6 
ltb4 
(pg/ml) 8.0 10.7 9.2 8.3 9.5 9.4 9.4 
